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Abstract
Musculoskeletal (MSK) conditions are a leading cause of pain and disability worldwide. Reha-
bilitation is critical for recovery from these conditions and for the prevention of long-term disability.
Robot-assisted therapy has been demonstrated to provide improvements to stroke rehabilitation in
terms of efficiency and patient adherence. However, there are no wearable robot-assisted solutions
for patients with MSK injuries. One of the limiting factors is the lack of appropriate models that
allow the use of biosignals as an interface input. Furthermore, there are no models to discern the
health of MSK patients as they progress through their therapy.
This thesis describes the design, data collection, analysis, and validation of a novel muscle
health model for elbow trauma patients. Surface electromyography (sEMG) data sets were col-
lected from the injured arms of elbow trauma patients performing 10 upper-limb motions. The
data were assessed and compared to sEMG data collected from the patients’ contralateral healthy
limbs. A statistical analysis was conducted to identify trends relating the sEMG signals to muscle
health.
sEMG-based classification models for muscle health were developed. Relevant sEMG features
were identified and combined into feature sets for the classification models. The classifiers were
used to distinguish between two levels of health: healthy and injured (50% baseline accuracy
rate). Classification models based on individual motions achieved cross-validation accuracies of
48.2–79.6%. Following feature selection and optimization of the models, cross-validation accuracies
of up to 82.1% were achieved.
This work suggests that there is a potential for implementing an EMG-based model of muscle
health in a rehabilitative elbow brace to assess patients recovering from MSK elbow trauma.
i
ABSTRACT ii
However, more research is necessary to improve the accuracy and the specificity of the classification
models.
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Chapter 1
Introduction
Musculoskeletal (MSK) conditions are disorders or injuries that affect the bones, joints, skeletal
muscles and/or connective tissues. MSK conditions are a dominant cause of long-term pain and
disability, affecting over 1.2 billion people worldwide [1] and 11 million Canadians annually [2].
MSK injuries are often chronic, and are responsible for 21% of the total years lived with disability
in the world [3]. Patients without adequate rehabilitation may suffer pain and disability for years.
This results in significant time lost from work, and psychological suffering for both the patient
and their family. Prolonged periods of disability also increase the risk of inactivity-associated
conditions including cardiovascular disease, diabetes, cancer, osteoporosis, and depression [2].
MSK conditions impose a significant burden on the Canadian economy. In 2010, MSK disorders
were estimated to cost the Canadian economy over $22 billion per year, and MSK injuries were
estimated to cost $15 billion per year [2]. Direct costs including hospitalization, doctor visits,
drugs, and private expenditures represented 20% of the total annual cost. Over 80% of the cost
was due to time lost from work [2].
Obesity and old age are both major risk factors for MSK conditions. With obesity anticipated
to rise over the coming decade, and with a demographically aging global population, the incidence
of MSK conditions is expected to increase concomitantly worldwide [3]. By 2031, an estimated
15 million Canadians will be affected annually by MSK conditions [2]. Innovative strategies and
treatments must be developed to reduce the imminent burden of these conditions on the economy
and on health care and social care systems. A potential area of innovation is in the development
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of technologies to assist with rehabilitation and mobility.
1.1 Motivation
Robotic devices have the potential to improve rehabilitation outcomes. Robot-assisted therapy
is currently employed for upper-extremity rehabilitation for patients suffering from neurological
disorders, primarily stroke. These devices assist patients with performing the repetitive exercises
required for stroke rehabilitation and decrease the amount of time therapists spend manually
assisting patients [4]. However, these devices are typically expensive, stationary, and confined to
the clinic. Mechatronic braces for patients with neurological disorders have been developed to
assist with mobility and to provide resistance during therapy [5]. These wearable devices allow
patients to perform exercises at home and at their own convenience.
There are currently no smart robotic devices that can assist patients recovering from MSK
injuries, despite the numerous potential improvements to the convenience and economy of therapy
that such devices could provide. Low adherence to rehabilitation exercises is an ongoing barrier to
patient recovery. Patients may fail to adhere to rehabilitation programs as a consequence of a lack
of sufficient education and training, or an unwillingness to adhere to regimens that require major
lifestyle changes [6]. Supervised exercise programs are more successful than home exercise programs
in terms of patient adherence and recovery [4, 7, 8], however these programs require the time and
attention of a therapist. Supervised exercise programs are also less accessible for Canadians who
live in rural areas and are unable to regularly travel to visit a qualified professional. Wearable
robotic rehabilitation devices could allow patients to perform therapy exercises independently,
thus mitigating accessibility issues. As well, comparable outcomes to supervised exercise programs
could be provided at a reduced cost.
An ideal rehabilitative smart device for MSK injuries would be capable of objectively deter-
mining a patient’s muscle health as they heal. This would allow for more accurate and objective
measurements of health, and would allow therapists to develop treatment recommendations and
rehabilitation exercises for individual patient requirements. Furthermore, the amount of mechan-
ical assistance provided by a smart brace to the patient could be modified based on the patient’s
1.2 General Problem Statement 3
health.
Electromyography (EMG), the study of the electrical currents generated during muscle contrac-
tion, offers the potential to provide a wearable rehabilitation device with muscle health assessment
capabilities. Quantitative EMG analysis is an established diagnostic tool for patients with nerve
damage and skeletal muscle damage [9], and there is some evidence that EMG data from patients
with MSK injuries conforms to patterns that distinguish the level of injury [10–12]. Little work
has been done, however, to quantify EMG data collected from patients with MSK injuries for use
in rehabilitation robots. Further research is necessary in order to develop an EMG-based model
for health that can be implemented in a wearable device to assess patient muscle health and to
inform individualized therapies.
1.2 General Problem Statement
Wearable robotic devices have the potential to improve MSK patient rehabilitation outcomes, and
to reduce the cost of rehabilitation. However, there is a lack of research towards identifying EMG
patterns associated with MSK patient health. Autonomous assessment of patient muscle health is
necessary to 1) improve diagnostics, 2) allow for the development of individualized therapies specific
to a patient’s level of health, and 3) create objective outcome measures to inform evidence-based
rehabilitation practices.
The purpose of this work is to identify patterns in EMG data that represent the injury levels of
patients with MSK elbow injuries. This work proposes that classification models based on EMG
data be implemented into the control system of a robotic device to identify the level of muscle
health in patients with MSK elbow injuries and to respond accordingly.
1.3 Research Objectives and Scope
This thesis specifically focuses on identifying and classifying patterns of muscle health based on
EMG data for patients recovering from MSK elbow trauma. A database of EMG signals was
collected from patients with MSK elbow injuries at several stages of healing. A control group of
data from healthy limbs was developed.
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The primary objectives of this thesis are as follows:
1. To acquire and analyze EMG data from patients with MSK elbow injuries while they perform
rehabilitation exercises.
2. To acquire and analyze EMG data from a control group of healthy subjects.
3. To evaluate and generalize the differences in EMG data between the healthy and injured
groups.
4. To identify EMG features that are best for evaluating muscle health.
5. To develop a decision system to predict patient muscle health.
6. To evaluate the decision system using new patient data.
1.4 Overview of the Thesis
The structure of this thesis is as follows:
Chapter 1 Introduction: The introductory chapter.
Chapter 2 Literature Review: A review of elbow anatomy, elbow trauma rehabilitation,
robotic rehabilitation, muscle physiology, and EMG signal acquisition,
processing, and analysis.
Chapter 3 Data Collection and Processing: Outlines the methods of EMG data
collection and processing including equipment specifications, data collection
protocol, and methods of data processing and data analysis.
Chapter 4 Results and Discussion: Presents the results of the data analysis and explains
their significance.
Chapter 5 Concluding Remarks: Highlights the contributions of this work, and provides
recommendations for future work.
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Appendix A Permissions and Approvals: Includes ethics permission and approval, consent
form, trial form, and permissions for images.
Appendix B MATLAB Code: Describes the MATLAB codes used for EMG analysis.
Chapter 2
Literature Review
2.1 Introduction
This chapter presents a review of the literature in the areas of elbow anatomy (Section 2.2),
elbow rehabilitation (Section 2.3), robotic rehabilitative devices (Section 2.4), muscle physiology
(Section 2.5), EMG (Section 2.6), surface EMG signal acquisition and processing (Section 2.7),
and EMG signal analysis, including EMG feature extraction and classification (Section 2.8). The
literature review provided a background into elbow rehabilitation processes and the procedure
for collecting, processing, and analyzing surface EMG signals. A literature search was conducted
using Google Scholar from September 2016 to August 2018. The keywords used in the search
included combinations of the following: elbow rehabilitation, EMG features, EMG control, elbow
rehabilitation. A total of 120 papers and books were incorporated into the literature review.
2.2 Elbow Anatomy
The elbow is a critical component of the upper body. The elbow functions as the point of rotation
for the forearm, as a link in the lever system that positions the hand in space, and as a load-
carrying joint [13]. The elbow also allows for powerful grasping and fine motions of the hand and
wrist. The loss of elbow function severely impacts the activities of daily living [14]. This section
describes the anatomy of the elbow.
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Figure 2.1: Anterior (left) and lateral (right) views of the right elbow. Reprinted, with permission,
from [15].
The elbow is generally considered a trochoginglymoid joint with two degrees of freedom:
flexion–extension and pronation–supination. The range of motion (ROM) for elbow flexion–
extension is 0–140 ± 10 degrees. The ranges of pronation and supination are 75 degrees and
85 degrees respectively. The elbow also exhibits varus–valgus motion during flexion and extension.
The axis of elbow flexion follows a helical motion of 3 to 4 degrees during a flexion–extension arc.
2.2.1 Osteology and Articulations
Three bones articulate at the elbow: the humerus, the ulna, and the radius. The humerus is the
single long bone from the shoulder to the elbow. In standard anatomical position, the ulna is
found in the medial forearm and the radius is found in the lateral forearm (Figure 2.1). These
bones provide the following three articulations: 1) ulnohumeral (ulnotrochlear), 2) radiohumeral
(radiocapitellar), and 3) proximal radioulnar. The ulnohumeral articulation resembles a hinge
(ginglymus) and allows for flexion and extension. The radiohumeral and proximal radioulnar
articulations allow for pivoting (trochoid) motion [13]. The three articulations are covered with a
single joint capsule [16].
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The distal humerus contains two condyles that form the articular surfaces of the trochlea and
the capitellum, which interact with the ulna and radius respectively. The trochlea articulates with
the sigmoid notch of the proximal ulna. The capitellum articulates with the radial head of the
radius [14].
The proximal radioulnar articulation is the major articulation of the elbow and provides sta-
bility [13]. The articulation between the radial head and the capitellum is also an important elbow
stabilizer [17].
2.2.2 Elbow Ligaments
The two major ligaments of the elbow are the medial and lateral collateral ligaments. The medial
collateral ligament provides valgus stability to the elbow and is a stabilizer of the ulnohumeral
joint during flexion [16]. The lateral collateral ligament is the primary ligament for providing
elbow stability, particularly to the radial head and lateral side of the elbow [17].
The lateral epicondyle, located at the capitellum, is the source of attachment for the lateral
collateral ligament and the supinator–extensor muscle groups. The medial epicondyle, located at
the trochlea, is the source of attachment for the medial collateral ligament and the flexor–pronator
muscle groups [13].
2.2.3 Elbow Muscles
The muscles that cross the elbow joint are summarized in Table 2.1. The primary elbow flexors are
the brachialis, biceps brachii, and brachioradialis. The secondary elbow flexors are the pronator
teres, extensor carpi radialis longus, and flexor carpi radialis. The primary elbow extensors are
the triceps brachii and the anconeus at the posterior of the elbow [18].
Pronation of the forearm is performed by the pronator teres and pronator quadratus. Forearm
supination is performed by the biceps and the supinator. The flexor–pronator muscles are located
at the medial elbow, and the extensor–supinator muscles are located in the lateral elbow [18].
The majority of the muscles crossing the elbow also provide forearm rotation and flexion–
extension of the wrist and fingers [18].
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Table 2.1: Summary of muscles crossing the elbow joint [14,19].
Muscle Origin Insertion Level Action
Posterior Elbow
Triceps
brachii
Scapula (Long Head)
Humerus (Lateral
and Medial heads)
Olecranon Superficial Elbow extension
Anconeus Lateral epicondyle Proximal ulna Intermediate Elbow extension,
abduction, and
stabilization
Extensor carpi
ulnaris
Lateral epicondyle Fifth metacarpal Superficial Wrist extension,
ulnar deviation
Extensor
digitorum
communis
Anterolateral
epicondyle
Extensor
mechanism of
each finger
Intermediate Metalcarpal
phalangeal joint
extension
Lateral Elbow
Extensor carpi
radialis
Lateral epicondyle
(brevis)
Lateral supra-
condylar ridge
(longus)
Third
metacarpal (brevis)
Second
metacarpal (longus)
Superficial Wrist extension,
radial deviation
Brachioradialis Lateral supra-
condylar ridge
Distal radius Superficial Elbow flexion
with forearm in
neutral rotation
Supinator Lateral epicondyle Proximal radius Deep Forearm
supination
Medial Elbow
Flexor
digitorum
superficialis
Medial epicondyle,
Proximal radius
Middle phlanges
of the fingers
Superficial/
Intermediate
Flexion of
proximal
interphalangeal
joints
Flexor
digitorum
profundus
Medial olecranon,
Proximal ulna
Distal phlanges
of the fingers
Deep Flexion of distal
interphalangeal
joints
Anterior Elbow
Biceps brachii Scapula Radius (bicepital
tuberosity)
Superficial Elbow flexion,
forearm
supination
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Prontator teres Medial epicondyle Pronator tuberosity
of radius
Superficial Forearm
pronation, weak
elbow flexion
Flexor carpi
radialis
Medial epicondyle Second and third
metacarpals
Superficial Wrist flexion,
weak forearm
pronation,
radial deviation
Palmaris longus Medial epicondyle Palmar aponeurosis Superficial Wrist flexion
Flexor carpi
ulnaris
Medial epicondyle Pisiform and fifth
metacarpal
Superficial Wrist flexion,
ulnar deviation
Brachialis Deltoid tuberosity Ulna
Superficial/
Deep
Elbow flexion
2.3 Elbow Trauma Rehabilitation
Due to the elbow’s complex anatomy, rehabilitation from elbow trauma is a challenging process.
The elbow capsule is prone to thickening, contracture formation, and stiffening following trauma
[16]. Furthermore, there is no standard guideline or protocol for elbow rehabilitation [20]. Most of
the scientific evidence to support rehabilitation approaches is based on retrospective and case series
studies with small sample sizes, not on randomized control trials (RCTs) [20, 21]. Rehabilitative
procedures tested are often poorly described and unreproducible [20]. However, there is expert
consensus and some weak clinical evidence to support certain rehabilitative approaches [22]. This
section reviews the existing methods of rehabilitation for elbow trauma, and the ongoing challenges
of rehabilitation.
2.3.1 Elbow Trauma and Surgical Rehabilitation
The rehabilitation methods used for recovery from elbow trauma and surgical procedures depend on
the stages of healing. These can be divided into the healing stage, and the functional rehabilitation
stage [20].
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2.3.1.1 Healing Stage: 0–6 weeks
In early stages of recovery from elbow injury or surgery, the elbow tissues undergo an inflammatory
phase. Elbow trauma typically impacts the lymphatic system of the elbow, resulting in edema. The
primary focus during this stage is on pain and edema management [20,22]. Rest, ice, compression,
and elevation (RICE) are used to manage pain and edema. Lymphatic drainage is an important
step for early rehabilitation [16].
Early mobilization is recommended to improve articular homeostasis, reduce edema and hema-
toma, and to progressively improve the ROM [20, 23]. Active ROM (AROM) and active assisted
ROM (AAROM) exercises are introduced at this stage [22]. ROM exercises influence collagen re-
modeling to ensure full motion of the joints, and to improve venous return and lymphatic drainage,
which reduces pain and edema.
Active elbow motion with the forearm in pronation is recommended following damage or repair
to the lateral collateral ligament. If both collateral ligaments are damaged, early active motion
with the forearm in midprone or neutral rotation is preferable [16].
2.3.1.2 Functional Rehabilitation Stage: 6–12 weeks
The primary focus of the later stage of rehabilitation is to restore elbow function [20,22]. This stage
can be further divided into the “intermediate stage of recovery” and the “advanced strengthening”
stages [20].
The intermediate stage of recovery involves a focus on restoring elbow extension and forearm
pronation [20]. Heat modalities such as hot packs or whirlpool treatments are used to increase
the plasticity of the tissues and make them amenable to stretching. Strengthening exercises are
performed to enhance the collagen orientation and the elongation of musculotendinous and capsular
tissues [16]. Exercises during the intermediate stage of recovery include stretches, functional
exercises, AROM, AAROM, and passive ROM (PROM) [20, 22]. Forearm pronation–supination
exercises are performed actively with the elbow at 90 degrees. AROM exercises of the shoulder,
wrist, and fingers are also performed throughout the rehabilitation program. Static progressive
splinting may be used to improve the ROM [16]. The required ROM for performing the activities
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of daily living is 30–130 degrees. Ranges of 50 degrees for pronation and supination are required
for performing the activities of daily living [13].
The advanced strengthening stage introduces strengthening exercises to reduce muscle weakness
[20, 22]. Muscle weakness due to pain, soft tissue injury, and/or immobilization, is a common
problem following an elbow fracture. Muscle weakness can persist up to 6 months following injury,
long after bone healing has occurred, and impacts everyday tasks such as grasping and lifting [22].
Strengthening exercises should not be introduced prematurely, particularly in older patients, as
this could place excessive stresses on the healing bone. It is recommended to begin strengthening
when the ROM is complete and painless and the power is at least 70% of the contralateral limb [20].
Typically, strengthening is begun after 8 to 12 weeks in complex fractures. There is no consensus,
however, with respect to the ideal dosage and type of strengthening exercises [16]. The American
College of Sports Medicine recommends performing 1–3 sets of 6–12 repetitions per exercise, at
80% of the one repetition maximum load that can be lifted by the patient, 3 times per week [24].
2.3.1.3 Rehabilitative Braces
There are several types of elbow braces that may be required during elbow trauma rehabilitation,
as follows [25]:
1. Immobilization braces are used to protect the limb by restricting movement. They are used
at the beginning of treatment. The amount of time an immobilization brace is worn should
be kept to a minimum.
2. Restriction braces allow for early movement, but provide protection by restricting the ROM
within a specified range of flexion and extension.
3. Mobilization braces exert forces on soft tissue, and are used to maintain or increase the ROM.
These are typically used during Weeks 2–8 of recovery, often to treat stiff elbow.
2.3.2 Specific Rehabilitation Practices
The specific rehabilitation practices and exercises performed depend on the type of injury to the
elbow. This section describes recommended practices with respect to common elbow traumas.
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2.3.2.1 Radial Head Fractures
Radial head fractures are the most common type of elbow fractures. Rehabilitation is similar
for both operative and nonoperative treatments. The ROM exercises performed typically include
forearm rotation with the elbow at 90 degrees of flexion, and elbow extension and flexion with
the forearm in pronation. ROM exercises are performed at a frequency of 10–15 repetitions per
hour. Strengthening exercises begin after 8 weeks. Elbow flexion–extension with the forearm in
pronation is performed, with the weight gradually increasing [16].
2.3.2.2 Elbow Dislocations
Elbow dislocation rehabilitation focuses on protecting the collateral ligaments and slowly increasing
the ROM by performing AROM exercises. Patients are splinted at 90 degrees of flexion for 5–7
days. If the elbow is stable, full active motion is permitted. If the elbow is unstable, full flexion is
permitted, and extension is slowly increased each week [16].
2.3.2.3 Arthroscopic Debridement
Arthroscopic surgical procedures are performed for loose body removal, synovectomy, contracture
release, radial head excision, and lateral epicondylitis debridement for tennis elbow. Rehabilitation
is similar to open surgical procedures in terms of treating pain and edema. The major difference
is that rehabilitation can start immediately following the procedure. AROM may be started on
the same day as the surgery. Continuous passive motion (CPM) exercises should start as early as
possible to improve tissue extensibility [26].
2.3.2.4 Stiff Elbow
The elbow capsule is prone to thickening, contracture formation, and stiffening following trauma
[16]. Stiff elbow is a common complication following elbow surgery or injury due to the decreased
compliance of the joint capsule. On a biochemical level, the joint capsule experiences structural
alterations in collagen crosslinks, decreased proteoglycan content, and decreased water content
[20]. However, the viscoelasticity of soft tissue in the elbow allows ligaments to regain their
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original length following injury. Stretching forces are exerted on the tissues by progressive splints
to stimulate tissue adaptation. PROM and AROM exercises are employed to increase tissue
length [27].
2.3.2.5 Bicep Tendon Tears
Distal bicep tendon tears typically result from an acute eccentric load on a flexed elbow. Patients
with a distal biceps tear suffer asymmetrical weakness in supination and elbow flexion [28]. Surgery
is typically performed to treat the tear, as nonoperative treatments result in reduced strength.
There is limited research on the optimal methods of bicep tear rehabilitation following surgery.
The current protocol is to maintain the arm in a sling for 3 to 5 days to minimize pain and edema.
Afterwards, early ROM exercises are introduced with a weight restriction. After 3 months, flexion
and supination exercises are performed [29].
2.3.3 Elbow Rehabilitation Challenges
Ongoing challenges for traditional rehabilitative approaches include a lack of patient adherence to
therapy, and the lack of evidence-based rehabilitation methods and objective outcome measures.
2.3.4 Adherence to Therapy
Patient adherence to therapy requires collaboration between the patient and the therapist to
produce the therapeutic result [30]. Non-adherence to therapy increases the risk of disability,
and reduces the effectiveness of the treatment [6]. Patient education is essential for adherence
to treatment during all phases of healing from elbow trauma [22]. Social determinants of health
(SDOH) including race, culture, poverty, illiteracy, unemployment, lack of social support, distances
from treatment, family problems, and the cost of travel and treatment are associated with factors
that affect adherence to long-term therapies [30].
2.3.5 Assessment and Outcome Measures
The most frequent assessment methods used by therapists throughout elbow rehabilitation include:
radiographs, ROM, functional performance assessments, strength assessments, and assessments of
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the presence of swelling and pain [22].
The outcome measures most commonly used by therapists include: goniometry, dynamometry,
and manual muscle testing (MMT) [22]. The current outcome measures often depend on the
therapist’s perspective. Subjective outcome measures pose difficulties for researchers who aim to
assess the effectiveness of a particular therapy.
Patient questionnaires to rate elbow pain and function include the DASH (disabilities of the
arm shoulder and hand) outcome measure, in which patients score items on a 5 point scale. The
American Shoulder and Elbow Surgeons elbow scale (ASES-e) consists of a patient questionnaire
and an assessment from the physician [31]. Finally, the Patient Rated Elbow Evaluation (PREE)
allows patients to rate pain, and their ability to perform specific activities and usual activities on
an 11 point scale [32].
2.4 Robotic Rehabilitation
The previous section described traditional elbow trauma rehabilitation methods and identified
challenges with these methods. Robot-assisted rehabilitation offers potential solutions to the chal-
lenges of patient adherence and the development of objective outcome measures. Robotic devices
can assist patients with performing multiple repetitions of exercises. Robotic rehabilitation could
also lead to more objective outcome measures of patient health. This section describes the prior
art and efficacy of robot-assisted rehabilitation.
2.4.1 Prior Art
A number of robotic systems have been developed to assist patients with rehabilitation and move-
ment. These devices were designed for patients with neurological disorders (e.g., stroke) [4]. The
key robotic rehabilitation devices are described below.
2.4.1.1 Stationary Robotic Systems
The robotic rehabilitation systems developed for stroke rehabilitation are primarily exoskeletons
attached to large stationary workstations. Stroke patients must perform repetitious exercises
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during their rehabilitation. Robot-assisted therapy allows patients to repeat exercises many times
and remain motivated, while reducing the time burden on the therapist. Table 2.2 summarizes the
major rehabilitative upper-limb exoskeleton systems.
Table 2.2: Summary of rehabilitative upper-limb exoskeleton systems.
Name DOF Shoulder Elbow Wrist
Commercial
Availability
Motion
Assistance
ARAMIS [33] 6 X X — — X
ABLE [34] 4 — X X — X
ArmeoPower [35] 7 X X X X X
ArmeoSpring [36] 8 X X X X —
EXO-UL7 [37] 7 X X X — X
CAREX [38] 7 X X X — X
IntelliArm [39] 6 X X X — X
BOTAS [40] 6 X X X — X
ALEx [41] 6 X X X — X
L-Exos [42] 4 X X X — X
Major commercially available upper-limb exoskeletons for stroke rehabilitation include the
ArmeoPower robot (commercial version of the ARMin III [35]) and the ArmeoSpring (commercial
version of the T-WREX [36]), both distributed by Hocoma [43]. The ArmeoPower is a 7 degree
of freedom (DOF) exoskeleton that assists with movement in the shoulder, elbow, and wrist.
Angular sensors and a grip pressure sensor determine when the patient is unable to perform
an exercise so that assistance-as-needed can be provided in response to individual requirements.
The ArmeoPower was designed for stroke patients in early stages of rehabilitation, and enables
the patient to perform repetitive therapeutic exercises to relearn motor function. Games are
integrated into the system to provide motivation during training [43]. The ArmeoSpring is an 8
DOF system designed for an intermediate stage of recovery from stroke. The ArmeoSpring allows
for simultaneous training of the shoulder, elbow, wrist, and hand. Games are also incorporated
into the device to improve patient motivation [43].
Stationary exoskeleton systems are beneficial because they provide a more controlled environ-
ment for patient movement, which allows for multiple DOF to be safely implemented into the
system, enabling patients to perform movements that closely approximate natural motion. How-
ever, the rehabilitative exercises can only be performed at a clinic [4]. Wearable rehabilitation
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devices could assist patients with performing the activities of daily living, and allow rehabilitation
exercises to be performed at home.
2.4.1.2 Wearable Devices
Several wearable robotic rehabilitative devices have been developed (Table 2.3). A key device
is the Myomo e100 (MyoPro), a commercial exoskeleton that provides mechanical assistance to
patients performing activities of daily living. The MyoPro can also provide resistance training for
strengthening exercises during rehabilitative therapy [5]. The MyoPro estimates joint torque using
EMG signals from the flexor and extensor muscles of the elbow. The MyoPro provides 1 DOF
(flexion–extension). The reduced complexity is necessary to allow for safety and portability.
Table 2.3: Summary of wearable rehabilitative robotic systems.
Name Description DOF Shoulder Elbow Wrist
Commercial
Availability
Motion
Assistance
Myomo [5] Upper-limb brace
with myoelectric
input
1 X X X X X
RUPERT IV [44] Upper-limb, portable
exoskeleton
5 X X X — X
ArmeoSenso [43] Enables self-
directed upper-limb
rehabilitation
6 X X X X —
Wear-ME Brace [45] Upper-limb brace 2 — X — — X
2.4.1.3 Health Monitoring Devices for Rehabilitation
Several devices have also been developed or proposed for monitoring and diagnosing the health
of patients undergoing upper-limb rehabilitation for stroke. A major focus has been on using
information from EMG, accelerometer, and/or flex sensors to autonomously determine outcome
measures of functional independence for stroke patients [46–48]. Stroke outcome measures, such as
the Fugl-Meyer assessment and Wolf Motor Function Test, are self-reported or observer-reported,
and can therefore be inaccurate. As well, observer-rated measures are time-consuming for the
caregiver to perform [47]. However, the Fugl-Meyer and Wolf Motor Function Test are both
ordinal scales that cannot accurately describe patient behaviour, therefore there is interest in
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using assessment devices to develop new outcome measures [49].
Hocoma supplies the ArmeoSenso device, which monitors patients with mild upper-limb im-
pairments as they undergo self-directed rehabilitation exercises [43]. The 6 DOF system includes
motivating exercises and provides summaries of the patient’s performance in terms of coordination
and reaction time.
2.4.2 Efficacy of Robotic Rehabilitation Therapy
Few clinical studies have been performed to study the efficacy of robot-assisted therapy. The
results of these studies are often difficult to compare because outcome measures are often based on
therapist opinion [4]. As well, the majority of the studies have used small numbers of participants
and/or lacked a control group [50,51].
Robot-assisted rehabilitation could be expected to maximize a patient’s effort and adherence
to the rehabilitation program and to improve rehabilitation outcomes. The evidence tends to
suggest, however, that there are no clinically significant differences in outcome between robot-
assisted therapy and intensive therapist-provided rehabilitation [4, 51]. For example, an RCT
that compared the efficacy of treatment provided by the ARMin III exoskeleton with conventional
stroke therapy found that the increase in the Fugl-Meyer score in patients assigned to robot-assisted
therapy was not clinically relevant, and that patients assigned to conventional therapy exhibited
larger gains in muscle strength [52]. A pilot trial that compared the efficacy of rehabilitation for
stroke patients using the MyoPro with patients who followed a manual regimen provided by a
therapist found that both groups of patients had similar increases in their Fugl-Meyer scores [53].
The current rehabilitative robotic devices are therefore unlikely to provide a significant im-
provement over therapist-assisted rehabilitation, but they can still reduce the burden on therapists
by reducing the time spent manually assisting patients, and by allowing patients to participate
in rehabilitation more independently. A study that evaluated the efficacy of the ArmeoSpring
as a rehabilitation method for patients suffering cervical spinal cord injuries found no significant
difference in rehabilitation outcomes, but found that robot-assisted training required therapist
involvement for only 25% of the normal time, indicating that robotic devices can greatly improve
efficiency [54]. A cost analysis and RCT study conducted in 2010 determined that there was
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no significant difference between outcomes of robot-assisted rehabilitation and intensive therapy.
The cost of robot-assisted therapy per patient was slightly less than the cost of therapist-assisted
therapy ($5,152 for robot-assisted therapy, $7,382 for intensive therapist-assisted therapy [55]).
Robot-assisted therapy will likely become increasingly desirable, as the cost of robot-assisted re-
habilitation therapy is expected to decrease over time [4].
2.4.3 Towards Robotic Systems for Musculoskeletal Rehabilitation
There are currently no commercial robotic systems developed specifically for MSK rehabilitation.
Work has been accomplished towards developing mechanisms of sensing patient motion [45], but
not towards sensing and identifying patient health. Further research is required to enable wearable
devices to identify the muscle health of patients suffering from MSK injuries.
2.5 Muscle Physiology
An understanding of muscle physiology and EMG is necessary in order to develop a system to
identify patient muscle health. This section briefly reviews the background knowledge required to
understand the physiological basis of the EMG signal.
2.5.0.1 Skeletal Muscle Fibres
Skeletal muscle is composed of numerous parallel fibres. Each muscle fibre is a single long tubular
cell. Muscle fibres are composed of fibrils, which are in turn composed of filaments. There are two
types of filaments: thick filaments, which are composed of the motor protein myosin-II, and thin
filaments, which are primarily composed of actin. The thick filaments and thin filaments overlap
and the thin filaments slide over the thick filaments during muscle contraction (Figure 2.2).
2.5.0.2 The Motor System
The central nervous system is arranged in a hierarchal structure. Motor programming begins
in the premotor cortex. The outputs from the premotor cortex, cerebellum, and basal ganglia
converge at the primary motor cortex to excite and inhibit the primary motor cortex neurons.
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Figure 2.2: Overlapping structure of thick and thin filaments. The thin filaments are composed
primarily of actin, and the thick filaments are composed of the double-headed motor
protein myosin-II. Reprinted, with permission, from [57] ©2016 McGraw-Hill Educa-
tion.
Figure 2.3: Structure of motor unit (MU) and muscle fibres. Reprinted, with permission, from [56].
The outputs from the primary motor cortex influence the neurons of the brain stem and spinal
cord. The motoneurons in the spinal cord innervate and activate skeletal muscle fibres. A motor
unit (MU) consists of a motoneuron and the muscle fibres that it innervates (Figure 2.3) [56].
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2.5.0.3 Action Potentials of Muscle Cells
Nerve and muscle cells are excitable cells that have the ability to generate a propagating wave
of depolarization known as the action potential. The action potential is generated following the
depolarization of the muscle fibre, and is produced by the flow of ions between the muscle cell
and the extracellular matrix (ECM). Voltage-gated ion channels allow ions to move inside and
outside of the cell. There are three ions involved in producing an action potential: sodium (Na+),
potassium (K+), and chloride (Cl-). Calcium ions (Ca2+) are involved in the process of muscle
fibre contraction [58].
The muscle cell has a resting potential of about -80 mV relative to the ECM. If the cell
membrane potential is depolarized from -80 mV to -65 mV, voltage-gated Na+ and K+ ion channels
open. Na+ ions flow into the cell due to the relative negative charge inside the cell, and due to the
concentration gradient. The flow of positive charge rapidly increases the cell membrane potential
to +10 mV [59].
Muscle fibre depolarization enables the opening of Ca2+ ion channels. Ca2+ ions flow into the
cell due to the concentration gradient. The influx of Ca2+ ions triggers the release of additional
Ca2+ stored in the sarcoplasmic reticulum of the cell. Ca2+ ions enable the formation of cross-
bridges between action and myosin-II, which allows the thin filament to slide across the thick
filament [57].
Cell permeability to Na+ rapidly decreases following depolarization, and permeability to K+
increases. The outflow of K+ ions due to the concentration gradient slowly returns the cell mem-
brane potential to resting potential [58].
2.5.0.4 Motor Unit Action Potentials (MUAPs)
The flow of Na+ ions into the muscle cell is equivalent to a current. The cellular region where
the Na+ ions are drawn to is known as a “current sink,” and the region of the ECM where the
Na+ ions are drawn from is the “current source.” Muscle tissues form a roughly cylindrical shape,
therefore, a central negative current sink surrounded by two positive current sources is observed
from the outside of the cell. This forms the tripole shape (+ - + ) of the action potential (Figure
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Figure 2.4: Triphasic extracellular action potential waveform. Reprinted, with permission, from
[58].
2.4) [58].
Each motoneuron innervates multiple muscle fibres. The summation of the individual potentials
of all of the muscle fibres within a motor unit is the motor unit action potential (MUAP) [58].
2.6 Electromyography (EMG)
Electromyography, the study of the currents generated by muscle contraction, is an important tool
for studying movement and neuromuscular physiology, and for diagnosing neuromuscular disorders.
EMG data can be collected by inserting a needle electrode into the desired muscle. This method
allows for individual MUAPs to be recorded, but it is invasive and only useful in a clinical setting.
Surface EMG (sEMG) signals are collected noninvasively by placing electrodes on the surface
of the skin. MUAPs produce extracellular currents that extend from the cell membrane to the
surface of the skin. The changing potential gradients on the skin will produce electrical currents
at the leads of an electrode. Electrodes applied the skin convert the ionic potentials generated by
the muscles into electric potentials. The sEMG signal is the sum of all of the MUAPs produced by
the muscle [59]. The sEMG signal is more difficult to interpret than EMG signals obtained from
needle electrodes, but it is simple to implement and practical for daily use. sEMG has potential
as a noninvasive assessment tool for MSK disease [60].
This section describes common applications of sEMG, including measurement of muscle force,
determination of muscle synchronization, and diagnosis of neuromuscular disorders. This section
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also discusses the limitations and challenges of sEMG signals.
2.6.1 sEMG and Muscle Force
The sEMG signal is often used to estimate muscle force. Muscle force is regulated by two mecha-
nisms: 1) the recruitment of MUs, and 2) the firing rate of MUs [61]. The amplitude and frequency
of the sEMG signal also depend on these two mechanisms, therefore the sEMG signal can be used
to estimate the muscle force. However, the relationship between the sEMG signal and muscle force
is very complex. The sEMG signal is the summation of the MUAPs, and since the MUAPs are
biphasic or triphasic, their summation may be destructive or constructive, whereas the contribu-
tion of MUs to force is always constructive. As well, the sEMG signal depends on the distance
from the electrode to the MUs. Only superficial MUs contribute to the sEMG signal, whereas
all MUs contribute to the force [61]. The sEMG–force relationship also depends on the muscle
contraction condition and the joint angle [59]. sEMG activity is higher in concentric contractions
compared to isometric contractions, and lower for eccentric contractions of the same force [61].
Furthermore, the sEMG signal is affected by muscle fatigue. During fatiguing isometric con-
tractions, the following events occur [61]:
1. The sEMG amplitude increases
2. There is a shift of signal power towards the lower end of the frequency spectrum (i.e. there
is a decrease in high frequency power and an increase in low frequency power).
2.6.2 Muscle Activity Profiles
Muscle activity profiles are developed from sEMG signals to study muscle coordination and muscle
activation synergy. A linear envelope is obtained by rectifying the sEMG signal and applying a
low pass filter. The cut-off frequency of the low pass filter should retain 95% of the total power of
the movement under consideration [62].
Muscle activity profiles should be normalized to a time scale when comparing between trials or
individuals. For cyclical behaviour, the time scale can be converted to a percentage of one cycle
of the motion. However, this method does not account for variations between individuals in terms
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of the ratios spent performing a certain type of behaviour within the motion cycle. To avoid this
problem, the motion profile can be normalized to kinematic data [62]. Normalizing the sEMG
signal amplitude is also important for comparing between subjects and muscles.
Upper-limb muscle activation patterns have been studied in neurologically intact subjects and
in stroke patients performing reaching trajectory tasks to identify muscle health and coordination
[63,64].
2.6.3 Diagnosis of Neuromuscular Disorders
EMG collected by inserting a needle into a single muscle fibre is an established method for the
diagnosis of neuromuscular disorders. Individual MUAPs can be classified as normal, neuropathic,
or myopathic [9]. Neuropathic muscles have a reduced numbers of MUs, however muscle fibres
reorganize to produce larger MUs. MUAPs for neuropathic muscles therefore have higher am-
plitudes and longer durations. The MUs also fire at a higher rate to compensate for the loss of
MUs. Myopathic muscles have reduced numbers of muscle fibres, and exhibit MUAPs with short
durations, and low amplitudes [9].
sEMG signals tend to be less reliable than needle EMG signals at identifying neuromuscular
health. There is also a great difficulty in correlating observations of sEMG signal qualities with
the underlying physiology of the muscle. However, sEMG parameters have been found to exhibit
differences between healthy subjects and patients with neuromuscular or muscle disorders including
Duchenne muscular dystrophy [65], non-specific arm pain [11], stiff elbow [10], and elbow trauma
[12].
2.6.4 Limitations and Challenges of sEMG
sEMG acquisition presents many challenges. The tissue between the muscle and the skin attenuates
high-frequency signals, acting as a low pass filter. Surface electrodes placed further away from a
signal source have lower signal amplitudes and greater attenuation [66]. sEMG disproportionately
represents the signals from superficial muscles. Finally, sEMG may pick up crosstalk recordings
from nearby muscles [59].
The sEMG signal is influenced by many factors. Physiological and anatomical features of the
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muscle that influence the sEMG signal include the following [59]:
1. Muscle Fibre Length: The distribution of muscle fibres is not uniform in all muscles. Some
muscles contain groups of muscle fibres that lie primarily in the proximal or distal end of
the muscle. Surface electrodes will only detect the muscle fibres directly underlying the
electrode.
2. Muscle Partitioning: Some muscles are partitioned into having different characteristics and
functions. For example, the flexor carpi radialis contains three major divisions that activate
differently during radial deviation and wrist flexion–extension. An electrode placed without
consideration of these specific divisions could lead to a misclassification of the motion being
performed.
3. MU Organization: The number of MUs and the number of muscle fibres per MU differs
according to the type of muscle. Typically, larger muscles have higher innervation ratios
but lower numbers of MUs, while smaller muscles have higher numbers of MUs but lower
innervation ratios.
4. Muscle Fibre Organization: The composition of muscle is not uniform, and generally involves
fast-twitch fibres closer to the skin, and slow-twitch fibres deeper in the muscle. A surface
electrode will be biased towards detecting the fast-twitch fibres closest to the surface of the
skin.
Inherent factors that unavoidably influence sEMG signals include noise from ambient electro-
magnetic radiation, motion artifacts, and the randomness of the MU firing rate. The electrode
material and placement are technical factors that should also be considered, and will be discussed
in detail in the next section.
2.7 sEMG Acquisition
Since the sEMG signal is inherently affected by various factors, there are several considerations and
requirements for the sEMG signal acquisition system. This section describes the recommendations
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for the sEMG acquisition system (consisting of the following components: electrodes, amplifiers,
filters, and an A/D converter) as well as the procedure for sEMG signal pre-processing.
2.7.1 Electrodes
SENIAM (Surface EMG for the Non-Invasive Assessment of Muscles) was founded in 1996 to pro-
vide recommendations for sEMG signal acquisition, electrodes, and electrode placement [60]. Stan-
dardization of sEMG acquisition methods between research groups promotes the reproducibility of
results and the development of a common body of knowledge. The SENIAM recommendations for
electrodes, as well as further recommendations proposed by other research groups, are described
in detail below.
2.7.1.1 Electrode Configuration
There are three major electrode configurations used in the literature for sEMG acquisition: bipolar,
monopolar, and grid [67].
The monopolar configuration measures the voltage difference between an electrode placed over
the muscle of interest and a reference electrode. The reference electrode is placed on a bony area
of the body, typically the elbow for upper-body measurements [67].
The bipolar configuration is recommended by SENIAM and is the most commonly used con-
figuration for sEMG acquisition [60]. The sEMG signal is the voltage difference between two
electrodes aligned in the direction of the muscle fibres. The bipolar configuration is more tolerant
to noise than the monopolar configuration because the electromagnetic interferences common to
both electrodes is reduced by determining the voltage difference between the electrodes [59].
Research has been moving towards the use of high density sEMG (HD-sEMG) electrode grids.
HD-sEMG provides both temporal and spatial information about muscle activity, and allows for
more accurate information about muscle fibre and MU properties, including muscle fibre conduction
velocity, muscle fibre length and orientation, MU location, and the decomposition of the sEMG
signal into individual MUAPs [66].
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2.7.1.2 Inter-electrode Distance
The inter-electrode distance (IED) is the centre-to-centre distance between the conductive areas of
two electrodes [60]. The IED determines the “distance volume,” or the volume of muscle tissue that
provides a meaningful sEMG signal. The distance volume is approximately a sphere with a radius
equal to the IED [59]. When the IED is increased, the sEMG signal exhibits greater amplitudes and
lower frequencies [59], however, a larger IED reduces spatial specificity and increases the likelihood
of crosstalk from nearby muscles [67].
SENIAM recommends an IED of 20 mm for electrodes in a bipolar configuration [60], however,
increasing the IED to 40 mm can improve the tolerance for electrode shifts, and motion classifi-
cation accuracy [68]. The IED for HD-SEMG configurations should be less than 10 mm to avoid
spatial aliasing [69].
2.7.1.3 Electrode Size and Shape
Electrode shape is not thought to have a major influence on the quality of sEMG recordings [60,67].
There are no SENIAM criteria for electrode shape, however most sEMG electrodes are either
circular or rectangular [60].
Electrode sizes of 1 cm × 1 cm, 2 cm × 2 cm, and 3 cm × 3 cm have not been found to
significantly differ in terms of motion classification accuracy. Larger electrodes are less sensitive
to changes caused by electrode shifts [68].
2.7.1.4 Electrode Type
sEMG recordings can be performed with either wet or dry electrodes. Wet electrodes require
the application of a conductive electrolyte gel between the electrode and the surface of the skin.
Dry electrodes do not require extensive skin preparation [67]. SENIAM recommends the use of
Ag/AgCl (silver plated with a thin layer of silver chloride) wet electrodes [60].
Wet electrodes are not optimal for long-term use because the electrolytic gel commonly causes
skin irritation as it dries [67]. Applying and removing the electrolytic gel is also time-consuming.
Dry electrodes have been observed to achieve signal qualities comparable to wet electrodes [70],
2.7 sEMG Acquisition 28
are more comfortable for subjects, and do not require extensive skin preparation [67].
2.7.1.5 Skin Preparation
Skin preparation is necessary for wet electrodes in order to reduce the impedance and noise of the
electrode–gel–skin interface. Imbalances between the two electrodes should be reduced by removing
body oils and flaky skin layers. SENIAM recommends shaving the skin, cleaning the skin with
alcohol, and waiting for the alcohol to dry before applying the sensor. The impedance of the skin
should be below 10 kΩ [60]. With respect to dry electrodes, shaving the skin was demonstrated
to improve the sEMG signal quality, however the use of alcohol was found to decrease the signal
quality [70].
Electrodes can be fixed to the skin with gel, double-sided adhesive tape, stickers, or elastic
bands. The electrode–skin connection should be secure to avoid motion artifacts due to a loss of
contact or due to changes in impedance. The electrode cables should be positioned so that they
do not tug on the electrodes and affect the sEMG signal [60].
2.7.1.6 Electrode Placement
SENIAM provides recommendations for electrode placements for major muscles [71]. In general,
electrodes should be placed over the belly of the muscle between the innervation zone and the
tendon, and oriented in the direction of the muscle fibres. Electrodes should not be placed near
the innervation zone of the muscle [60].
2.7.2 Amplification
The amplitude of the sEMG signal is usually less than 10 mV. An instrumentation amplifier close
to the recording electrodes is used to amplify the sEMG signal by 100–5000× [67].
2.7.3 Filtering
sEMG signals can be filtered within the hardware prior to A/D conversion or following A/D
conversion using software. A high pass filter with a cut-off frequency of 20–50 Hz is typically
applied to remove low frequency components due to motion artifacts and the instability of the
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electrode–skin interface. The dominant energy of the sEMG signal is limited to frequencies of up
to 400–500 Hz, therefore a low pass filter of 400–450 Hz is typically applied to the sEMG signal [67].
Power line interference at frequencies of 60 Hz in North America can corrupt sEMG recordings.
A digital notch filter centred at 60 Hz can be applied to the sEMG signal to remove the interference
[61]. However, the notch filter may influence the perceived onset of contraction and the mean and
median frequencies [72].
2.7.4 A/D Conversion
The final step of the sEMG signal acquisition process is to convert the signal from an analog
signal to a digital signal. The Nyqust rule requires the sampling rate for A/D conversion to be at
least twice the highest frequency of interest to avoid aliasing. The useful frequencies of the sEMG
signal range up to 500 Hz, therefore the sampling rate for sEMG recordings should be at least
1000 Hz [67]. The resolution and range of the A/D converter should be carefully selected to ensure
that all of the required information within the sEMG signal is recorded [72].
2.7.5 Normalization of sEMG Signals
Due to the many inherent and technical factors influencing the sEMG signal, when sEMG signal
amplitudes are compared between trials, between muscles, or between individuals, signals should
be normalized to a reference value. SENIAM recommends that sEMG signals be normalized by
dividing the amplitude of the signal by the value of a reference contraction. The amplitude of the
signal is then defined as a percentage of the reference value [60]. There are several methods of
obtaining a reference contraction, as follows.
2.7.5.1 Maximum Voluntary Contraction (MVC)
The maximum voluntary contraction (MVC) is frequently used as a reference contraction, and is
the reference contraction recommended by SENIAM. However, the use of the MVC as a reference
contraction has been criticized because values greater than 100% MVC are often observed dur-
ing rapid and forceful contractions, which indicates that the MVC is not truly representative of
maximum muscle activation. Difficulties can also arise in obtaining accurate MVC readings for
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older subjects or for subjects with injuries or pathologies [73]. Clarys found that using reference
contractions at submaximal values of 80% of the MVC provided a more stable reference value [74].
2.7.5.2 Submaximal Contraction
Isometric submaximal contraction methods provide good reliability. The angle of the contraction
does not provide better reliability than using a specific angle, hence it is unnecessary to obtain
submaximal MVCs from a range of joint angles [73].
2.7.5.3 Mean and Peak sEMG Amplitude
Normalization can also be performed using the mean or peak sEMG amplitude when performing a
task. Mean and peak methods reduce inter-individual variability and should be used if the goal is
to reduce the sEMG variability within groups of participants; however, this may not be desirable
for all research. Peak and mean methods may not be able to detect alterations in magnitude or
patterning of sEMG signals between trials, muscles, or individuals [73].
2.7.6 Detection of Muscle Activation Onset
The detection of the point of the onset of muscle activation in the sEMG signal is important for
a variety of applications including motor control analysis, clinical applications, and the control of
prosthetic and orthotic devices. Detection can be performed by visually inspecting the signal, or by
using algorithms. Visual inspection is time consuming, subjective, and depends on the experience
of the examiner. Several algorithms for sEMG onset detection have been proposed [75].
2.7.6.1 Single-threshold Method
The single-threshold method is the most intuitive algorithm. The muscle activation onset is es-
timated as the point at which the amplitude of the rectified sEMG signal exceeds a predefined
threshold. However, the performance of this method depends on the choice of the threshold. The
single-threshold method is prone to false alarms [75].
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2.7.6.2 Double-threshold Method
The double-threshold method was proposed as an improvement to the single-threshold method
in order to decrease the number of false alarms and improve the sensitivity of detection. The
double-threshold method detects the muscle activation onset only when a predefined number of
consecutive samples exceeds a second threshold [76].
2.7.6.3 Other Methods
Several other methods for muscle activation onset detection have been proposed. The maximum-
likelihood method detects the onset of muscle activation by identifying abrupt changes in the
variance of the sEMG signal [75, 77]. Merlo et al. proposed a real-time onset detection method
based on the identification of single MUAPs from an sEMG signal [78].
Computationally complex methods have also been developed for off-line analysis. Drapaa et
al. proposed a two state detection method. In the first stage the onset is roughly estimated using
probability density function estimates of muscle activity and background noise. In the second
stage, a more accurate estimate is found by analyzing the neighbourhood of the sample found in
the first stage [75].
2.7.6.4 Teager–Kaiser Energy Operator
Regardless of the method of onset detection, the accuracy of detection improves following signal
conditioning with the Teager–Kaiser energy operator (TKEO) [79].
The TKEO, Ψ( ), is defined as:
Ψ(xi) = x2i − (xi+1 · xi−1) (2.1)
where xi is the ith EMG value.
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2.8 Pattern Recognition of EMG Signals
Pattern recognition techniques have been applied to the problems of classifying sEMG signals by
motion [80], force [81], neuromuscular health [9], and fatigue [82].
A general procedure for EMG data classification using pattern recognition techniques is sum-
marized in Figure 2.5. The procedure is as follows [83,84]:
1. Data Collection: Data must be collected and preprocessed.
2. Data Windowing: Data are often divided into segments and analyzed in windows of a certain
time length to allow for real-time analysis.
3. Feature Extraction: Relevant features are extracted from the data to aid with classification.
4. Feature Selection and/or Reduction: The number of features required should be minimized
to reduce the feature extraction time and the information size required for classification. The
selection of appropriate features is a critical step, as the features must be able to provide
high differentiability between categories.
5. Selection of Classification Model: An appropriate classification model should be selected
based on the data. Classifier efficiency may also depend upon the type of features that are
used.
6. Training and Evaluation of Classifier: Supervised classifiers must be trained using a set of
known data. However, classification models must not be overfitted to a specific set of data,
and become unable to classify new data. Therefore, training data must provide a good
representation of the data that will be classified.
The performance of a classifier is assessed by attempting to classify a test data set. The
effectiveness of a classification model is evaluated based on the system performance as a
whole. The computational complexity of the classifier should be evaluated, and a compromise
between complexity and performance may be required.
The process of EMG data collection was described in detail in Section 2.6. The remainder of
this section describes the subsequent steps of EMG pattern recognition.
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Figure 2.5: Method for pattern recognition.
2.8.1 Data Windowing
The instantaneous EMG signal is not useful for real-time motion classification. EMG features
must be extracted from analysis windows of a predefined duration. These windows can be either
contiguous or overlapping (Figure 2.6). Window length (Ta) and window increment (Tinc) should
be selected according to the required classification accuracy and controller delay. There is a
trade-off between classification accuracy and delay. Larger window sizes generally provide greater
classification accuracies, but lead to larger controller delays that make interactions unintuitive for
users [85].
The optimal window length for upper-limb myoelectric devices is within the range of 150–
250 ms [85]. Many myoelectric control systems in the literature follow the recommendations of
Englehart and Hudgins [86], who state that the longest acceptable controller delay is 300 ms.
Englehart and Hudgins also recommend that Tinc is set equal to the processing delay, Td, to
maximize the density of the processing stream [86]. Oskoei and Hu [87] found that using 200
ms windows with increments of 50 ms resulted in four times faster control without a significant
degradation of the motion classification accuracy. They also observed that classification accuracies
do not differ significantly with window size, as long as the window size remains between 50–500
ms.
2.8.2 EMG Feature Extraction
Following data segmentation, the next step of pattern recognition is feature extraction. Over
forty features for sEMG analysis have been described in the literature. sEMG features can be
categorized by the type of information about the EMG signal that they provide.
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Figure 2.6: EMG signal with overlapping windows. Ta is the duration of the window, Tinc is the
duration of the increment of new data added to each window, and Td is the processing
time. Reprinted, with permission, from [85] ©2011 IEEE.
2.8.2.1 Time Domain Features
Time domain features are frequently used for real-time applications because they provide high
motion classification accuracies at a low computational cost. EMG features extracted from the
time domain can provide information about the energy, frequency, and information complexity of
the signal. Multiple time domain features can be generated per window.
2.8.2.2 Time Domain: Energy
Time domain features derived from the amplitude of the EMG signal provide information about the
energy of the signal. The mean absolute value (MAV) is one of the most popular features for motion
recognition. Modifications to the MAV feature have been proposed to improve robustness to noise.
The modified MAV Type 1 (MMAV1) feature applies a discrete weighted window function to the
MAV feature, and the modified MAV Type 2 (MMAV2) applies a continuous window function [80].
The integrated EMG (IEMG) signal is commonly used for muscle activation onset detection,
particularly in clinical settings. The simple square integral (SSI) feature is an energy index. The
variance of EMG (VAR) feature is the average of the square values of the standard deviation of
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the signal. The root mean square (RMS) is used to estimate the muscle force in non-fatiguing
contractions. Finally, the log detector (LOG) feature also provides an estimate of the muscle
contraction force [80]. Definitions for these features are provided in Table 2.4.
2.8.2.3 Time domain: Information Complexity
The waveform length (WL), average amplitude change (AAC), and difference absolute standard
deviation value (DASDV) describe the information complexity of the sEMG signal. Table 2.5
provides the definitions of these features. The WL feature is the cumulative length of the sEMG
signal over a time segment. The AAC feature is similar to the WL feature, but averages the
waveform length over the time segment. The DASDV feature provides a standard deviation value
of the waveform length [80].
2.8.2.4 Time domain: Frequency
Mathematical definitions of time domain features that describe the frequency of the EMG signal
are provided in Table 2.6. The zero crossing (ZC) feature is the number of times the sEMG signal
crosses zero. The slope sign change (SSC) is the number of times that the slope of the EMG signal
changes sign [86]. A threshold function may be applied to both of these features to reduce the
background noise [80].
The myopulse percentage rate (MYOP) is the average number of times the EMG signal exceeds
a threshold value. The Willison amplitude (WAMP) is the number of times the difference in EMG
amplitude between two adjoining segments exceeds a threshold value. It is related to the firing of
MUAPs, and the muscle contraction force [80].
The optimum threshold values for these features are data and subject dependent [88]. Thresh-
old values are typically selected between 50 µV and 100 mV [80]. A threshold value of 0 mV for the
ZC and SSC features was found to be the most generalizable to various data sets and subjects [88].
2.8.2.5 Time domain: Multiple features
The value of time domain features can be improved by deriving multiple features for each window
segment. Time domain features that provide multiple values per window include the histogram of
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Table 2.4: Definitions of time domain features that describe EMG signal energy [80]. N is the
length of the EMG signal and xi is the ith sample of the EMG signal.
Feature Definition
Mean Absolute Value
(MAV)
MAV =
1
N
N∑
i=1
|xi |
Modified Mean
Absolute Value 1
(MMAV1)
MMAV1 =
1
N
N∑
i=1
Wi |xi |
Wi =
{
1, if 0.25N ≤ i ≤ 0.75N
0.5, otherwise
}
Modified Mean
Absolute Value
(MMAV2)
MMAV2 =
1
N
N∑
i=1
Wi |xi |
Wi =

1, if 0.25N ≤ i ≤ 0.75N
4i/N, elseif i < 0.25N
4(i-N)/N, otherwise

Integrated EMG
(IEMG)
IEMG =
N∑
i=1
|xi |
Simple Square Integral
(SSI)
SSI =
N−1∑
i=1
x2i
Variance of EMG
(VAR)
VAR =
1
N − 1
N−1∑
i=1
x2i
Root Mean Square
(RMS)
RMS =
√√
1
N
N∑
i=1
x2i
Log Detector (LOG) LOG = e
1
N
∑N
i=1 log10( |xi |)
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Table 2.5: Definitions of time domain features that describe EMG information complexity [80]. N
is the length of the EMG signal and xi is the ith sample of the EMG signal.
Feature Definition
Waveform Length
(WL)
WL =
N−1∑
i=1
|xi+1 − xi |
Average Amplitude
Change (AAC)
AAC =
1
N
N−1∑
i=1
|xi+1 − xi |
Difference Absolute
Standard Deviation
Value (DASDV)
DASDV =
√√
1
N − 1
N−1∑
i=1
(xi+1 − xi)2
EMG (HIST), mean absolute value slope (MAVS), and multiple window (MW) features.
The HIST feature is an extension of the ZC and WAMP features. The EMG signal is divided
into voltage bins symmetrical about the signal baseline. The number of times that the EMG voltage
falls within each of the voltage bins is calculated. Nine voltage bins are recommended for EMG
signals [89]. HIST features were applied to motion classification in several older papers [89, 90],
however Phinyomark et al. [80] reported more recently that HIST provides poor classification
performances.
The MAVS is calculated as the difference between two MAV values calculated over adjacent
time windows [90]. The MW features are created by applying a windowing function to the EMG
signal, and using the energy within each window as a feature. The Hamming windowing function
and the trapezoidal windowing function are typically used [91]. Table 2.7 provides the definitions
for the MAVS and MW features.
2.8.2.6 Frequency Domain Features
Frequency domain features (Table 2.8) are used to study muscle fatigue and MU recruitment [80].
They have also been used for motion recognition with some success. Frequency domain features
are primarily calculated from the power spectral density of the EMG signal.
2.8 Pattern Recognition of EMG Signals 38
Table 2.6: Definitions of time domain features that describe EMG signal frequency [80]. N is the
length of the EMG signal, xi is the ith sample of the EMG signal, and  is a predefined
threshold value.
Feature Definition
ZC (zero crossing)
ZC =
N−1∑
i=2
[(−sgn[xi · xi+1]) ∩ (|xi − xi+1 | ≤ )]
sgn(x) =
{
1, if x ≥ 0
0, otherwise
}
SSC (slope sign change)
SSC =
N−1∑
i=2
[ f [(xi − xi−1)(xi − xi+1)]]
f (x) =
{
1, if x ≥ 
0, otherwise
}
MYOP (myopulse
percentage rate)
MYOP =
1
N
N∑
i=1
[ f (xi)]
f (x) =
{
1, if x ≥ 
0, otherwise
}
WAMP (Willison
amplitude)
WAMP =
N−1∑
i=1
[ f (|xi − xi+1 |)]
f (x) =
{
1, if x ≥ 
0, otherwise
}
Table 2.7: Definitions of time domain features that involve multiple features per window [80]. K
is the number of windows and xi is the ith sample of the EMG signal.
Feature Definition
Mean Absolute Value
Slope (MAVS) MAVS = MAVk+1 − MAVk k = 1, ...,K
Multiple Window (MW)
MWk =
N−1∑
i=0
(xiWi−ik )2, k = 1, ...,K
where Wi is the ith value of the windowing function.
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The mean frequency (MNF) and median frequency (MDF) can be used for motion recogni-
tion [87]. Mean frequency was found to be a highly robust feature when the EMG signal was
contaminated with white Gaussian noise [92].
The peak frequency (PKF) is the frequency at which the maximum power occurs. The mean
power (MNP) and the total power (TTP) are other frequency features [80].
The first three spectral moments of the signal (SM1, SM2, SM3) can be used as features. The
variance of central frequency (VCF) is an important characteristic of the power spectrum and is
calculated using the spectral moments [80].
Frequency features can be generated by determining ratios of frequency components within the
power spectrum. The frequency ratio (FR) is used to distinguish between muscle contraction and
relaxation by using a ratio of low frequency and high frequency components of the signal. The
upper and lower cut-off frequencies of the low frequency band and high frequency band must be
determined. Typically the value can be assigned using the mean frequency. The power spectrum
ratio (PSR) extends the FR feature. It is the ratio of the energy near the maximum of the EMG
power spectrum and the whole energy of the power spectrum [80].
2.8.2.7 Prediction Model Coefficients
Feature vectors consisting of coefficients from the autoregressive (AR) prediction model have been
implemented as EMG features. The EMG spectrum changes with muscle contraction state, which
results in changes in the prediction model coefficients.
The AR model represents each sample of the EMG signal as the linear combination of the
previous p samples and a white noise error term. The AR equation is as follows:
xi =
P∑
p=1
apxi−p + wi (2.2)
where P is the order of the model, wi is white noise, and ap is the pth AR coefficient.
The fourth order AR model (AR4) is most commonly used for EMG signals, but the second
order AR coefficients (AR2) have also been successful for motion classification when combined with
the RMS time domain feature [87]. The AR model coefficients are estimated using the Yule-Walker
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Table 2.8: Definitions of frequency domain features [80]. Pj is the EMG power spectrum at bin j,
fj is the frequency of the spectrum at bin j, and M is the length of the frequency bin.
Feature Definition
Mean Frequency (MNF) MNF =
M∑
j=1
fjPj
/
M∑
j=1
Pj
Median Frequency
(MDF)
MDF∑
j=1
Pj =
M∑
j=MDF
Pj
Peak Frequency (PKF) PKF = fmax(Pj ), j = 1, . . . ,M
Mean Power (MNP) MNP =
M∑
j=1
Pj
/
M
Total Power (TTP) TTP =
M∑
j=1
Pj = SM0
Spectral Moments (SM0,
SM1, SM2)
SMs =
M∑
j=1
Pj f sj
where s is the order of the spectral moment.
Variance of Central
Frequency (VCF)
VCF =
SM2
SM0
−
(
SM1
SM0
)2
Frequency Ratio (FR)
FR =
ULC∑
j=LLC
Pj
/
UHC∑
j=LHC
Pj
where ULC and LLC are the upper and lower
cut-off frequency of the low frequency band and
UHC and LHC are the upper and lower cut-off
frequency of the high frequency band respectively.
Power Spectrum Ratio
(PSR)
PSR =
P0
P
=
f0+n∑
j= f0−n
Pj
/ ∞∑
j=−∞
Pj
where f0 is the frequency at which the maximum
power occurs, and n is the integral limit (typically
set to 20).
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method [93].
Cepstral analysis is the inverse Fourier transform of the logarithm of the power spectrum
magnitude of the EMG signal. The coefficients of cepstral analysis (CC) can be derived using the
coefficients from the AR model as follows:
c1 = −a1
cp = −ap −
p−1∑
l=1
(
1 − l
p
)
apcp−l (2.3)
where cp represents the coefficient of the cepstral analysis and 1 ≤ l ≤ P, where P is the order
of the model. This eliminates the requirement of computing the Fourier transform. The fourth
order model is typically used for determining the CC features. AR features have been observed to
perform slightly better than CC features in terms of recognition of upper-limb motions [94].
2.8.2.8 Entropy Features
Another category of feature that has been applied to EMG signals consists of features that describe
non-linear entropy. Entropy is a measure of the complexity and randomness of a system. The
approximate entropy (ApEn) and sample entropy (SampleEn) are entropy features that have been
applied to EMG analysis for motion classification [95,96].
The approximate entropy (ApEn) describes the self-similarity of a time-series, and is a measure
of system complexity [97]. ApEn represents the likelihood that patterns of observations will not be
followed by similar observations. A less predictable system has a higher ApEn. ApEn requires two
parameters: a positive integer, m, representing the sequence length to be compared, and a positive
real number, r, the tolerance for matching the similarity between sequences. These parameters are
typically set to m = 2 and r = 0.2 × σ, where σ is the standard deviation of the signal, for EMG
analysis [98].
ApEn is calculated by producing a sequence of vectors u1,u2, ...,uN−m+1 in IRm, where N is the
length of the sEMG signal and ui = [xi, xi+1, ..., xi+m−1], where xi is the ith sample of the sEMG
signal.
For each i when 1 ≤ i ≤ (N − m + 1), the value of Cmi (r), the probability that any vector ui is
2.8 Pattern Recognition of EMG Signals 42
within a distance of r of vector uj where 1 ≤ j ≤ (N − m + 1), is calculated as follows:
Cmi (r) =
number of j such that d[ui,uj] ≤ r
N − m + 1 (2.4)
where:
d[ui,uj] = max
k=1,2,...,m
(|xi+k−1 − xj+k−1 |) (2.5)
Next, the following function is defined:
Φm(r) = (N − m + 1)−1
N−m+1∑
i=1
lnCmi (r) (2.6)
ApEn is then defined as follows [97]:
ApEn(m, r) = Φm(r) − Φm+1(r) (2.7)
The ApEn feature is subject to a self-matching bias because each vector is counted as being a
distance less than r from itself [99]. SampleEn is a refinement of ApEn that eliminates this bias,
and improves the consistency of comparisons between data sets.
SampleEn is calculated by first defining:
Bmi (r) =
number of times d1[ui,uj] ≤ r
N − m + 1 1 ≤ j ≤ N − m, j , i (2.8)
Ami (r) =
number of times d2[ui,uj] ≤ r
N − m + 1 1 ≤ j ≤ N − m, j , i (2.9)
where:
d1[ui,uj] = max
k=1,2,...,m
(|xi+k−1 − xj+k−1 |) (2.10)
d2[ui,uj] = max
k=1,2,...,m+1
(|xi+k−1 − xj+k−1 |) (2.11)
The averages of the Bmi (r) and Ami (r) values are then calculated as follows:
Bm(r) = (N − m)−1
N−m∑
i=1
Bmi (r) (2.12)
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Am(r) = (N − m)−1
N−m∑
i=1
Ami (r) (2.13)
Bm(r) is the probability that two sequences match for m points, and Am(r) is the probability
that two sequences match for m + 1 points. Finally, SampleEn is defined as [99]:
SampleEn(m, r) = − ln A
m(r)
Bm(r) (2.14)
SampleEn has been used for muscle activation onset detection and motion recognition. Sam-
pleEn is useful for identifying bursts of EMG activity with low sensitivity to individual spikes [96].
2.8.2.9 Fractal Dimension (FD) Features
Fractal dimension (FD) features provide information about the morphology, spectrum, and vari-
ance of the EMG signal. The FD is a measurement of the non-linear property of a signal, and is
related to muscle size and complexity, but is unrelated to the strength of muscle contraction. FD
is useful for classifying motions using single EMG channels, and low-level muscle activations [94].
Several FD features have been proposed for the classification of EMG signals.
Higuchi’s Fractal Dimension (HFD) is one of the most popular fractal time-series algorithms.
HFD first constructs a new EMG time series, Xkm, as follows:
Xkm = [xm, xm+k, xm+2k, ..., xm+b N−mk ck] (2.15)
where the integer k is the time interval between points, the integer m = 1, 2, ..., k represents the
initial time value, and
⌊
N−m
k
⌋
is the integer part of N−mk . The length of each curve, Lm(k) is then
defined as follows:
Lm(k) = 1k

N − 1⌊
N−m
k
⌋
k
×
b N−mk c∑
i=1
|xm+ik − xm+(i−1)k |
 (2.16)
L(k), the length of the curve for time interval k, is calculated as the average length of the m curves
as follows:
L(k) =
∑k
m=1 Lm(k)
k
(2.17)
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L(k) vs. k is plotted on a log-log graph and the HFD is estimated by finding the negative slope of
the line relating log (L(k)) and log (k) [94].
Another common FD feature is the maximum fractal length (MFL), which is applied to the
measurement of low-level muscle activation. The MFL is defined as:
MFL = log10
(√√N−1∑
i=1
(xi+1 − xi)2
)
(2.18)
where N is the length of the EMG signal and xi is the ith sample of the EMG signal [94].
Detrended fluctuation analysis (DFA) is a fractal time-series algorithm that was found to
perform well for identifying low-level muscle activations in upper-limb EMG signals [94]. The DFA
feature uses a self-similarity parameter, α, to represent the FD. A larger value of α corresponds to
a smaller FD. The process of calculating the DFA involves first integrating the EMG signal as:
y(k) =
k∑
t=1
[xi − xi], k = 1, ..., N, (2.19)
where xi is the ith sample of the EMG signal, xi is the average value of xi and N is the length of the
EMG signal. The integrated signal is divided into boxes of size ν. Next, a quadratic least-square
fit is applied to the signals in each box. The y coordinate of the fitted function, yν(k), is used to
calculate the RMS fluctuation of profiles in each box as follows:
F(ν) =
√√
1
N
N∑
k=1
[y(k) − yν(k)]2 (2.20)
This value is computed for box sizes from ν = 4 to ν = N/10, with the box size incrementing by
powers of 2, in order to obtain a relationship between F(ν) and ν. The value of α is determined
by calculating the slope of the line on a log-log graph of log(F(ν)) vs. log(ν) [94].
2.8.2.10 Higher Order Statistics Features
Higher order statistics of EMG signals, such as skewness (SKEW) and kurtosis (KURT) can
identify details of the EMG signal that are missed when the signal is assumed to be a Gaussian
process. The definitions for these features are provided in Table 2.9.
2.8 Pattern Recognition of EMG Signals 45
Table 2.9: Definitions of higher order statistics features. N is the length of the EMG signal, xi
is the ith sample of the EMG signal, x is the mean of the EMG signal, and σ is the
standard deviation of the signal.
Feature Definition
Skewness (SKEW) SKEW =
(
1
N
N∑
i=1
( xi − x
σ
)3)
Kurtosis (KURT)
(
1
N
N∑
i=1
( xi − x
σ
)4) − 3
Skewness is the measure of the degree of symmetry of data around the mean. If the skewness
is negative, the data are spread to the left of the mean, and if it is positive, the data are spread
to the right of the mean. The skewness of a normal distribution is zero. The SKEW feature has
been used for motion classification of facial EMG [100].
Kurtosis describes the peakedness of a probability distribution relative to a normal distribu-
tion. Kurtosis values greater than 0 are more prone to outliers (the graph has a “heavy-tailed
distribution”), and values less than 0 are less prone to outliers (the graph has a “light-tailed dis-
tribution”). The kurtosis of the EMG signal tends to be greater than 0, and to decrease as the
contraction level increases. This indicates that as the contraction level increases, the EMG signal
begins to approximate a Gaussian distribution [101].
2.8.2.11 Time-Scale Features
The classification accuracies achieved with time domain and frequency domain EMG features may
be improved upon by using wavelet methods for time–frequency analysis. Features derived from
the wavelet transform have been used to identify MUAPs, determine muscle force and fatigue, and
classify motions [102].
The discrete wavelet transform (DWT) is implemented to develop a feature vector, however
this process requires a high computational complexity. A wavelet function, typically from the
Daubechies wavelet family, is applied to the EMG signal. The EMG signal is transformed into
subsets of coefficients, and the original signal is passed through high pass and low pass filters. This
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Figure 2.7: Illustration of sEMG spikes and peaks. Spikes are numbered and indicated with red
circles. The peak is indicated with a black “x”. Reprinted from [104] ©2007, with
permission from Elsevier.
achieves a detailed coefficient subset and an approximation coefficient subset. Each subset can be
reconstructed to estimate an EMG component using the inverse DWT [103].
2.8.2.12 Spike Shape Analysis Features
Further information about muscle activation and MU activity can be assessed from the morphology
of the sEMG signal with the spike shape analysis (SSA) technique [11]. A spike is defined as a
single upward and downward deflection that is greater than a predefined threshold amplitude.
The threshold is typically the 95% confidence interval for baseline EMG activity [104]. A peak is
defined as an upward and downward deflection within a spike (Figure 2.7).
Table 2.10 provides the definitions for the spike shape features: mean spike amplitude (MSA),
mean spike frequency (MSF), mean spike slope (MSS), mean number of peaks per spike (MNPPS),
and mean spike duration (MSD). Increased MU recruitment is associated with increases in MSA,
MSF, MSS, and MNPPS, and decreases in MSD. Increased MU synchronization is associated with
increases in MSA, MSS, and MSD, and decreases in MSF and MNPPS [11].
Spike shape analysis was implemented for identifying and evaluating patients of non-specific
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Table 2.10: Definitions of spike shape features [104]. Ax, Bx, Cx, Ay, By, and Cy are the x and y
coordinates of the points on the spike, indicated in Figure 2.7. NS is the number of
spikes, TD is the total duration of the EMG segment, SA is the spike amplitude, SS is
the spike slope, and NP is the number of peaks in the EMG segment.
Feature Definition
Mean Spike Amplitude
(MSA)
SAi =
(By − Ay) + (By − Cy)
2
MSA =
NS∑
i=1
SAi
NS
Mean Spike Frequency
(MSF)
MSF =
NS
TD
Mean Spike Slope
(MSS)
SS i =
By − Ay
Bx − Ax
MSS =
NS∑
i=1
SSi
NS
Mean Number of Peaks
Per Spike (MNPPS)
MNPPS =
NP
NS
Mean Spike Duration
(MSD)
MSD =
NS∑
i=1
Cx − Ax
NS
arm pain. Significant increases in MSA, MSF, MSS, and MNPPS and significant decreases in MSD
were observed in the sEMG signals collected from the extensor carpi radialis muscle in subjects
with non-specific arm pain compared to controls [11].
2.8.3 Feature Selection and Feature Reduction
EMG features are typically organized into feature sets to improve classification accuracy by in-
corporating multiple types of information as inputs into a classifier. The number of features in a
feature set should be minimized in order to reduce the size of the data set, and computational and
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memory requirements.
2.8.3.1 Feature Selection
Features should be selected for inclusion within a feature set according to the following specifica-
tions [89]:
1. Class Separability: Clusters of motions or muscle states should have as little overlap as
possible within the feature space.
2. Robustness: Class separability should be preserved in noisy environments.
3. Computational complexity: The computational complexity of the features should be low
enough for real-time applications and the processing power of small devices, as required for
a wearable device.
This section describes algorithms that assist with feature selection and provides a review of
the literature concerning the performance of EMG features.
2.8.3.2 Davies–Bouldin Index
The first of these algorithms is the Davies–Bouldin cluster validity index (DB index) [105], which
is a measure of cluster separation and is used to determine the class separability of EMG features.
Clusters with greater dispersions and smaller distances between them have higher similarities. The
similarity between two clusters, Ri j , is therefore defined as:
Ri j =
Si + Sj
Mi j
(2.21)
where Si and Sj are the dispersions of clusters i and j, and Mi j is the distance between the clusters.
The dispersion of a cluster is calculated as follows:
Si =
√√
1
Ni
Ni∑
j=1
(yi −mi)T (yj −mi) (2.22)
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where Ni is the number of elements within the ith cluster, yi is the ith input vector, and mi is the
mean vector of cluster i.
The distance, Mi j is usually defined as the Euclidean distance between the mean vectors of the
clusters as follows:
Mi j =
√
(mi −mj)T (mi −mj) (2.23)
The DB index, R, is the average of the similarity of each cluster to its most similar cluster, i.e.,
R =
1
κ
k∑
i=1
max(Ri j) (2.24)
where κ is the number of clusters.
Higher values of R indicate low cluster separation. A good cluster separation measure is
considered to be R <1 [106].
The DB index can be used to obtain relative rankings of feature spaces for classifying sEMG
signals [89,106,107].
2.8.3.3 RELIEFF Algorithm
The importance of individual features in predicting an outcome can be ranked using the RELIEF
algorithm. RELIEF works well for features with conditional dependencies, but can only be applied
to two-class problems [108].
The RELIEF algorithm provides a weight for each feature based on its predictive ability.
Features are first scaled on the interval [0,1]. A set of n instances is randomly selected. For each
instance, the RELIEF algorithm searches for the nearest neighbour in the same class (nearest hit)
and a different class (nearest miss). A good feature should have high similarity between each
instance and the nearest hit, and a low similarity between each instance and the nearest miss.
Therefore, the difference between each instance and the nearest hit is added to the feature weight,
and the difference between the instance selected and the nearest miss is subtracted from the feature
weight as follows:
ζ
j
i = ζ
j−1
i +
∆(fi − fH )
n
− ∆(fi − fM )
n
(2.25)
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where ζ
j
i is the weight for the i
th instance at iteration j, fi is the feature vector for the ith instance,
∆( ) is a function that provides the difference between two vectors (typically the Euclidean dis-
tance), fH is the nearest hit, and fM is the nearest miss [108]. The updates are divided by n to
ensure that the weights are normalized on the interval [-1, 1].
The RELIEFF algorithm [108] extends the RELIEF algorithm to multi-class data sets. RE-
LIEFF searches for k near misses from each different class and averages them when updating the
weight vector.
The RELIEFF algorithm ranks features in decreasing order of importance. The appropriate
number of top-ranked features to select for a feature set can then be determined by calculating the
DB index for the feature space as each additional feature is added. The optimal cut-off point for
adding more features occurs when adding an additional feature leads to no significant improvement
in the DB index [48].
2.8.3.4 Individual Feature Evaluation
The DB index has been employed to evaluate the performance of individual EMG features. Of a set
of time domain features, HIST and RMS were found to provide the best DB indices when classifying
upper-limb motions [89]. Boostani and Moradi used the DB index and a scattering criterion to
evaluate the effectiveness of 19 EMG features for the control of a prosthetic hand. Features studied
included time domain, frequency domain, cepstral coefficients, and features derived from wavelet
and wavelet packet coefficients. A feature vector of wavelet packet coefficients, and a feature vector
of cepstral coefficients were found to provide the greatest separabilities [109].
Oskoei and Hu reported that WL, followed by MAV and RMS, offers the best class separability
when features are examined individually [87]. Phinyomark et al. assessed the performances of
EMG features for the classification of upper-limb motions based on the type of information that
they provide [80]. WL was found to be the best single feature in terms of classification accuracy,
stability, and computation complexity. MAV1 and MAV2 did not provide any more discriminative
information than MAV. RMS and VAR had similar performances, with RMS performing slightly
better. WAMP, ZC, and SSC were similar in terms of the computation method and performance,
with WAMP having the highest performance.
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2.8.3.5 Robustness
Phinyomark et al. [92] assessed the classification accuracies obtained from features when EMG
signals were contaminated with white Gaussian noise. The most robust features were HIST, WL,
and MNF. Individually, WL was the best feature for discerning between different upper-limb
motions. MAV and WAMP were also found to be useful features. AR features and RMS were
useful for noisy situations.
2.8.3.6 Feature Set Evaluation
The Hudgins feature set, developed by Hudgins in 1993, consists of the following five time domain
features: MAV, SSC, WL, ZC, and MAVS [90]. MAVS is typically omitted from the Hudgins set
in the most recent literature [86]. Many myoelectric devices implement the Hudgins feature set
or a variation of the Hudgins feature set because it includes features that are effective for motion
classification and are computationally simple to extract [86]. The ZC and SSC features have similar
spatial distributions, therefore the Hudgins set can be simplified to include only MAV, WL, and
SSC without a large reduction in classification accuracy [80]. Oskoei and Hu [87] determined that
the Hudgins feature set worked well for pattern classification, but that a feature set of RMS and
AR2 was best for time segments of 200 ms. Phinyomark et al. [80] concluded that time domain
features are superior to frequency domain features because time domain features achieve similar
classification accuracies, but require less computational resources.
Haddara [12] compared six sEMG features (RMS, MAV, MSA, ZC, MDF, MNF) collected from
elbow trauma patients and a group of healthy subjects. Statistically significant differences were
primarily identified using the RMS and MAV features. The RMS and MAV features collected from
the patients at the end of the therapy program were found to more closely resemble the healthy
population. The frequency domain features, MDF and MNF, showed no significant differences
between the groups.
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2.8.3.7 Feature Reduction
Feature reduction is performed to reduce the dimensional space of the feature set, which can
improve both the speed of classification and the classification accuracy. The most common feature
reduction method applied to EMG signals is principal component analysis (PCA).
2.8.3.8 Principal Component Analysis (PCA)
PCA is a method of representing data in a lower dimensional feature space. PCA develops new
features in a lower dimensional space by projecting existing features along the directions of their
greatest variances. The feature data are projected onto the most significant eigenvectors of the
covariance matrix of the data. PCA is for data representation, not for data classification, therefore
PCA is only effective for data classification if the directions of the greatest variances are important
for classification [83]. PCA has been successfully applied to several EMG motion recognition
problems in order to improve the classification accuracy and increase the classification rate [110].
2.8.4 Classification Models
This section reviews the classifiers commonly used in the literature to develop models for EMG
signals. Machine learning classifiers (including linear discriminant analysis (LDA), support vector
machines (SVM), k -nearest neighbours (k -NN), and decision tree classifiers), and artificial neural
network (ANN) classifiers are described below.
2.8.4.1 Linear Discriminant Analysis (LDA)
LDA uses hyperplanes to separate a feature space into linear decision regions. LDA minimizes the
distances between feature vectors of the same class, and maximizes the distances between different
classes. Observations within each class are assumed to come from a Gaussian distribution, and the
covariance of all classes is assumed to be equal, therefore LDA is best for Gaussian distributions
with equal covariance, but can work well for data with other distributions. The LDA decision
regions must be spatially contiguous and convex. If the regions are not linearly separable, a linear
machine will not work [111].
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LDA is a robust classifier and is advantageous for embedded processors involved with real-
time applications because it provides fast prediction speeds and small memory usages. LDA
has been applied to a variety of EMG classification problems [112], and is generally found to
provide acceptable classification accuracies [86] and to provide superior classification accuracies
for fluctuating EMG signals [98].
2.8.4.2 Quadratic Discriminant Analysis (QDA)
Quadratic discriminant analysis (QDA) is an extension of LDA that assumes each class has a
different covariance matrix. QDA is best for large data sets as it may overfit data sets with a low
number of observations and high variance. QDA provides nonlinear quadratic decision boundaries.
LDA performance for classifying EMG signals is typically better or comparable to QDA [113,114].
2.8.4.3 Support Vector Machines (SVM)
An extension of the LDA classification method is the SVM classifier, which uses separating hyper-
planes to distinguish between two classes of data. An ideal separating hyperplane should be as far
away as possible from any sample, to maximize the probability of classifying new data correctly.
If a hyperplane cannot be constructed to separate all classes, a margin must be tuned to allow for
some violations. The data samples that are closest to a separating hyperplane are called “support
vectors”. These data are the most difficult to classify. An optimal SVM separating hyperplane
is defined solely by the support vectors. The SVM classifier is robust to observations far from
the hyperplane. The SVM method only works for two-class problems, however, multiple SVM
classifications can be performed to apply this method to multi-class problems [111].
Pattern classifications in high dimensional space are more likely to be linearly separable than
in low dimensional space. Data can be projected into higher dimensions to achieve better clas-
sifications. Since these types of functions require high computational power, they can be solved
implicitly using kernel functions. Commonly used kernel functions include the polynomial kernel
function and the radial basis function [111].
The SVM classifier typically allows for better classifications than LDA, but the prediction
speed and memory usage is worse than for LDA. The SVM classifier has been used for many EMG
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applications including motion classification [87] and the diagnosis of neuromuscular disorders [115].
2.8.4.4 K-Nearest Neighbours Classification (k-NN)
The k-NN classification method works well on data that are not linearly separable. k-NN is an
unsupervised learning method that allows unlabeled data to be organized into “clusters.” Clusters
of data should have small inter-cluster distances, and large intra-cluster distances. Data points
are assigned to the clusters such that the sum of the squares of the distances of each data point
to the centre of the cluster is at a minimum. k-NN classifies each new datum by determining the
most common class among the k closest data points. k-NN was found to be very effective for using
sEMG forearm signals to distinguish between upper-limb motions [113,114].
2.8.4.5 Decision Trees
Linear models are simple, but perform poorly if the relationships between features are non-linear.
Decision tree classifiers are simple models that provide easily interpretable results, and can outper-
form linear models when classifying non-linear data. A single decision tree classifier determines an
outcome based on a series of splitting rules starting at the top of a tree and continuing into a series
of branches. The decision tree stratifies the feature space into regions to provide the prediction.
A single decision tree model is susceptible to over-fitting and a lack of robustness. These
problems can be avoided by aggregating many decision trees. The tree bagging method builds
hundreds to thousands of decision trees by taking repeated samples from the data set. The most
common decision obtained from the trees is used as the final output.
An improvement upon the tree bagging method is the random forest (RF) algorithm, which
ensures that decision trees will not be highly correlated due to the influence of a very strong
predictor. The RF algorithm prevents decision tree models from considering most of the available
predictors at each split (usually the number of predictors considered is the square root of the total
number of predictors) [48].
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2.8.4.6 Artificial Neural Networks (ANNs)
The ANN is another classification method that works well for non-linear data. ANNs are designed
to imitate the networks of neurons in the brain. The most basic ANN is the multilayer perceptron,
or feed-forward neural network, which consists of an input layer of neurons, one or more hidden
layers, and an output layer. The output of each neuron is determined by a non-linear function of
the sum of its inputs.
ANNs have high generalization abilities and can learn directly from large data sets. They
work well with data that are not linearly separable, or when the classes of the training data are
unknown. ANNs can be also be implemented in real-time.
ANN models have been used for the classification of motions [81]. Often a back-propagation
neural network is employed. More sophisticated ANNs such as deep belief networks [116] have been
used to classify sEMG signals with greater success than traditional methods such as LDA. ANNs
have also been successfully used with needle EMG data to classify neuromuscular disorders [9].
2.8.4.7 Classification Model Evaluation
Classification models, as the ones presented above, should be developed using a training set and
a validation set. The model is fitted using the training set, and then the fitted model is used to
predict the classes of the validation set and to determine the classification error.
k-fold cross-validation divides the data set into k groups, or folds. The first fold is the validation
set and the remaining k − 1 folds are the training set. This procedure is repeated k times, and the
average of the classification error is obtained [111].
Leave-one-out cross-validation can be used for data sets with a low number of observations.
A single observation is used as the validation set, and the remaining observations are used as the
training set. This is repeated until each observation has been used as the validation set, and the
average of the classification error is obtained. This method decreases the bias in determining the
classification error [111].
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2.9 Conclusion
This chapter reviewed the anatomy of the elbow, and the motivation and methods for elbow
rehabilitation following trauma. The prior art in robot-assisted upper-limb rehabilitation was
described. Finally, EMG data acquisition, analysis, and classification methods were reviewed.
These topics will be explored in the following section in order to progress towards an EMG model
of muscle health.
Chapter 3
Data Collection and Processing
This chapter describes the procedure for EMG data collection and processing. The following
section outlines the equipment, patient recruitment, electrode placement, data collection protocol,
and signal processing methods implemented to move towards the objective of quantifying health
in patients rehabilitating from elbow trauma.
3.1 Equipment
3.1.1 Acquisition System
The sEMG signals were collected with a commercial wireless myoelectric system (Trigno Wireless
system, Delsys Inc., USA). The Trigno system includes a base station that interfaces with 16
wireless radio frequency sensors (Figure 3.1). Each 27 × 37 × 15 mm sensor (Figure 3.2) was
composed of sEMG electrodes and a triaxial accelerometer. The EMG sampling frequency was
1925.93 Hz and the accelerometer sampling frequency was 148.1 Hz. The signals were amplified
300× and filtered on-board with a 20–450 Hz Butterworth bandpass filter. The signals were
digitized with a 16 bit A/D converter with 168 nV/bit resolution.
The sEMG detection system consisted of four silver bar electrodes. The electrodes were ar-
ranged into two pairs of contacts: 1) a positive signal detection and reference contact, and 2) a
negative signal detection and reference contact. This unique electrode configuration was designed
to eliminate the need for a separate reference electrode. The stabilizing reference electrodes re-
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Figure 3.1: Trigno base station for charging and RF communication with sEMG sensors.
duced motion artifact by limiting the impact of disturbances on the surface of the skin [117]. The
contact surface on the skin for each bar was 5 × 1 mm, and the IED was 10 mm. The sensors were
affixed to the skin using Trigno Sensor Skin Interface (SCF03) double-sided adhesive stickers.
The Trigno commercial system was selected for data collection because it promised to mitigate
common sEMG signal acquisition difficulties, while fulfilling the requirements for sEMG data
collection. The use of a wireless system ensured for more natural movements and eliminated
the possibility of motion artifacts due to moving electrical cables. The use of silver electrodes
eliminated the need for gel which simplified the data acquisition process, and was more suitable
for a prospective wearable application.
3.1.2 Data Recording and Analysis Software
Data were recorded with the Delsys EMGworks 4.3.0 Acquisition software installed on a laptop
(Figure 3.3). Delsys EMGworks 4.3.0 Analysis software (Figure 3.4) was used to convert the data
to comma-separated format. All off-line data analysis was performed using MATLAB software
(The MathWorks Inc., Natick, MA, USA, Version R2017b).
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Figure 3.2: Trigno sensor. The front of the sensor (left) includes an arrow to assist with the
direction of sensor placement. The arrow should be aligned in the direction of the
muscle fibres. The x axis of the accelerometer is parallel to the sensor arrow, and
y axis is perpendicular and coplanar to the sensor arrow. The back (right) of the
electrode contains 4 bar electrodes.
Figure 3.3: Data acquisition software.
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Figure 3.4: Data analysis software.
3.1.3 Load Cell
A load cell (American Archery Products M110 Digital Bow Hang Scale 110 lbs) with an accuracy
of 0.05 lbs was used to obtain the peak weight and the holding weight exerted when performing
flexion MVC and extension MVC (Figure 3.5).
Figure 3.5: Load cell.
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3.2 Patient Recruitment
Trials began after permission was received from the Human Research Ethics Board at Western
University. Patients were recruited over a period of 12 months from January to December 2017 from
the Roth McFarlane Hand and Upper Limb Centre at St. Joseph’s Hospital in London, Ontario.
All patient trials were performed at St. Joseph’s Hospital. Patients were excluded from the
trials if they indicated that they had congenital musculoskeletal defects, or if they had previously
experienced elbow trauma on their contralateral limb. The majority of patients (92%) presented
with elbow fractures resulting from elbow trauma. Other injuries studied were biceps tendon tears
and surgery to treat osteoarthritis. Table 3.1 shows a summary of the patient information.
Table 3.1: Elbow trauma patient information.
Sex Age (years) Height (cm) Weight (kg) Injured Hand
Time since
Injury (weeks)
21 Male
9 Female
45.0 ± 11.5 175 ± 9.8 89.2 ± 20.3 17 Dominant
13 Non-Dominant
9.6 ± 5.9
3.3 Electrode Placement
Electrodes were placed to obtain sEMG recordings from the following muscles:
1. Biceps brachii (BB)
2. Triceps brachii lateral head (TBlat)
3. Triceps brachii long head (TBlong)
4. Pronator teres (PT)
5. Brachioradialis (BRD)
6. Extensor carpi ulnaris (ECU)
7. Flexor carpi ulnaris (FCU)
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Electrodes were placed on the skin in accordance to the SENIAM recommendations [71]. The
muscle groups not included in SENIAM were placed in the direction of the muscle fibres near the
belly of the muscle as recommended by literature guidelines [60]. A sensor was also placed on the
inside of the patient’s wrist to collect acceleration data. Figure 3.6 and Figure 3.7 indicate the
anterior and posterior views of the electrode placement, respectively.
Figure 3.6: sEMG sensor placement (anterior view).
3.4 Motions
This section describes the motions performed during each trial. The motions were selected based
on standard elbow rehabilitation exercises. Wrist and hand exercises were included because elbow
trauma patients are also encouraged to perform wrist and finger exercises during rehabilitation [16].
The forearm, wrist, and hand exercises were performed with the elbow held at approximately 90
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Figure 3.7: sEMG sensor placement (posterior view).
degrees.
1. Elbow Flexion–Extension: Patients were asked to perform elbow flexion (EF) by moving the
forearm from approximately 0 degrees to the maximum point of flexion, approximately 120
degrees for healthy subjects [13] (Figure 3.8). Elbow extension (EE) was then performed
by moving the arm from the point of maximum possible flexion back to a relaxed position
(Figure 3.9). The patients were instructed to keep the wrist at a neutral position while
performing this motion.
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Figure 3.8: Elbow flexion (EF).
Figure 3.9: Elbow extension (EE).
2. Forearm Pronation–Supination: Patients were asked to perform forearm pronation (P) by
rotating the forearm until the palm of the hand faced down (Figure 3.10). Forearm supination
(S) was performed by rotating the forearm so that the palm of the hand faced up (Figure
3.11).
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Figure 3.10: Forearm pronation (P).
Figure 3.11: Forearm supination (S).
3. Wrist Flexion–Extension: Patients were asked to perform wrist flexion (WF) (Figure 3.12)
and wrist extension (WE) (Figure 3.13).
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Figure 3.12: Wrist flexion (WF).
Figure 3.13: Wrist extension (WE).
4. Ulnar–Radial Deviation: Patients were asked to perform ulnar deviation (UD) by moving
the hand downward towards the ulna (Figure 3.14) and radial deviation (RD) by moving the
hand upward towards the radius (Figure 3.15).
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Figure 3.14: Ulnar deviation (UD).
Figure 3.15: Radial deviation (RD).
5. Hand Open–Close: Patients were asked to close their hand into a fist (HC) (Figure 3.16),
and then to open their hand with their fingers spread out (HO) (Figure 3.17).
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Figure 3.16: Hand close (HC).
Figure 3.17: Hand open (HO).
6. Maximum Voluntary Contraction (MVC): An elbow flexion MVC was performed by having
the patient pull up on a band attached to the load cell. An extension MVC was performed
by pulling down on the load cell (Figure 3.18). Patients were instructed to avoid using their
shoulder to assist with this exertion and to keep the elbow at a 90 degree angle. The EMG
signals and the maximum force exerted in pounds were recorded for each MVC.
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Figure 3.18: Extension MVC.
3.5 Data Collection Protocol
The following protocol was adopted for all patients. If specific motions were deemed unsafe by the
patient’s therapist, these motions were not performed.
1. Patients were asked to report the following information:
(a) Age
(b) Sex
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(c) Height
(d) Weight
(e) Dominant Hand
(f) Type of Injury
(g) Date of Injury and/or Surgery
2. The sEMG sensors were placed on the areas specified in Section 3.3 on both the injured and
contralateral uninjured limb.
3. The patient was asked to perform the following sets of motions:
(a) Elbow Flexion–Extension (EF–EE)
(b) Forearm Pronation–Supination (P–S)
(c) Wrist Flexion–Extension (WF–WE)
(d) Ulnar–Radial Deviation (UD–RD)
(e) Hand Open–Close (HO–HC)
Each motion set was performed with the injured arm three times and with the healthy arm
three times. The patient was instructed to perform all motions at a comfortable pace.
4. If agreed upon by the therapist, the patient was asked to perform a static elbow flexion MVC
and a static elbow extension MVC with both the injured and uninjured limb. A load cell
was used to record the maximum force exerted.
3.6 Data Processing
The EMG signals were further processed and filtered prior to feature extraction. The data pro-
cessing was performed using MATLAB. The steps of data processing, data segmentation, feature
extraction, feature selection, and classification are described in this section.
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3.6.1 Data Segmentation
The EMG data were divided into segments representing each motion based on muscle activation.
The double-threshold method for detecting EMG onset [75] was used to facilitate segmentation.
The first threshold, th1, (the amplitude the EMG signal must exceed) was defined as b + 15σ,
where b is the baseline value of the EMG signal and σ is the standard deviation of b. The second
threshold, th2, (the number of consecutive EMG samples that must exceed th1) was set to 25
based on trial and error. The signals were conditioned with the Teager–Kaiser energy operator
(TKEO) using Equation 2.1 and then rectified and passed through a 2nd order Butterworth 50 Hz
low pass filter to improve the robustness and accuracy of muscle activation onset detection [79].
An example of the segmentation output is shown in Figure 3.19.
The segmentations for each EMG recording were verified visually and sets that were not seg-
mented correctly by the algorithm were segmented manually. About 50% of the data sets had to
be resegmented manually. Data sets from three subjects were excluded from further analysis after
visual inspection indicated that the data were corrupted.
3.6.2 Filtering
The EMG signals were filtered with a 2nd order Butterworth 20–400 Hz band pass filter in order
to remove low frequency motion artifacts, and uninformative high-frequency components. The
signals were also filtered with a 60 Hz notch filter to reduce power line interference in accordance
with literature recommendations [67].
3.6.3 Feature Extraction
Forty EMG features were extracted from each EMG segment. The definitions for these features
were provided in Section 2.8.2. These features were also used to develop three preliminary feature
sets, as follows:
 Feature Set 1 (FS1) : MAV, SSC, WL, ZC.
 Feature Set 2 (FS2) : RMS, AR2.
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Figure 3.19: Segmentation for EMG signal filtered with TKEO. The green circle indicates the
point of muscle activation. The red circle indicates the point of muscle deactivation.
 Feature Set 3 (FS3) : MSA, MSF, MSS, MNPPS, MSD.
FS1 is the Hudgins feature set [90]. FS2 is the feature set developed by Oskeoi and Hu [87]
that was observed to perform well for motion classification. FS3 is a feature set consisting of spike
shape features [104].
Each feature was calculated from the signal collected over the entire motion. One feature was
obtained for each muscle. For example, for FS1 there were 4 features × 7 EMG muscle channels
= 28 total features in the feature vector for each segment.
3.6.4 Classification
Classification models were developed and evaluated for each of the ten motions separately. The
LDA, SVM, and RF classification models were investigated. The LDA classifier was selected
because it is simple, and has been found to be effective for classifying EMG signals in the liter-
ature. The SVM classifier was selected as an extension of the LDA classifier. The RF classifier
was selected due to its usefulness for classifying stroke rehabilitation outcomes [118]. The RF
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classifier was generated from 200 decision trees. Classification models were initially developed to
distinguish between healthy and injured limbs. The classification models were also investigated for
distinguishing between patients at two different stages of rehabilitation: 0–6 weeks and 7+ weeks.
3.6.5 Evaluation
The classification accuracies were evaluated for each model using a leave-one-patient-out cross-
validation method [119]. All of the trials from one patient were used as a test set, and the
remaining patients were used as the training set. This process was repeated for each patient. The
accuracy was calculated as the number of correct classifications divided by the total number of
patients.
3.6.6 Optimization of Feature Sets and Models
Both the feature sets and classification models were further optimized. A majority vote was
performed for each patient to combine the outputs of the individual motion models. The majority
vote models were further optimized by generating weighted majority vote models.
The process of feature selection was performed in two ways. The best individual features
were found by comparing their individual performances in a majority vote model. The RELIEFF
algorithm [108] was used with k=10 as recommended in [118] to search for the best combinations
of features within a feature set.
3.6.7 Identification of Patient Characteristics Influencing the Perception of
Patient Health
Following the development and testing of the various classification models, the influence of patient
characteristics (sex, age, body mass index (BMI), and the time since injury) on the outcomes of the
models was investigated. The patient characteristics were input into the classification models as
non-zero ordinal categories, and the models were reevaluated. Decision tree models were explored
to determine the patient characteristics that were used for splitting rules.
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This chapter described the methods of data collection and processing, feature extraction and
selection, and classification model development. The next chapter will describe and discuss the
results of the feature selection and the classification model performance.
Chapter 4
Results and Discussion
This chapter describes the results obtained following the execution of the procedure of EMG data
collection and analysis described in Chapter 3. First, models were developed to classify between
the healthy and injured limbs of subjects. Feature sets based on recommendations in the literature
were used for the initial classification. Models were developed for each individual motion, and were
then aggregated into majority vote models. New feature sets were developed and optimized based
on the performances of individual features. Optimization of the feature sets was performed using
the RELIEFF algorithm.
Further explorations were conducted towards improving the classification models. Patient
characteristics were added to the models to determine if knowledge of specific characteristics could
improve the classification. Time windowing of the EMG data was also investigated. Finally, models
were developed to investigate the possibility of classifying between different stages of rehabilitation.
A statistical analysis was performed to identify EMG feature differences between healthy and
injured limbs. An analysis was also performed on returning patients to study the changes in EMG
features following therapy.
4.1 Healthy–Injured Models
A preliminary goal was to determine if classification models based on EMG features could be
developed to distinguish between the healthy and injured limbs of patients. This section describes
75
4.1 Healthy–Injured Models 76
the development and evaluation of classification models to differentiate between two levels of health
(healthy and injured).
4.1.1 Preliminary Feature Sets
Three preliminary feature sets (FS1–FS3) were developed based on feature set recommendations
in the literature. Features were extracted from EMG segments consisting of the entire motion.
Classification models were developed for each individual motion. Classification accuracies were
obtained using a leave-one-patient-out cross-validation. The classification results for each feature
set and motion are shown in Table 4.1.
The models distinguished between the two levels of health with accuracies ranging from 45.9–
79.6%, depending on the classification algorithm and the motion. The RF models provided the
best classification accuracies for the majority of the motions when used with FS1 and FS2. For
example, the RF classification accuracies for FS1 ranged from 56.8–72.2%, while the LDA and
SVM classification accuracies ranged from 55.6–69.1% and 54.9–67.9% respectively (Figure 4.1).
The better performances of the non-linear RF classifier suggest that many of the relationships
between the features in FS1 and FS2 that influence health are non-linear. There was no evident
best classifier for FS3, although the best accuracy was obtained with the LDA model for WF,
which provided an accuracy of 79.6%.
The performances of the classification models were influenced by the feature sets. When com-
pared to FS1, FS2 had similar performances and performed similarly with the various classifiers,
but had an overall worse performance than FS1. FS3 was unique in that there was not a single
classifier that was the best, however, FS3 also provided the highest accuracies out of all feature
sets. These observations are consistent with the literature, which suggests that feature set selection
is more important than classifier selection for obtaining good classification accuracy with EMG
signals [67].
The addition of more features in the feature set can improve accuracy, until an asymptote is
reached, at which point adding new features will not improve the accuracy [80]. FS1 consisted
of four features. FS2 contained two features, although the AR2 feature produced two values per
window, providing the FS2 with effectively three features in the feature set. FS3 contained five
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Table 4.1: Classification accuracies for each feature set. The best classification result for each
motion within each feature set is in bold.
Feature Set Motion
Classification Accuracy (%)
LDA SVM RF
FS1 (MAV, SSC,
WL, ZC)
EF 62.3 60.5 70.3
EE 65.4 62.3 71.6
P 69.1 67.9 67.3
S 60.5 62.3 68.5
WF 67.3 56.8 69.1
WE 55.6 64.8 56.8
UD 58.6 62.3 71.6
RD 61.7 65.4 66.0
HC 64.8 54.9 72.2
HO 55.6 61.1 57.4
FS2 (RMS, AR2)
EF 59.9 57.4 67.9
EE 61.7 64.8 69.8
P 67.3 49.4 71.6
S 58.6 54.9 69.8
WF 63.6 59.3 65.4
WE 60.5 54.3 59.9
UD 62.3 57.4 63.0
RD 59.1 45.9 69.2
HC 63.0 56.2 66.7
HO 58.6 64.2 63.0
FS3 (MSA, MSF,
MSS, MNPPS, MSD)
EF 74.1 61.1 64.8
EE 61.1 77.8 68.5
P 72.2 63.0 61.1
S 50.0 63.0 72.2
WF 79.6 64.8 75.9
WE 57.4 66.7 64.8
UD 72.2 68.5 61.1
RD 61.1 77.8 57.4
HC 57.4 59.3 64.8
HO 48.2 50.0 51.9
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Figure 4.1: Classification accuracies for each motion when using the LDA, SVM, and RF classifiers
with FS1. The range of the y axis has been adjusted for clarity. The motions tested
were as follows: elbow flexion (EF), elbow extension (EE), forearm pronation (P),
forearm supination (S), wrist flexion (WF), wrist extension (WE), ulnar deviation
(UD), radial deviation (RD), hand close (HC), and hand open (HO). The RF classifier
tended to provide the best accuracy.
features. The inclusion of a greater number of features in FS1 compared to FS2 could account
for the better classification performances of FS1. Likewise, FS3 contained the greatest number of
features of the three feature sets tested, and displayed higher accuracies than FS1 and FS2.
The initial classification results also suggest that some motions are better than others for
classifying patient health. The EE motion provided the range with the highest accuracies overall
(62.3–77.8%). The models for the WE and HO motions provided the ranges with the lowest
classification accuracies (54.3–66.7% and 48.2–64.2% respectively). All other motions achieved a
classification accuracy of at least 72.2% for one of the models, however the RD motion provided
classification accuracies below 70% with the exception of only one classification model. Table 4.2
shows the range of classification accuracies for each motion.
The WE, HO, and RD motions are hand and wrist motions, therefore, the performance of these
motions may be less impacted by an injury to the elbow. For example, the HO motion involves the
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relaxation of the forearm muscles as the hand is released from the closed position, which may be
less strenuous on the elbow. The lower classification performances may also be due to the muscles
involved in the motion. The primary muscles involved in RD, the extensor carpi radialis and the
flexor carpi radialis, were not used as inputs for the classification models. The WE motion is
primarily performed by the ECU muscle, which suggests that the activation of the ECU muscle is
less informative for assessing elbow health.
The performances of the initial models ranging from 45.9–79.6% were not ideal. This raises
the possibility of exploring additional options to improve the performance. The next section will
describe the aggregation of the individual motion models into single models in an attempt to
improve the classification performances.
Table 4.2: Range of classification accuracies for each motion.
Motion Classification Accuracy (%)
EF 57.4–74.2
EE 62.3–77.8
P 49.4–72.2
S 50.0–72.2
WF 56.8–79.6
WE 54.3–66.7
UD 57.4–72.2
RD 45.9–77.8
HC 54.9–72.2
HO 48.2–64.2
4.1.2 Majority Vote Models
The classification models for each motion were next aggregated into a majority vote. The decision
agreed upon by the majority of the ten individual motion models for each patient was selected as
the final classification result. This procedure reduced the effect of errors made by individual motion
models. The majority vote models were evaluated using a leave-one-patient-out cross-validation.
The results of the majority votes for each feature set and classification model are shown in Table
4.3.
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The classification accuracies ranged from 58.6–74.7%. Most of the accuracies obtained with
the majority vote models were within the upper range of accuracies that had been achieved with
the individual motion models. Two of the majority vote models (SVM with FS1 and LDA with
FS2) surpassed the accuracies of all of the individual motion models (see Table 4.1). This indicates
that misclassification can be reduced by performing a majority vote, although the motion models
often still agree on incorrect classifications.
Table 4.3: Majority vote classification accuracies. Majority vote decisions were developed from all
ten motions. The best classification results within each feature set are in bold.
Feature Set Classification Accuracy (%)
LDA SVM RF
FS1 67.9 69.8 71.0
FS2 70.4 58.6 69.8
FS3 71.6 74.7 71.6
The majority vote model was further extended by implementing a weighted majority vote
decision. The individual motion models were weighted by their respective classification accuracies.
For example, when using the LDA classifier with FS1, the weights for each decision model were
selected as follows: EF = 62.3, EE = 65.4, P = 69.1, S = 60.5, etc., based on the classification
results found in Table 4.1. The sum of the weights of the decision models that identified the
patient as healthy was determined, as well as the sum of the weights of the models that identified
the patient as injured. The highest sum (representing either healthy or injured) was selected as the
final weighted majority vote decision. The classification results for the weighted majority vote are
shown in Table 4.4. The weighted majority vote classification accuracies ranged from 64.8–77.2%,
and the weighted vote provided improvements to the basic majority vote classification accuracy
for all models. This improvement was expected, as the influence of models that were known to
be less accurate was reduced. The weighted majority vote provided the highest accuracies when
combined with the RF classifier.
The weighted majority vote requires the prior knowledge of how to weight the motion models,
and still requires the patient to perform all ten motions. The benefits of using a weighted majority
vote could be improved if some of the motions were completely eliminated from consideration in
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Table 4.4: Weighted majority vote classification accuracies. The best classification results within
each feature set are in bold.
Feature Set Classification Accuracy (%)
LDA SVM RF
FS1 72.2 71.0 74.1
FS2 73.5 64.8 75.3
FS3 71.6 73.5 77.2
the vote. This would decrease the number of motions that a patient would be required to perform,
as well as the size of the input data sets.
The WE and HO motions provided low ranges of classification accuracies (Table 4.2), so they
were eliminated from the majority vote decision. The RD motion was also removed from the
majority vote decision because, with the exception of one classification model, the individual
motion models provided classification accuracies below 70%. Majority vote decisions based on
the outputs of the top motions (EF, EE, P, S, WF, UD, and HC) were weighted equally. The
classification results for the majority vote models using only the top motions are shown in Table
4.5.
Table 4.5: Majority vote classification accuracies of majority vote decisions developed from the
top motions (EF, EE, P, S, WF, UD, and HC). The best classification results within
each feature set are in bold.
Feature Set Classification Accuracy (%)
LDA SVM RF
FS1 70.4 69.1 75.3
FS2 69.1 60.5 67.9
FS3 72.2 72.8 74.1
The majority vote classification accuracies ranged from 60.5–75.3% for the top motion models.
The highest classification accuracy of 75.3% was achieved using the RF classifier combined with
FS1.
The implementation of only the top motion models in the majority vote improved upon the
original majority vote. However, out of the three majority vote types investigated, the weighted
majority vote provided the best classification accuracies. It should be noted that the improvements
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obtained by using the weighted models and the top motion models may have upward bias, as the
same set of patient data was used to validate these models.
The majority vote models provided more consistent results than the individual motion models,
however, a maximum accuracy of only 77.2% was achieved. Other potential methods of improving
performance will be discussed in the following sections.
4.2 Data Windows
The classification models for health must be implemented in a wearable device, which will restrict
the computational power and memory of the system. Data windowing would allow for smaller
data sets, faster processing times, and lower computational and memory requirements. Data
windowing would also be able to provide real-time estimates of patient health. The classification
models discussed so far in this chapter were developed from features that were extracted from the
entire segment of the EMG signal representing each motion. This section will discuss the effect of
applying data windows to the patient data.
The EMG data from each motion were divided into the following segmentation windows of 50%
overlap: 250 ms with 125 ms increments, and 125 ms with 75 ms increments. The segmentation
window sizes were based on commonly used window sizes in the literature, and the recommended
window sizes for myoelectric control [85,86].
FS1–FS3 were extracted from the data windows. Classification models were developed for
each feature set and motion individually, and were evaluated using a leave-one-patient-out cross-
validation. The classification results for the 250 ms windows are shown in Table 4.6, and the
results for the 125 ms windows are shown in Table 4.7. The accuracies for the 250 ms windows
ranged from 52.0–70.8%, and the accuracies for the 150 ms windows ranged from 49.3–69.8%.
The performances of the window sizes depended on both the classifier used and the motions
that were performed. Windows consisting of the entire motion tended to provide better results
for the RF classifier (Figure 4.2). Windows for the full motion also tended to provide better
performances for the EF, EE, P, and WF motions. The 250 ms window worked best for the HO
motion. The 150 ms and 250 ms windows both tended to outperform the full window when used
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Table 4.6: Classification accuracies for each feature set extracted from window segments of 250 ms
with 50% overlap. The best classification result for each motion within each feature set
is in bold.
Feature Set Motion
Classification Accuracy (%)
LDA SVM RF
FS1 (MAV, SSC,
WL, ZC)
EF 62.4 65.0 61.1
EE 64.6 65.0 67.0
P 63.1 60.4 65.8
S 65.8 61.9 68.1
WF 64.9 61.2 60.4
WE 62.6 63.6 63.2
UD 65.8 65.2 63.9
RD 65.4 63.1 65.1
HC 59.0 52.0 68.1
HO 67.6 65.3 66.0
FS2 (RMS, AR2)
EF 62.3 58.2 64.0
EE 66.4 64.6 65.6
P 62.3 57.0 59.7
S 60.9 57.1 64.1
WF 62.5 56.0 62.9
WE 67.6 57.6 62.2
UD 59.7 59.6 65.9
RD 61.6 57.4 61.6
HC 62.4 54.3 70.8
HO 61.4 68.1 64.4
FS3 (MSA, MSF,
MSS, MNPPS, MSD)
EF 64.0 67.2 65.0
EE 63.2 65.0 65.2
P 63.4 64.2 62.6
S 69.4 62.6 67.8
WF 61.1 63.4 60.7
WE 62.8 65.6 64.6
UD 65.6 67.2 63.4
RD 64.5 63.1 70.4
HC 61.8 53.4 68.0
HO 64.5 60.0 62.3
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Table 4.7: Classification accuracies for each feature set extracted from window segments of 150 ms
with 50% overlap. The best classification result for each motion within each feature set
is in bold.
Feature Set Motion
Classification Accuracy (%)
LDA SVM RF
FS1 (MAV, SSC,
WL, ZC)
EF 64.8 63.1 60.8
EE 64.4 63.6 63.5
P 61.6 56.9 66.4
S 68.8 59.2 65.4
WF 62.0 58.6 61.2
WE 63.8 60.8 61.1
UD 65.1 59.5 68.0
RD 62.7 58.7 69.8
HC 61.8 52.8 60.8
HO 62.1 59.9 59.9
FS2 (RMS, AR2)
EF 64.3 60.5 62.8
EE 65.6 64.8 63.5
P 61.0 59.6 64.8
S 62.3 57.3 68.6
WF 63.7 55.3 63.5
WE 66.7 60.4 63.2
UD 63.7 57.5 67.0
RD 62.3 57.4 67.0
HC 61.9 57.2 63.4
HO 57.6 56.9 63.6
FS3 (MSA, MSF,
MSS, MNPPS, MSD)
EF 57.5 52.5 59.8
EE 52.9 48.8 56.2
P 57.6 50.9 61.9
S 62.0 59.8 60.8
WF 61.8 58.4 64.2
WE 62.9 49.3 63.7
UD 63.7 53.4 64.4
RD 57.7 50.2 67.9
HC 58.1 50.9 56.5
HO 56.4 49.3 56.8
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(a) LDA (b) SVM
(c) RF
Figure 4.2: FS1 classification accuracies for 150 ms windows, 250 ms windows, and windows con-
sisting of the full motion. The range of the y axis has been adjusted for clarity. The
motions tested were as follows: elbow flexion (EF), elbow extension (EE), forearm
pronation (P), forearm supination (S), wrist flexion (WF), wrist extension (WE), ul-
nar deviation (UD), radial deviation (RD), hand close (HC), and hand open (HO).
with the S, WE, RD, and HO motions.
The optimal window size is likely influenced by the average duration of the motions that were
performed. Elbow motions (EF, EE, P, and S) typically take more time to perform than wrist and
hand motions. The 250 ms and 150 ms window sizes therefore represent a lower proportion of the
overall motion for the elbow motions than for the hand and wrist motions.
Changing the window size from 250 ms to 150 ms did not significantly degrade the classification
accuracies, which is consistent with Oskoei and Hu’s observation that classification accuracies do
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not significantly differ if the window size remains between 50–500 ms [87].
The results indicate that there is the possibility of using windowed segments to achieve similar
or even better results than using a window representing the full duration of the motion.
4.3 Feature Selection
In order to identify EMG features and feature sets that are useful for differentiating between
healthy and injured limbs, the process of feature selection was performed. First, all of the features
summarized in Section 2.8 were extracted from the EMG data sets. The performances of each
feature were then evaluated individually, and feature sets were developed based on combinations
of the best individual features. Feature reduction was performed with the RELIEFF algorithm
in order to further optimize feature sets. Classifiers developed using the new feature sets were
evaluated.
4.3.1 Individual Feature Performances
The classification performances for individual EMG features were evaluated by developing models
for each feature and each motion, combining the motion models into a majority vote, and then
evaluating the final models with a leave-one-patient-out cross-validation. The individual feature
models classified between healthy and injured limbs with accuracies ranging from 46.3–76.5%. The
LDA classifier provided the highest classification accuracy for most individual features. Table 4.8
shows the individual classification performances ranked in order of LDA classification performance.
The individual features were then organized and ranked by classification performance based
on the type of information that each feature provides (Table 4.9). The following features were
ranked the highest for each feature category: LOG (time domain: energy), DASDV (time domain:
information complexity), MYOP (time domain: frequency), MAVS (time domain: multi-window),
PSR (frequency domain), AR4 (prediction model coefficients), ApEn (entropy), MFL (fractal
dimension), SKEW (higher order statistics), and MSD (spike shape analysis).
4.3 Feature Selection 87
Table 4.8: Majority vote classification accuracies for individual features. Features are ordered by
LDA classification accuracy. The best classifier result for each feature is in bold.
Feature LDA SVM RF
MFL 76.54 73.45 59.88
MYOP 74.69 66.67 58.64
MSD 74.69 54.94 55.56
AR4 74.07 59.88 50.00
MSF 72.84 72.84 54.94
MNPPS 70.99 64.20 52.47
PSR 70.99 66.67 56.17
ApEn 69.14 65.43 57.41
LOG 69.14 57.41 63.58
MNF 69.14 68.52 54.32
ZC 68.52 62.35 55.56
DASDV 68.52 51.85 61.73
VCF 68.52 57.41 56.17
AAC 67.90 51.85 59.88
MSS 67.90 51.85 56.17
MMAV2 67.38 54.32 61.73
WL 66.05 51.85 56.17
CC4 66.05 51.23 50.62
MDF 65.43 65.43 56.79
SampleEn 65.43 64.81 56.17
SSC 64.81 61.73 51.85
MMAV1 64.81 54.94 62.35
HFD 64.20 62.35 59.88
MAVS 64.20 50.00 56.17
PKF 63.58 67.9 61.11
MAV 63.58 55.60 64.81
MSA 63.58 53.70 62.35
MTW 62.96 50.62 64.20
RMS 62.35 57.41 65.43
MHW 61.73 51.85 62.34
SM3 60.49 61.73 60.49
MNP 59.88 52.47 63.58
TTP 58.79 51.85 64.20
VAR 58.64 52.47 64.20
FR 58.02 67.90 58.02
SM1 58.02 51.85 61.11
SKEW 57.41 53.09 50.00
DFA 56.80 46.30 50.00
SM2 55.56 56.79 59.23
WAMP 54.32 56.17 50.62
KURT 52.47 53.70 50.00
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Table 4.9: Individual feature performances organized by feature category.
Feature Type Ranking
Time Domain: Energy 1. LOG
2. MMAV2
3. MMAV1
4. MAV
5. RMS
6. VAR
Time Domain: Information Complexity 1. DASDV
2. AAC
3. WL
Time Domain: Frequency 1. MYOP
2. ZC
3. SSC
4. WAMP
Time Domain: Multi-Window 1. MAVS
2. MTW
3. MHW
Frequency Domain 1. PSR
2. MNF
3. VCF
4. MDF
5. PKF
6. SM3
7. MNP
8. TTP
9. FR
10. SM1
11. SM2
Prediction Model Coefficients 1. AR4
2. CC4
Entropy 1. ApEn
2. SampleEn
Fractal Dimension 1. MFL
2. HFD
3. DFA
Higher Order Statistics 1. SKEW
2. KURT
Spike Shape Analysis 1. MSD
2. MSF
3. MNPPS
4. MSS
5. MSA
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4.3.2 FS4 and FS5 Feature Set Performances
The individual feature performances were used to inform the development of new feature sets. FS4
consisted of the overall top ranked features. The MFL and MYOP features were selected because
adding subsequent features was found to degrade the classification accuracy.
FS5 was developed to include the the maximum ranked feature within each feature category.
SKEW was excluded because of its low individual performances (below 60% for all classifiers). FS5
ultimately consisted of the following features: LOG, DASDV, MYOP, MAVS, PSR, AR4, ApEn,
MFL, MSD.
Feature reduction is necessary in order to improve the performance, speed, and memory usage
of the classifiers. FS5 contained nine features, therefore it was desirable to minimize the number of
features in this set. The RELIEFF algorithm with k=10 was used to rank the top scoring features
in FS5. The MSD, PSR, and MFL features were consistently ranked among the best features in
FS5 for all motions, and were selected for the optimized feature set.
The classification accuracies for the new feature sets are summarized in Table 4.10. FS4 pro-
vided the best ranges of classification accuracies when used with the LDA and SVM classifiers
(63.0–78.4% and 60.5–79.6%), however the ranges achieved with the RF classifier were poor (57.4–
70.4%). FS5 tended to work better with the SVM and RF classifiers, and tended to have poor
classification accuracies when used with the LDA classifier. Following optimization with the RE-
LIEFF algorithm, FS5 tended to achieve higher classification accuracies (Figure 4.3), although
the accuracies were degraded for some of the motions and classifiers. The LDA classifier demon-
strated the greatest improvement following feature reduction. The RF classification results did
not improve following the feature reduction.
The majority vote classification accuracies for FS4 and FS5 are shown in Table 4.11. As was the
case with FS1–FS3, the weighted majority vote provided the best results, followed by the majority
vote of the top motions, and then the majority vote of all motion models. The highest accuracies
were achieved with FS4 using the LDA classifier. FS5 provided higher accuracies following feature
reduction with the RELIEFF algorithm.
Both of the new feature sets (FS4, and FS5 optimized with RELIEFF) provided higher clas-
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Table 4.10: Classification accuracies for each new feature set. The best classification result for
each motion within each feature set is in bold.
Feature Set Motion
Classification Accuracy (%)
LDA SVM RF
FS4 (MFL, MYOP)
EF 78.4 70.4 63.6
EE 68.5 65.4 67.3
P 71.6 70.4 63.6
S 72.2 71.0 70.4
WF 70.3 70.4 70.4
WE 66.0 60.5 57.4
UD 77.2 79.6 67.3
RD 74.7 69.1 67.9
HC 69.8 69.8 63.6
HO 63.0 70.4 63.6
FS5 (LOG, DASDV, MYOP,
MAVS, PSR, AR4,
ApEn, MFL, MSD)
EF 61.7 73.5 71.0
EE 75.9 72.8 72.8
P 59.9 66.7 67.9
S 58.0 71.0 67.9
WF 64.8 59.9 69.1
WE 51.9 58.6 63.0
UD 69.1 74.7 64.8
RD 61.1 73.5 67.3
HC 56.2 63.6 67.3
HO 56.8 64.8 60.5
FS5 Optimized with
RELIEFF (PSR, MFL, MSD)
EF 69.8 71.6 64.8
EE 72.5 72.2 75.9
P 72.8 70.4 66.0
S 71.0 72.8 70.4
WF 56.8 69.1 68.5
WE 61.7 66.7 64.2
UD 72.2 76.5 69.1
RD 67.3 64.8 68.5
HC 65.4 71.0 61.7
HO 63.6 66.7 71.6
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(a) LDA (b) SVM
(c) RF
Figure 4.3: FS5 classification accuracies for all features and after feature reduction with RELIEFF.
The range of the y axis has been adjusted for clarity. The motions tested were as
follows: elbow flexion (EF), elbow extension (EE), forearm pronation (P), forearm
supination (S), wrist flexion (WF), wrist extension (WE), ulnar deviation (UD), radial
deviation (RD), hand close (HC), and hand open (HO).
Table 4.11: Majority vote classification accuracies for feature sets FS4 and FS5. The best classi-
fication result for each feature set is in bold.
Classification Accuracy (%)
LDA SVM RF
Feature Set All Weighted Top All Weighted Top All Weighted Top
FS4 77.8 82.1 79.6 73.4 74.1 77.8 62.3 71.0 64.2
FS5 64.8 67.3 68.5 73.5 75.9 76.5 66.7 75.3 65.4
FS5 Optimized
with RELIEFF
74.1 79.6 74.1 78.4 81.5 77.2 63.0 77.2 62.3
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sification accuracies than the feature sets developed from the literature (FS1–FS3). These results
suggest that the MFL, MYOP, PSR, and MSD features are preferable to the more commonly used
EMG features for identifying muscle health.
4.4 Patient Characteristics
Further improvement to the classification models was attempted by introducing patient character-
istics into the models. The sex, age, BMI, and time since injury of the patients were included as
features in the LDA, SVM, and RF classification models.
These characteristics were input into the classification models as the following feature values:
 Sex:
– Male: 1
– Female: 2
 Age (Years):
– <30: 1
– 30–45: 2
– >45: 3
 BMI (kg/m2):
– Normal (18.5–25): 1
– Overweight (25–30): 2
– Obese (>30): 3
 Time Since Injury:
– Early (0–6 weeks): 1
– Late (7–12 weeks): 2
 Injured Limb Dominance:
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– Dominant: 1
– Non-Dominant: 2
The patient characteristic features were added to FS1–FS5, and the classification accuracies were
obtained using leave-one-patient-out cross-validation (Table 4.12). The results were compared with
the classification accuracies obtained from FS1–FS5 without the patient characteristics included.
The inclusion of the patient characteristic features did not significantly improve the classification
accuracies for any of the motion models. Comparisons of the classification accuracies for FS4 with
and without the patient characteristic features are shown in Figure 4.4.
The individual decision tree classification models within the RF classifier were assessed to
determine if patient characteristic features were selected as splitting rules. The number of instances
that each feature type was selected for a splitting rule was counted for 2000 decision trees (200
per motion model). The average number of times that each patient characteristic feature was used
for a splitting rule was calculated and compared to the average number of times that the LOG
features were used (Figure 4.5). The features selected for decision branches by the RF algorithm
were overwhelmingly EMG features.
Based on this analysis, the patient characteristics of sex, age, BMI, time since injury, and hand
dominance do not provide important information for the classifiers tested that could assist with
determining the category of muscle health.
4.5 Three-Class Models
Following the development of models with only two categories of health (healthy and injured),
models were developed to distinguish between three categories of health: healthy, the early stages
of rehabilitation (0–6 weeks of therapy), and the late stages of rehabilitation (7+ weeks of therapy).
The rationale behind these divisions was that strengthening rehabilitation exercises begin at 7–8
weeks of therapy [16, 20]. As well, patients in later stages of recovery have been observed to have
more similar EMG metrics to healthy subjects [12]. A three-class model could therefore be expected
to improve classification over a two-class model if patients in the later stages of rehabilitation were
more likely to be misclassified as healthy by the two-class model.
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Table 4.12: Classification accuracies for feature sets including patient characteristic features. The
best classification result for each motion within each feature set is in bold.
Feature Set Motion
Classification Accuracy (%)
LDA SVM RF
FS1 (MAV, SSC,
WL, ZC)
EF 65.4 66.7 71.0
EE 66.0 60.5 74.1
P 61.1 68.5 67.9
S 56.8 51.9 67.9
WF 64.8 59.9 71.6
WE 55.6 62.3 54.3
UD 54.9 67.3 68.5
RD 59.9 66.0 66.0
HC 63.6 59.9 73.5
HO 59.8 60.5 59.9
FS2 (RMS, AR2)
EF 61.1 58.0 70.4
EE 63.6 74.1 70.4
P 64.8 58.6 69.8
S 54.9 61.7 73.5
WF 58.6 63.6 71.0
WE 61.7 53.7 61.7
UD 61.1 65.4 68.5
RD 57.4 57.4 72.8
HC 66.7 59.9 72.8
HO 58.0 65.4 66.0
FS3 (MSA, MSF,
MSS, MNPPS, MSD)
EF 63.6 64.8 69.8
EE 66.0 67.3 71.6
P 67.3 66.0 65.4
S 58.6 66.0 73.5
WF 60.5 64.8 71.0
WE 61.7 71.6 68.5
UD 61.7 70.4 66.0
RD 59.9 73.5 66.0
HC 59.3 64.2 67.9
HO 56.2 56.2 58.6
FS4 (MFL, MYOP)
EF 71.6 66.0 61.7
EE 65.4 64.2 67.9
P 72.2 66.7 63.6
S 70.4 72.2 71.0
WF 69.8 66.0 70.4
WE 60.5 63.6 57.4
UD 74.1 77.8 54.2
RD 71.0 63.0 69.8
HC 69.8 59.9 64.8
HO 64.8 72.8 63.0
FS5 Optimized with
RELIEFF (PSR, MFL, MSD)
EF 64.2 69.1 67.9
EE 70.4 74.1 75.9
P 73.5 64.2 70.4
S 69.8 74.1 72.2
WF 58.0 69.8 67.9
WE 60.5 69.8 69.8
UD 69.8 76.5 69.8
RD 70.4 69.1 73.5
HC 66.0 71.0 63.0
HO 67.3 67.3 70.4
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(a) LDA (b) SVM
(c) RF
Figure 4.4: FS4 classification accuracies with and without patient information. The range of the
y axis has been adjusted for clarity. The motions tested were as follows: elbow flexion
(EF), elbow extension (EE), forearm pronation (P), forearm supination (S), wrist
flexion (WF), wrist extension (WE), ulnar deviation (UD), radial deviation (RD),
hand close (HC), and hand open (HO).
Of the patients evaluated, 13 patients were considered to be in the early stages of injury and
14 patients were considered to be in the later stages. Healthy data sets were collected from the
27 healthy patient arms. In order to prevent imbalance in the number of instances in each class,
12 data sets were randomly selected from each of the three classes for training, and one data set
was selected from each category for testing. This process was repeated 10 times, and the average
of the accuracies obtained was used as the final result.
The three-class model classification results are shown in Table 4.13 for FS1–FS5. The accuracies
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Figure 4.5: Average number of times features were used for decision tree splitting rules in RF
classifier.
ranged from 23.3–63.3%. Most results were equal to or slightly greater than the baseline accuracy
of 33.3%. These levels of accuracy would not be adequate for determining muscle health.
Confusion matrices were developed to determine if the models tended to have difficulties dis-
tinguishing between specific classes. The confusion matrices for the EF and EE motions for the
LDA classifier are shown in Table 4.14 and Table 4.15 respectively.
The rows of the confusion matrix represent the actual classes, and the columns represent the
predicted classes. Each cell of the confusion matrix represents the percentage of instances within
a specific actual class that were classified as a specific predicted class. The ideal confusion matrix
for a three-class classification problem would have 33.33% in each of the three cells along the
left diagonal of the matrix (representing the correct predictions), and 0% in the remaining cells
(representing the incorrect predictions).
In general, the confusion matrices for the classification results tended to indicate that more
misclassifications occur between the early and late patient categories than between the early and
healthy and the late and healthy categories. The patients included in this study suffered from
various types and severities of injuries, hence the number of weeks spent in therapy is likely a poor
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Table 4.13: Classification accuracies for three categories of health (baseline accuracy = 33.33%).
The best classification result for each motion within each feature set is in bold.
Feature Set Motion
Classification Accuracy (%)
LDA SVM RF
FS1 (MAV, SSC,
WL, ZC)
EF 33.3 35.6 36.7
EE 32.2 38.9 41.1
P 36.7 37.8 28.9
S 63.3 47.8 54.4
WF 51.1 40.0 35.6
WE 50.0 37.8 35.6
UD 34.4 33.3 45.6
RD 50.0 48.9 37.8
HC 38.9 45.6 43.3
HO 34.4 41.1 30.0
FS2 (RMS, AR2)
EF 46.7 45.6 53.3
EE 44.4 41.1 38.9
P 47.8 35.6 31.1
S 45.6 48.9 42.2
WF 43.3 50.0 31.1
WE 35.6 40.0 34.4
UD 46.7 37.8 34.4
RD 55.6 26.7 26.8
HC 37.8 31.1 54.4
HO 32.2 57.8 40.0
FS3 (MSA, MSF,
MSS, MNPPS, MSD)
EF 38.9 26.7 26.7
EE 36.7 56.7 36.7
P 40.0 31.1 36.7
S 43.3 43.3 37.8
WF 38.9 33.3 38.9
WE 41.1 43.3 34.4
UD 53.3 44.4 41.1
RD 30.0 37.8 35.6
HC 41.1 58.9 37.8
HO 34.4 36.7 35.6
FS4 (MFL, MYOP)
EF 50.0 43.3 33.3
EE 37.8 61.1 46.7
P 35.6 36.7 31.1
S 48.9 53.3 56.7
WF 35.6 36.7 37.8
WE 34.4 32.2 26.7
UD 48.9 53.3 34.4
RD 52.2 41.1 38.9
HC 51.1 50.0 44.4
HO 40.0 41.1 41.1
FS5 Optimized with
RELIEFF (PSR, MFL, MSD)
EF 35.6 36.7 33.3
EE 45.6 41.1 33.3
P 38.9 30.0 32.2
S 47.8 51.1 47.8
WF 33.3 44.4 33.3
WE 53.3 32.2 34.4
UD 56.7 61.1 38.9
RD 47.8 42.2 23.3
HC 36.7 52.2 43.3
HO 41.1 45.6 47.8
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Table 4.14: Confusion matrix for elbow flexion with LDA classifier. Correct predictions are in
bold.
Predicted
Actual Healthy Early Late
Healthy 15.11% 8.89% 9.33%
Early 3.56% 17.78% 12.00%
Late 8.89% 16.00% 8.44%
Table 4.15: Confusion matrix for elbow extension with LDA classifier. Correct predictions are in
bold.
Predicted
Actual Healthy Early Late
Healthy 18.89% 9.33% 5.11%
Early 4.22% 18.67% 10.44%
Late 12.67% 8.89% 11.78%
estimate of the patient health, and this is reflected by the poor classification results. The results
suggest that the stage of injury was not discernible based on the EMG signals.
4.6 Statistical Analysis of Features
Following the development of classification models, a statistical analysis of the EMG features was
conducted in order to identify trends in the EMG data related to patient health. The Statistical
Package for Social Sciences v.24 (SPSS) software was used to perform all analyses, and a statistical
significance of 0.05 was used.
Paired difference tests were conducted to identify differences between the healthy and injured
limbs of the patients. A repeated measures analysis was also conducted for the patients who
performed trials at multiple stages of their rehabilitation. This section will discuss the significant
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differences found in the results.
4.6.1 Paired Difference Tests
Paired difference tests were performed for the following EMG features: LOG, DASDV, MYOP,
PSR, ApEn, MFL, and the spike shape analysis features (MSA, MSF, MSS, MNPPS, MSD). These
features were selected for analysis because they had exhibited the highest individual classification
performances within their respective feature categories.
The EMG features for each muscle were first averaged over the three repetitions of each motion
for each patient. Pairs were then formed between the healthy and injured features for each patient.
The distribution of each EMG feature for each muscle was evaluated for normality using the
Shapiro–Wilk test. A paired samples t-test was applied to the pairs observed to have normal dis-
tributions. A Wilcoxen signed rank test was applied to pairs that were not normally distributed.
There were 11 features tested over 7 muscles and 10 different motions, therefore 770 paired differ-
ence tests were performed. Using a statistical significance of 0.05, 266 significant differences were
identified. The false discovery rate [120] for this dataset was estimated to be 14.5%. The muscles
and the motions that exhibited statistically significant differences between healthy and injured
limbs are summarized for each feature tested in Tables 4.16–4.25.
The mean values of the healthy LOG features were higher for the healthy muscles for all muscles
and motions tested. The significant differences were primarily observed in the forearm muscles
(PT, BRD, ECU, FCU), and are listed in Table 4.16. The MFL feature was also observed to have
a higher mean in the healthy limb for all muscles and motions. The significant differences are
shown in Table 4.17.
The mean MYOP values for the healthy muscles were higher than the mean values for the
injured muscles for all instances with significant differences (Table 4.18). The BB and TB1 muscles
showed a trend towards having lower mean MYOP values for the healthy limb, although none of
these differences were significant.
Fewer significant differences between the healthy and injured means were observed for the
DASDV, PSR, and ApEn features. The healthy group had higher mean DASDV values than the
injured group for all instances (Table 4.19). The PSR feature was significantly lower for the TB1
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Table 4.16: Significant differences for paired difference tests for the LOG feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF PT 8.96E-04 3.77E-04 0.005
BRD 7.92E-03 2.14E-03 <0.001
ECU 1.01E-03 4.51E-04 0.025
FCU 1.32E-03 3.21E-04 <0.001
EE TB2 1.14E-03 9.34E-04 0.006
PT 1.01E-03 4.39E-04 0.025
BRD 8.33E-03 2.22E-03 <0.001
FCU 9.60E-04 2.89E-04 0.008
P TB2 1.26E-03 4.38E-04 0.004
PT 1.05E-03 3.10E-04 0.002
BRD 7.58E-03 1.96E-03 <0.001
FCU 7.13E-04 2.76E-04 0.006
S PT 7.19E-04 3.24E-04 0.003
BRD 7.63E-03 1.87E-03 <0.001
ECU 1.20E-03 4.50E-04 0.021
FCU 7.06E-04 2.42E-04 0.007
WF BRD 5.89E-03 1.82E-03 <0.001
ECU 2.45E-03 7.91E-04 0.005
WE PT 6.75E-04 2.12E-04 0.001
BRD 7.40E-03 1.88E-03 <0.001
ECU 1.42E-03 5.81E-04 0.017
FCU 7.09E-04 1.74E-04 <0.001
UD PT 5.19E-04 2.19E-04 0.015
BRD 6.86E-03 1.77E-03 <0.001
ECU 2.10E-03 7.45E-04 0.005
FCU 1.67E-03 5.32E-04 0.001
RD PT 8.29E-04 3.00E-04 0.011
BRD 7.32E-03 2.14E-03 <0.001
ECU 1.26E-03 5.29E-04 0.020
FCU 1.28E-03 2.70E-04 <0.001
HC PT 5.34E-04 1.85E-04 0.001
BRD 6.55E-03 1.88E-03 <0.001
ECU 2.20E-03 7.47E-04 0.005
FCU 1.42E-03 5.68E-04 0.015
HO PT 4.64E-04 2.03E-04 0.014
BRD 7.32E-03 1.98E-03 <0.001
ECU 2.25E-03 7.48E-04 0.004
FCU 1.00E-03 4.49E-04 0.014
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Table 4.17: Significant differences for paired difference tests for the MFL feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF PT 4.14E-01 1.31E-01 0.004
BRD 1.05E+00 2.56E-01 <0.001
FCU 4.07E-01 1.00E-01 0.001
EE TB1 3.41E-01 1.42E-01 0.020
TB2 4.57E-01 1.72E-01 0.006
PT 4.12E-01 1.78E-01 0.029
BRD 1.14E+00 2.47E-01 <0.001
FCU 2.39E-01 1.30E-01 0.021
P TB2 3.77E-01 1.32E-01 0.019
PT 4.10E-01 1.24E-01 0.003
BRD 9.87E-01 2.26E-01 <0.001
S PT 3.66E-01 1.31E-01 0.010
BRD 1.10E+00 2.05E-01 <0.001
WF BRD 8.90E-01 1.91E-01 <0.001
ECU 5.16E-01 1.98E-01 0.015
WE PT 3.33E-01 7.65E-02 <0.001
BRD 8.95E-01 1.43E-01 <0.001
ECU 4.77E-01 1.67E-01 0.008
FCU 3.83E-01 8.82E-02 <0.001
UD TB2 3.11E-01 1.33E-01 0.034
PT 2.79E-01 7.82E-02 0.002
BRD 1.00E+00 2.08E-01 <0.001
ECU 5.24E-01 1.77E-01 0.006
FCU 5.70E-01 1.36E-01 <0.001
RD PT 2.89E-01 1.17E-01 0.02
BRD 8.53E-01 1.96E-01 <0.001
FCU 4.74E-01 9.56E-02 <0.001
HC PT 1.96E-01 7.40E-02 0.011
BRD 7.13E-01 1.74E-01 <0.001
ECU 4.60E-01 1.32E-01 0.002
FCU 3.44E-01 1.43E-01 0.023
HO PT 2.14E-01 7.61E-02 0.008
BRD 1.02E+00 2.17E-01 <0.001
ECU 5.97E-01 1.80E-01 0.003
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Table 4.18: Significant differences for paired difference tests for the MYOP feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF TB2 3.55E-02 6.82E-03 0.010
PT 1.85E-02 3.56E-03 <0.001
BRD 3.10E-02 5.97E-03 <0.001
ECU 3.69E-02 7.10E-03 0.019
FCU 2.70E-02 5.21E-03 <0.001
EE BB 2.75E-02 5.30E-03 0.027
TB1 3.60E-02 6.92E-03 0.045
TB2 3.31E-02 6.36E-03 <0.001
PT 4.28E-02 8.25E-03 0.028
BRD 2.68E-02 5.15E-03 <0.001
FCU 3.98E-02 7.66E-03 0.020
P TB2 4.60E-02 8.86E-03 0.001
PT 2.67E-02 5.14E-03 0.002
BRD 4.12E-02 7.92E-03 0.009
FCU 2.72E-02 5.24E-03 0.002
S TB2 5.27E-02 1.01E-02 0.013
PT 3.19E-02 6.14E-03 0.015
BRD 3.52E-02 6.78E-03 0.005
ECU 2.74E-02 5.28E-03 0.044
FCU 3.51E-02 6.76E-03 0.044
WF BRD 3.43E-02 6.61E-03 <0.001
ECU 3.46E-02 6.66E-03 0.005
WE PT 2.48E-02 4.77E-03 0.012
BRD 3.26E-02 6.27E-03 0.002
FCU 2.65E-02 5.10E-03 0.012
UD TB2 4.93E-02 9.49E-03 0.005
PT 2.66E-02 5.12E-03 0.010
BRD 3.10E-02 5.97E-03 0.010
FCU 2.62E-02 5.05E-03 0.034
RD TB2 4.92E-02 9.46E-03 0.002
PT 2.71E-02 5.21E-03 0.013
BRD 3.89E-02 7.49E-03 0.020
FCU 2.48E-02 4.77E-03 0.005
HC TB2 5.41E-02 1.04E-02 0.009
PT 2.47E-02 4.76E-03 0.004
BRD 3.44E-02 6.61E-03 0.004
HO TB2 5.43E-02 1.05E-02 0.011
PT 2.78E-02 5.34E-03 0.100
BRD 3.70E-02 7.13E-03 0.007
ECU 3.61E-02 6.94E-03 0.026
FCU 2.82E-02 5.42E-03 0.004
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Table 4.19: Significant differences for paired difference tests for the DASDV feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF TB1 3.28E-06 1.54E-06 0.016
PT 7.12E-06 2.77E-06 0.001
BRD 7.27E-05 2.23E-05 <0.001
FCU 4.40E-06 1.61E-06 <0.001
EE BRD 6.30E-05 2.06E-05 <0.001
P PT 4.68E-06 1.93E-06 0.002
BRD 5.03E-05 2.00E-05 <0.001
S BRD 5.44E-05 2.22E-05 <0.001
WF BRD 3.52E-05 1.49E-05 <0.001
ECU 1.71E-05 6.17E-06 0.009
WE PT 1.89E-06 5.65E-07 0.001
BRD 4.93E-05 1.74E-05 0.001
FCU 2.38E-06 7.39E-07 0.001
UD PT 1.37E-06 5.41E-07 0.005
BRD 4.66E-05 1.68E-05 <0.001
RD BRD 5.22E-05 1.97E-05 0.001
FCU 5.69E-06 1.59E-06 <0.001
HC PT 1.34E-06 4.56E-07 0.007
BRD 4.28E-05 1.70E-05 0.018
ECU 1.56E-05 7.02E-06 0.035
HO PT 8.89E-07 4.18E-07 0.012
BRD 5.28E-05 1.90E-05 0.001
ECU 1.34E-05 6.02E-06 0.008
muscle and significantly higher for the BRD muscle in the healthy limb (Table 4.20). The ApEn
feature tended to have a lower mean value in healthy muscles (Table 4.21). The ApEn values
showed a trend towards higher values in the healthy BB muscle, although these differences were
not significant.
All of the spike shape analysis features were investigated because these features provided rela-
tively high individual performance classification accuracies. The MSA (Table 4.22) and MSS (Ta-
ble 4.23) features primarily exhibited significant differences in the PT and BRD muscles. Higher
activations were observed in the healthy muscle groups for all motions.
The MSF feature primarily exhibited significant differences between healthy and injured means
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Table 4.20: Significant differences for paired difference tests for the PSR feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF TB1 -1.09E-01 3.13E-02 0.002
BRD 1.83E-01 4.49E-02 <0.001
EE TB1 -7.33E-02 3.43E-02 0.044
PT 9.73E-02 4.22E-02 0.029
BRD 2.63E-01 5.71E-02 <0.001
FCU 1.35E-01 4.53E-02 0.011
P TB1 -6.91E-02 3.14E-02 0.037
BRD 1.77E-01 6.66E-02 0.027
S TB1 -6.56E-02 2.66E-02 0.021
BRD 1.73E-01 6.75E-02 0.029
WF BRD 1.53E-01 6.58E-02 0.021
WE BRD 1.67E-01 6.33E-02 0.041
UD TB1 -1.07E-01 3.85E-02 0.010
BRD 1.55E-01 6.61E-02 0.049
RD TB1 -1.37E-01 3.22E-02 <0.001
HC TB1 -7.47E-02 2.74E-02 0.008
HO TB1 -8.51E-02 3.38E-02 0.018
in the BB, TB1, and BRD muscles. Higher MSF values were observed in the healthy BB and TB1
muscles, and lower values were observed in the BRD and PT muscles (Table 4.24).
Conversely, healthy subjects had lower MSD values for the BB and TB1 muscles, and higher
values for the forearm muscles, although only the BRD muscle showed significant differences (Table
4.25).
The MNPPS feature tended to exhibit lower mean values in healthy patients for the TB1
muscle and higher values for the BRD muscle (Table 4.26).
The general trends observed for each feature did not change depending on the specific motions
that were performed. This could indicate that the EMG trends for injured and healthy patients
are similar regardless of the type of motion performed. However, this could also suggest that
factors outside of the muscle activity influence the EMG signals. For example, decreased muscular
strength in the injured arm due to a period of inactivity could affect the EMG recordings regardless
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Table 4.21: Significant differences for paired difference tests for the ApEn feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF PT -1.25E-01 3.52E-02 0.002
BRD -2.66E-01 7.19E-02 0.002
FCU -1.24E-01 4.48E-02 0.010
EE TB2 -9.57E-02 5.21E-02 0.078
PT -1.98E-01 5.85E-02 0.002
BRD -3.17E-01 6.86E-02 <0.001
P BRD -1.69E-01 7.24E-02 0.028
S TB2 -9.00E-02 4.30E-02 0.011
BRD -2.30E-01 7.76E-02 0.004
WF TB1 1.01E-01 3.04E-02 0.002
BRD -1.82E-01 6.30E-02 0.008
WE BRD -1.53E-01 4.54E-02 0.002
ECU -9.09E-02 3.36E-02 0.012
FCU -9.86E-02 3.70E-02 0.013
UD BRD -1.79E-01 5.82E-02 0.005
RD BRD -1.45E-01 4.64E-02 0.002
FCU -8.20E-02 2.35E-02 0.002
HC BRD -1.48E-01 4.85E-02 0.005
FCU -4.97E-02 2.32E-02 0.042
HO TB1 6.95E-02 3.30E-02 0.045
BRD -1.66E-01 6.49E-02 0.037
of the motion performed.
The EF, EE, WF, and WE motions exhibited the most significant differences between motion
pairs, and P and HO had the least significant differences. This is consistent with the P and HO
motion models tending to provide lower classification accuracies.
The forearm muscles (PT, BRD, ECU, FCU) tended to provide significant differences between
healthy and injured groups for all of the motions performed, with the BRD muscle exhibiting
the most differences for all motions. The major elbow flexors and extensors (BB, TB1, and TB2
muscles) tended to exhibit the most differences when the EF, EE, P, S, and WF motions were
performed. With the exception of the WF motion, this is consistent with the necessity of the
activation of the major elbow muscles to perform the EF, EE, P, and S motions.
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Table 4.22: Significant differences for paired difference tests for the MSA feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF BRD 8.76E-02 3.06E-02 <0.001
FCU 2.76E-05 8.66E-06 <0.001
EE BRD 8.04E-04 2.79E-04 <0.001
P PT 3.20E-05 1.37E-05 0.002
BRD 6.14E-04 1.99E-04 0.001
S BRD 6.06E-04 2.11E-04 <0.001
WF BRD 4.23E-04 2.01E-04 <0.001
ECU 1.11E-04 4.05E-05 0.012
WE PT 1.35E-05 4.65E-06 0.002
BRD 6.83E-04 2.50E-04 <0.001
ECU 6.03E-05 2.77E-05 0.009
FCU 1.30E-05 3.57E-06 0.001
UD PT 8.78E-06 3.92E-06 0.015
BRD 5.39E-04 1.80E-04 0.001
FCU 6.36E-05 3.10E-05 0.002
RD BRD 7.11E-04 2.96E-04 0.001
FCU 3.71E-05 1.05E-05 <0.001
HC PT 9.50E-06 3.96E-06 0.002
BRD 6.12E-04 2.46E-04 0.001
ECU 1.10E-04 4.88E-05 0.008
HO BRD 7.01E-04 2.53E-04 0.001
ECU 8.93E-05 3.97E-05 0.009
The results of the paired difference tests suggest that there is more activation in healthy muscles
compared to injured muscles, particularly in terms of signal energy and information complexity of
the EMG signal. MSA and MSS were also always higher in the healthy group, which suggests that
there was both higher MU recruitment and synchronization in the healthy muscles. The ApEn
feature was lower in most healthy muscles, indicating that the EMG signal had a greater amount
of predictability for healthy muscles.
The injured BB and TB1 muscles were observed to have more activity in the MYOP, MSF,
and MNPPS features. The PSR feature also demonstrated a higher TB1 activation in the injured
subjects. The ApEn and MSD features demonstrated the reverse of this pattern. This suggests
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Table 4.23: Significant differences for paired difference tests for the MSS feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF TB1 2.11E-03 1.00E-03 0.031
PT 5.98E-03 2.21E-03 0.007
FCU 5.05E-03 1.53E-03 <0.001
EE BRD 7.90E-02 3.00E-02 <0.001
P PT 6.39E-03 2.39E-03 0.001
BRD 6.65E-02 2.86E-02 <0.001
S PT 3.99E-03 1.85E-03 <0.001
BRD 7.30E-02 3.42E-02 <0.001
WF ECU 2.64E-02 9.50E-03 0.009
WE PT 2.74E-03 7.10E-04 <0.001
BRD 6.71E-02 2.77E-02 0.001
FCU 2.56E-03 7.07E-04 <0.001
UD PT 1.57E-03 6.88E-04 0.002
BRD 5.75E-02 2.51E-02 <0.001
RD BRD 6.60E-02 2.87E-02 0.002
FCU 8.23E-03 2.39E-03 <0.001
HC PT 2.17E-03 8.14E-04 0.002
BRD 6.03E-02 2.71E-02 0.002
ECU 2.34E-02 9.88E-03 0.006
HO BRD 6.91E-02 2.79E-02 0.001
ECU 1.96E-02 8.61E-03 0.015
that the major elbow flexors and extensors may be more active in injured limbs. The MYOP and
PSR features both represent the frequency of the EMG signal, indicating that the EMG frequency
is higher for the injured BB and TB1 muscles. The increase in the MSF and MNPPS features and
the decrease in the MSD features indicates increased MU recruitment and synchronization.
The results for the LOG, MYOP, MSA, and PSR features are of particular interest because the
efficacy of using similar features for assessing elbow muscle health was studied by Haddara [12].
Haddara compared EMG data collected from elbow trauma patients with EMG data collected
from healthy subjects performing upper-limb motions. The injured subjects exhibited significantly
higher RMS, MAV, ZC, and MSA feature values compared to the healthy subjects. A general
trend of higher values for the MNF and MDF frequency domain features was found in the patient
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Table 4.24: Significant differences for paired difference tests for the MSF feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF BB 1.10E+01 3.23E+00 0.002
TB1 1.06E+01 4.61E+00 0.029
PT -9.09E-02 3.48E+00 0.979
EE BB 1.49E+01 3.23E+00 0.001
BRD -4.05E+01 9.64E+00 0.001
P BB 1.05E+01 3.75E+00 0.010
TB1 1.03E+01 3.91E+00 0.014
S TB1 1.15E+01 2.90E+00 <0.001
BRD -2.34E+01 1.01E+01 0.016
WF BB 1.07E+01 4.69E+00 0.029
TB1 1.54E+01 4.29E+00 0.002
WE TB1 1.12E+01 4.96E+00 0.032
BRD -2.15E+01 9.15E+00 0.027
UD TB1 1.48E+01 4.65E+00 0.004
RD BB 8.35E+00 3.30E+00 0.018
TB1 1.45E+01 4.36E+00 0.003
HO TB1 1.27E+01 4.61E+00 0.011
population, however no significant differences were found.
The results of this study were not in agreement with the conclusions made by Haddara. The
LOG feature values were higher in the healthy group, which was the opposite of Haddara’s ob-
servation that injured patients exhibit higher values for the time domain features that describe
signal energy (RMS and MAV). Furthermore, with the exception of the BB muscle, the MYOP
feature was lower for injured muscles. This was the opposite of Haddara’s observations for the ZC
feature, which like MYOP is a time domain feature that describes the signal frequency. Finally,
several significant differences were observed for the PSR feature in this study, whereas Haddara
found that frequency domain features do not demonstrate significant differences.
The differing results between this study and Haddara’s study could be due to the differences
in the data collection protocols. In this study, control values were obtained from the contralateral
healthy arm of the each patient. In Haddara’s trials, the healthy controls were obtained from a
separate population of subjects. There was no effort to ensure that the healthy subjects resembled
4.6 Statistical Analysis of Features 109
Table 4.25: Significant differences for paired difference tests for the MSD feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF BB -9.68E-04 2.92E-04 0.004
TB1 -1.05E-03 4.31E-04 0.022
BRD 2.81E-03 7.83E-04 0.002
EE BB -8.81E-04 1.98E-04 <0.001
BRD 4.54E-03 1.29E-03 0.002
P BB -7.62E-04 2.98E-04 0.008
TB1 -6.30E-04 2.23E-04 0.008
BRD 3.31E-03 1.48E-03 0.020
S TB1 -7.55E-04 1.79E-04 <0.001
BRD 3.15E-03 1.40E-03 0.033
WF BB -1.01E-03 4.18E-04 0.022
TB1 -8.50E-04 2.46E-04 0.002
WE TB1 -7.12E-04 2.85E-04 0.012
UD TB1 -9.97E-04 3.06E-04 0.002
RD BB -8.50E-04 2.67E-04 0.005
TB1 -9.13E-04 3.08E-04 0.004
HC TB1 -6.39E-04 2.65E-04 0.017
HO TB1 -7.70E-04 2.60E-04 0.003
the characteristics of the elbow trauma patients in terms of age, sex, BMI, etc. Therefore, some
of the differences that Haddara observed could have been unrelated to subject health, and due to
differences between two groups with different attributes.
However, using the contralateral limb as a control, while avoiding issues with differences in
subject characteristics, could also introduce other confounding factors, particularly differences in
handedness. As well, patients may have begun to overuse their healthy arm. Therefore, the
healthy patient arm may not have represented the state of the patient’s healthy arm under normal
conditions.
The results indicate that while there are some significant differences between the features, there
is often an overlap between healthy and injured EMG feature values. This limits the ability for
the classification models to assess patient health. As well, the trends observed in this study differ
from the trends observed in a similar EMG study. The collection of more data could ameliorate
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Table 4.26: Significant differences for paired difference tests for the MNPPS feature.
Motion Muscle
Mean
(Healthy - Injured)
Standard Error
(Healthy - Injured)
Significance
EF TB1 -8.12E-02 3.11E-02 0.019
BRD 2.21E-01 5.47E-02 <0.001
EE BRD 3.33E-01 8.54E-02 0.001
FCU 7.96E-02 3.70E-02 0.041
P BB -6.30E-02 3.03E-02 0.048
TB1 -6.40E-02 3.06E-02 0.047
S TB1 -6.04E-02 2.69E-02 0.033
BRD 2.01E-01 9.65E-02 0.046
WF TB1 -7.22E-02 3.37E-02 0.041
FCU -4.16E-02 1.97E-02 0.045
WE BRD 1.73E-01 8.04E-02 0.014
UD TB1 -1.04E-01 4.46E-02 0.027
RD TB1 -1.17E-01 3.96E-02 0.007
HO TB1 -7.16E-02 3.34E-02 0.020
the understanding of the differences between healthy and injured limbs.
4.6.2 Returning Patients
A three-level repeated measures comparison was conducted for elbow trauma patients that returned
over the course of their therapy to re-perform the trials. Four patients agreed to return. The
average time since injury was 5.5 weeks for the initial trial, and 8.5 weeks for the subsequent trial.
Repeated measures comparisons were conducted between the three health conditions (healthy, early
stage of rehabilitation, and late stage of rehabilitation). Unfortunately, the data sets for one of the
patients were compromised during some of the trials, therefore the repeated measures comparisons
could only be performed with all four patients for the WF, WE, UD, and RD motions. The
LOG, DASDV, MYOP, PSR, MFL, and spike shape analysis features (MSA, MSF, MSS, MNPPS,
MSD) were tested for significant differences. Table 4.27 and Table 4.28 summarize the muscles and
features that exhibited a significant difference for the WF–WE and UD–RD motions respectively.
The false discovery rate was estimated to be 16.8%.
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The mean values of the PSR and ApEn features were observed to be higher in the healthy
limbs for all muscles and motions tested. The LOG, DASDV, MYOP, and MFL features tended
to have higher values for the healthy forearm muscles (PT, BRD, ECU, FCU) than for the injured
forearm muscles. The BB muscle exhibited higher feature values in the injured limbs than in the
healthy limbs.
Patients re-tested at a later stage of therapy exhibited increases in the PT and BRD muscles
features to more closely resemble the values for the healthy muscles. As well, the BB feature
values decreased to more closely resemble the observations for the healthy limbs. However, the
FCU muscle activity tended to decrease for patients measured at the later stage of rehabilitation,
indicating that there was a greater difference between the injured and healthy muscle activity
following therapy. Examples for these trends are summarized for the LOG feature and the UD
motion in Figure 4.6.
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Table 4.27: Repeated measures comparison for wrist flexion and extension for returning subjects.
Significant differences are in bold.
Instance Factor 1 Factor 2
Mean Difference
(Factor 1 - Factor 2)
Std Error Significance
WF
ApEn BB Healthy Early 0.172 0.016 0.002
Healthy Late 0.039 0.061 0.564
Early Late -0.133 0.065 0.133
MFL TB1 Healthy Early 0.695 0.074 0.003
Healthy Late 0.414 0.27 0.223
Early Late -0.28 0.201 0.256
MFL PT Healthy Early 0.895 0.264 0.043
Healthy Late 0.628 0.079 0.004
Early Late -0.267 0.298 0.436
WE
DASDV ECU Healthy Early 1.17E-05 0.000 0.168
Healthy Late 1.337E-05 0.000 0.022
Early Late -1.66E-06 0.000 0.662
MYOP ECU Healthy Early 0.139 0.126 0.352
Healthy Late 0.046 0.009 0.016
Early Late -0.093 0.133 0.534
MSA ECU Healthy Early 8.85E-05 0.000 0.126
Healthy Late 9.842E-05 0.000 0.017
Early Late 9.94E-06 0.000 0.709
MSS ECU Healthy Early 0.009 0.007 0.328
Healthy Late 0.016 0.003 0.039
Early Late 0.007 0.004 0.214
The general trends suggest that muscle activation in elbow trauma patients is higher in BB
muscles and lower in the TB and forearm muscles. The results also indicate that as the patients
progressed in their therapy, the muscle activity of the injured limb tended to approximate the
healthy EMG signal patterns, with the exception of the FCU muscle. However, the results are not
conclusive, as only four patients were tested.
These results are somewhat similar to the paired difference test observations described in
Section 3.6.1, in which muscle activation was observed to be higher in the TB2 and forearm muscles,
and lower for some features, particularly in features describing the frequency of the EMG signal,
for the BB and TB1 muscles. The paired difference tests and the repeated measures comparisons
both indicate that there is a possibility of using EMG signals to measure the progression of patient
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Table 4.28: Repeated measures comparison for radial and ulnar deviation for returning subjects.
Significant differences are in bold.
RD
Instance Factor 1 Factor 2
Mean Difference
(Factor 1 - Factor 2)
Std Error Significance
LOG FCU Healthy Early 0.001 <0.001 0.82
Healthy Late 0.001 <0.001 0.017
Early Late <0.001 <0.001 0.56
DADSV FCU Healthy Early 1.554E-06 <0.001 0.54
Healthy Late 1.576E-06 <0.001 0.21
Early Late 2.218E-08 <0.001 0.917
MYOP FCU Healthy Early 0.022 0.01 0.115
Healthy Late 0.27 0.003 0.004
Early Late 0.006 0.008 0.561
ApEn BB Healthy Early 0.209 0.061 0.042
Healthy Late 0.069 0.073 0.416
Early Late -0.14 0.127 0.351
UD
LOG FCU Healthy Early 0.002 <0.001 0.015
Healthy Late 0.003 <0.001 0.002
Early Late 0.001 <0.001 0.137
DADSV FCU Healthy Early 1.35E-05 <0.001 0.01
Healthy Late 1.65E-05 <0.001 0.001
Early Late 2.95E-06 <0.001 0.168
MYOP FCU Healthy Early 0.004 0.013 0.791
Healthy Late 0.03 0.005 0.008
Early Late 0.026 0.011 0.099
MFL TB1 Healthy Early 0.782 0.186 0.024
Healthy Late 0.594 0.403 0.237
Early Late -0.189 0.225 0.464
MFL FCU Healthy Early 0.862 0.076 0.001
Healthy Late 1.152 0.191 0.009
Early Late 0.29 0.205 0.251
MSA FCU Healthy Early 7.00E-05 <0.001 0.004
Healthy Late 8.73E-05 <0.001 <0.001
Early Late 1.73E-05 <0.001 0.216
MSS FCU Healthy Early 0.017 0.003 0.011
Healthy Late 0.022 0.002 0.001
Early Late 0.005 0.002 0.13
MNPPS PT Healthy Early -0.159 0.016 0.002
Healthy Late -0.096 0.007 0.001
Early Late 0.063 0.011 0.011
MSD PT Healthy Early -0.001 <0.001 0.027
Healthy Late 0.000 <0.001 0.08
Early Late 0.001 <0.001 0.089
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healing.
There are multiple potential causes for the general trends observed in this study. The lower
muscle activations observed in most of the injured muscles could be due to tissue damage. Greater
activation in the BB and TB1 muscles, particularly in the frequency domain, could be due to
increased MU firing frequency and recruitment required to achieve the motion while injured.
There are other factors that could affect the EMG signals that are indirectly related to the
injury. All of the patients tested would have experienced a loss of muscle mass due to immobility,
which could have resulted in the decrease in muscle activation observed in most muscles. Immo-
bility during the injury could also increase the amount of fatty tissue on the skin, which could
attenuate the signals and provide the appearance of lower muscle activation.
4.7 Conclusion
This concludes the discussion and results section. There is an indication that it is possible to
identify trends, and to differentiate between healthy and injured limbs, based on EMG features.
The features that indicated the most promise towards this objective were the MFL, MYOP, PSR,
and the spike shape analysis features. Statistical analysis revealed that injured subjects generally
have lower muscle activity, although higher muscle activity was observed in the BB and TB1
muscles. Patients tested at later stages of their therapy tended to display EMG signals closer to
the expected properties of healthy EMG signals. A greater number of patients should be studied
and analyzed to validate these results.
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(a) BB (b) TB1
(c) TB2 (d) PT
(e) BRD (f) ECU
(g) FCU
Figure 4.6: LOG feature values for returning subjects. The boxplots are shown for each muscle
during the UD motion.
Chapter 5
Concluding Remarks
The work presented in this thesis was towards developing an EMG-based model of muscle health
for elbow trauma patients. The purpose of the model was to allow for an objective metric of
muscle health to be determined that could identify if a patient was healing. This work was also
towards identifying trends in EMG behaviour that reflect muscle health following elbow trauma.
A literature review was performed to identify the current challenges in elbow rehabilitation, and
the gaps in the development of rehabilitative robotic devices for elbow trauma patients. EMG has
been used to study the muscle health of patients with neuromuscular injuries, however, no models
have yet been developed to identify and diagnose the muscle health of elbow trauma patients.
EMG features have been applied to the myoelectric control of rehabilitative devices for patients
with neuropathologies, and have been used for studying muscle activation and health in certain
patients, however, there has not been any significant work done towards an EMG-based model
of muscle health for elbow trauma rehabilitation. This study attempted to develop EMG-based
classification models to distinguish between the healthy and injured limbs of elbow trauma patients
as a precursor to developing a more advanced model of elbow muscle health. EMG data from
elbow trauma patients performing elbow, hand, and wrist motions were collected, processed, and
analyzed. EMG recordings from the contralateral healthy arm of the patients were collected to
provide a control. Feature extraction and selection were performed. Classification models were
developed and improved. Majority votes of the motions were studied in order to improve accuracy
of the models. Accuracies of up to 82.1% were achieved for these models. However, attempts to
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adequately classify the results based on the time that the patient had spent in rehabilitation were
unsuccessful with the existing data.
Additionally, a statistical analysis of the EMG features was performed. In general, injured
patients tended to show lower muscle activity in most muscles, particularly the forearm muscles.
The BB and TB1 muscles in injured subjects tended to exhibit higher activity in some of the
features than in healthy limbs. There was some evidence, based on patients who returned to
perform the study, that as healing progressed, the behaviour of the injured limbs began to more
closely resemble the behaviour of the healthy limb.
This work helped to identify general trends in EMG signals during elbow trauma healing, and
some of the best features for identifying patient health. The classification models developed in
this thesis achieved results of 48.2–82.1%, and there is much room for improvement.
5.1 Contributions
The contributions of the work presented in this thesis are as follows:
1. A database of sEMG signals was developed from elbow trauma patients and their healthy
limbs. This data can be used towards informing the design of future models and control
systems for a wearable elbow brace. The patient data are particularly useful because the
healthy and injured data sets were collected from the same patient, so that the healthy data
sets can be compared to the injured sets, and can allow for a better representation of the
population of patients (in terms of age, sex, BMI) presenting at clinics with elbow trauma
injuries.
2. EMG features capable of predicting muscle health were identified. An extensive variety of
EMG features was investigated. The best individual features were identified to be MFL,
MYOP, PSR, and spike shape analysis features, in particular MSD.
3. EMG feature sets were developed and evaluated for efficacy of evaluating muscle health. The
spike shape analysis feature set (FS3) provided the best performances of existing feature sets
in the literature. New feature sets were proposed based on combinations of features that
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performed well individually, and the best feature set overall was a feature set consisting of
the MFL and MYOP features.
4. The first classification models to distinguish between healthy and injured limbs of elbow
trauma patients based on EMG data were developed. The highest classification accuracy
achieved (82.1%) was not ideal, however, this sets a baseline for future comparisons.
5.2 Future Work
The work performed indicates that extensive future work will be necessary in order to develop a
practical model of muscle health for a wearable device. The following steps would be required to
improve the results of this specific project:
1. Development of a database of healthy sEMG signals specific to the population for which the
elbow brace will be designed. The average elbow trauma patient recruited for this study was
45 years old and overweight. Only a few studies have examined the muscle activation patterns
of subjects representative of middle-aged and elderly populations [63,121]. There is evidence
that the decrease in strength, power, and upper extremity function with age begins around
age 40, and subjects over the age of 65 experience decreased ROM. Work by Syczewska et al.
found that EMG activation patterns in healthy subjects differed between age groups [121].
Further research should be directed towards further understanding the effects of obesity, age,
BMI, and handedness on healthy sEMG signals and motion activation patterns.
2. Recruitment of elbow trauma patients based on the type and severity of elbow injury. The
patient data sets collected in this study varied in terms of the severity of the injury and the
treatment for their injury. Most notably, some patients had received only non-surgical treat-
ments, some had received arthroscopic surgery, others had received more extensive surgeries
to treat elbow fracture, and one patient underwent multiple surgeries. As well, a variety of
injury types were included in the trial including bicep tendon tears, radial head fractures,
multiple fractures, and elbow dislocations. In order to obtain a more specific model of muscle
health, data sets should be collected from patients who had experienced similar severity and
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types of injuries. Due to the limited availability of subjects from where the patients for this
study were recruited, a multi-site study would most likely be necessary in order to recruit
enough patients in a timely manner.
3. Improve knowledge of the consistency of therapy treatments. The patients’ schedules some-
times took precedence over therapist recommendations. Some of the patients delayed the
start of therapy until up to two weeks after the recommended start time following injury.
Patient adherence to home therapy exercises was also not measured. For a few cases, the
therapist indicated that they believed that the patient had not followed their exercise reg-
imen. Finally, although the patients in the study were recruited from the same site, they
were recruited from different therapists. The treatments recommended to each patient could
have varied based on each therapist’s opinion. Future studies should attempt to record
information about the recommended treatment program and patient adherence.
4. Collect data from the same patients at multiple stages of recovery. Unfortunately, it was
difficult to convince patients to complete the study multiple times. Only four patients were
willing to repeat the study. Issues encountered included the time constraints and availability
of the patients, as well as the fact that some of the patients attending the clinic lived several
hours away and performed the remainder of their therapy treatments in their hometown.
This issue could be diminished if the ease of sEMG acquisition was improved, as described
below.
5. Perform research towards improving the interpretation of sEMG recordings from elbow trauma
patients. The interpretation of sEMG signals is an ongoing challenge. For example, an ob-
served decrease in muscle activity based on sEMG recordings could be due to many underly-
ing factors. Such concerns were observed in a follow-up of patients with Duchenne muscular
dystrophy, in which it was unknown if the decrease in muscle activity was due to the loss
of muscle fibres or to nonmuscular factors such as the increase of fatty tissues near the skin
due to inactivity [65]. Likewise for elbow trauma patients, muscle health will be affected by
both the initial injury and by the periods of relative inactivity following the injury.
Over the course of the study, possibilities for future work with sEMG signal acquisition and
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analysis were identified that are outside of the scope of the work for this project, but would greatly
improve the results of this project. The following issues should be addressed:
1. Ease of sEMG acquisition and interpretation. The use of a commercial dry electrode sEMG
system greatly improved the ease of recording over the standard wet electrode and wired
system, however, the setup for data collection was not without tedium or difficulty. The
patients had to agree to move to a separate room to allow for the space and time for 16
electrodes to be correctly placed on their arms by the experimenter. The process required
the experimenter to be present at the clinic to perform all of the tests.
The improvement of the ease of use of sEMG acquisition systems could lead to an increase in
the amount of data collected for experiments. An acquisition system that is extremely simple
to use could allow therapists to collect data from patients during therapy instead of requiring
the patient to spend additional time with the experimenter to collect data. An sEMG system
that is easy to use could be sent home with the patient, so that data collection could be
obtained as the patient performs home exercises. For example, HD-sEMG technology could
be applied to this problem to allow patients to place an array of electrodes over the entirety
of the desired region, and the experimenter could later assess which electrodes provide the
desired signals. The improvement in the ease of acquisition of EMG signals will be critical
for the development of a smart brace, as patients will eventually be required to use the device
at home without the help of a therapist or researcher.
2. Improvement of sEMG signal quality. sEMG signal quality is a major concern for identifying
patient muscle health. Care should be taken to ensure that the best signal can be read from
the patient. The susceptibility of sEMG signals to noise and motion artifact, as well as the
dependency of sEMG signals on environmental factors such as temperature and humidity,
will be an ongoing issue. As well, the EMG sensors will need to be placed correctly on each
patient’s limb while wearing the device. Again, the use of HD-sEMG electrode arrays may
assist with these issues.
The purpose of this thesis was to develop and evaluate EMG-based classification models for
identifying and monitoring the health of elbow trauma patients. Classification models were de-
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veloped that indicated possible to discern between healthy and injured limbs of patients with
accuracies of up to 82%. This work also indicated that there are EMG trends that may be used
to evaluate patient health. However, the models developed in this thesis are not yet useful for a
practical elbow brace. There is the potential for implementing a classification model of health in a
rehabilitative elbow brace to assess patients recovering from elbow trauma, however, further work
in this direction, including further data collection, validation, optimization, and improvements to
the existing state-of-the-art EMG acquisition systems will be necessary to achieve this goal.
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Appendix A
Permissions and Approvals
The following ethics permission statements and forms are presented in this Appendix:
1. Ethics Approval for Trials on Patients from the Research Ethics Board for Health Sciences
Research Involving Human Subjects at the University of Western Ontario
2. Patient Consent Form
3. Patient Trial Form
4. Permissions for Images
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Sponsor Information:  
  
Intronix Technologies Corporation designs and produces progressive portable medical 
devices for neuromuscular diagnostics and treatment delivery. Its innovations in injection 
guidance provide technology that drives clinical solutions to deliver confidence, improve workflow 
efficiency, and provide a better patient experience. Intronix has extensive experience within the 
neuromuscular diagnostic and treatment delivery market. Intronix quality system is registered to 
both ISO 9001:2008 and ISO 13485:2003 (CMDCAS), and is fully USFDA compliant.  
For this project, Intronix has lent the WearME Lab their electromyography data collection 
system and is developing software that will help with improved data collection strategies. All of 
the data analysis will be performed at the WearMe Lab. Some data samples will need to be sent 
to Intronix so that they can fine-tune the software to improve the data collection  
  
Conflict of Interest:  
  
There are no real or perceived conflicts of interest in this study.  
  
Details of the Study:  
  
You are being invited to participate in this research study about collecting muscular activity 
signals because you have a musculoskeletal injury or disorder in your arm.   
  
Musculoskeletal Conditions cost the Canadian health care system over $17 billion yearly. The 
purpose of this study is to create a reference base of task-specific bio-signals of people’s arm 
motions in order to inform the development of smart rehabilitation technologies (smart braces). 
Our smart brace, the WearMe Brace, is a rigid brace in development for the purpose of 
supporting a patient’s weak or deformed arm to enable functional activities. In order to enhance 
in the development of the brace, muscle activity data will be collected and analyzed to determine 
how muscle activity changes when the muscles heal. This will provide more intuitive and 
interpretable information for the control system of the smart brace. The results of the trials will 
provide valuable information for future improvements of the brace, such that it can provide 
therapy and assist individuals with upper arm musculoskeletal conditions.  
  
You are being asked to participate because you have a musculoskeletal injury or disorder in your 
arm. Your usual standard of care will not be altered.   
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Up to 300 people will participate in this study and it will take 1 year to complete. It is expected 
that you will be in this study throughout the length of your treatment, until you fully recover 
(rehabilitation time is different from patient to patient).  
  
Study Design and Procedures:  
  
The experiments will be conducted at the Hand Therapy Clinic at Saint Joseph’s Hospital. If 
you agree to participate, you will be first asked to sign the consent form. You will also be asked 
to fill out a self-reported trial form with your personal information as follows: age, gender, weight, 
height, and hand dominance. After that, a research coordinator will measure the dimensions of 
your arm. The one-time collection of such personal information is required because muscle 
activity is intimately related to these characteristics and being able to relate the data to these 
baseline values is critical for proper analysis.   
  
You will then be asked to sit down on a chair. Surface electrodes (small sensors) will be placed 
on the skin overlying each muscle or group of muscles in the upper arm and forearm (using sticky 
pads). These sensors do not obstruct normal movement and are not invasive. The skin where 
the sensors will be placed will be cleaned with alcohol. As the alcohol vaporizes, two electrodes 
will be placed on the biceps, four on the triceps, and four on the forearm.  
  
You will then be directed to perform the exercises prescribed by your hand therapist in his or 
her presence and guidance. The therapy normally provided by the therapist will not be modified. 
The activity of the arm muscles will be recorded during the tasks using the surface electrodes. A 
video camera will record the motions of your arm as you are performing the exercises. Your face 
will not appear in the frame of the camera at any time.  
  
If your other arm is healthy and uninjured, you will be asked to participate in a one-time trial. 
If you agree, surface electrodes will also be placed on that arm. You will then be asked to put 
your arm in an adjustable mechanical brace. Your arm will then be secured to the brace using 
padded straps. The brace limits the arm motion in one of your natural directions of motion. You 
will be asked to hold a 5-pound weight on your hand and will be instructed to perform elbow 
flexion-extension tasks (biceps-curls) requiring you to move your lower arm through a specified 
range at a low speed. You will perform 3 sets of 3 repetitions at 6 different ranges of motion (for 
a total of 54 repetitions), with a 2-minute break in between sets. We will measure arm motion 
and muscle activity while you perform these tasks. You will be given a few trial runs to help you 
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learn and understand the process and the speed required for the motions. This experiment is a 
one-time process and you will not be asked to do it again during your next visits. It is estimated 
to take up to 45 minutes for this one-time experiment.  
  
Your participation in this study is voluntary. You may decide not to be in this study, or to be in 
the study now and then change your mind later. You may leave the study at any time without 
affecting your care. We will give you new information that is learned during the study that might 
affect your decision to stay in the study.  
  
Withdrawal:  
If you decide to withdraw from the study, the information that was collected before you leave 
will still be used in order to help answer the research question. No new information will be 
collected without your permission.  
  
Risks:  
There are no added risks to you since you will be performing what your hand therapist is 
prescribing you to do.  
  
For the healthy arm, there may be temporary muscle discomfort/fatigue due to the tasks being 
performed. The mechanical brace will limit your motion in a single plane, which is one of your 
natural motion directions. The operation can be stopped immediately at any time you wish. The 
loads for the trial are comparable to the weight of a textbook.  
 
Benefits:  
There are no direct benefits to you by participating in this study. Although you may not benefit 
directly from this study, your participation may contribute to our basic knowledge of human 
mechanical dynamics, human muscle recruitment, and how to incorporate this knowledge into 
improving the treatment of musculoskeletal disorders. It will also allow us to advance in the 
development of a mechatronics-enabled elbow brace in our lab through tuning the system and 
using the data to allow the brace to provide individualized therapy to its wearers.  
  
Confidentiality:  
Confidentiality cannot be 100% guaranteed. All data will be stored in password-protected 
personal computer (University of Western Ontario, Spencer Engineering Building, Room 2091). 
Hardcopies of any documents will be stored in locked cabinets in TEB 373. The only documents 
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containing your name will be the Consent Forms, which will not be linked to any of the recorded 
data. Access to records and data is limited to authorized persons.   
  
Qualified representatives of the following organizations may look at your study records at the site 
where these records are held, for quality assurance (to check that the information collected for 
the study is correct and follows proper laws and guidelines).  
  
Examples include:  
• Representatives of Lawson Quality Assurance Education Program  
• Representatives of University of Western Ontario Health Sciences Research Ethics Board 
that oversees the ethical conduct of this study.  
• Representatives of Health Canada or other regulatory bodies (groups of people who 
oversee research studies) outside of Canada, such as the United States food and Drug 
Administration.  
• Intronix Technologies Corporation and its affiliated companies   
  
Some of the muscle activity data collected will be transferred to Intronix Technologies 
Corporation by using an encrypted USB hard drive in order to improve the data collection 
software.  Your anonymity will be protected through the use of alphanumeric codes when 
analyzing your experimental data.  
  
This project is supported by a Discovery Grant and an Engage grant of the Natural Sciences and 
Engineering Research Council (NSERC) of Canada, by the Western Strategic Support for 
NSERC Success Grant, by the Academic Development Fund, Western University, and by the 
Ontario Centres of Excellence with support from Intronix Technologies Corporation.   
  
If you have any questions or concerns regarding participation in our study, please contact Dr. 
Ana Luisa Trejos at (519) 661-2111 Ext. 89281, email: atrejos@uwo.ca  
If you have any questions about the conduct of this study or your rights as a research subject 
you may contact Dr. David Hill, Scientific Director, Lawson Health Research Institute at (519) 
667-6649.  A copy of this information package is yours to keep for your personal records.    
  
 
 
 
   Please Initial:________  
Version 2 (16-01-2017)                                                                                                             Page 6 of 6        
  
The research institute of London Health Sciences Centre  and 
St. Joseph’s Health Care, London.  
  
  
CONSENT FORM  
  
Title of Research:   Title: Patient Data Collection and Analysis for an Elbow Smart 
Brace  
Principal Investigator:  Dr. Ana Luisa Trejos  
Co-Investigators:  Shrikant Chinchalkar  
Collaborators:  Emma Farago, Abelardo Escoto, and Intronix Technologies 
Corporation  
  
For the Participant:  
I have read and understand the above information describing this study. I have had the purposes, 
procedures and technical language of this study explained to me. I have been given sufficient 
time to consider the above information and to seek advice if I chose to do so. I have had the 
opportunity to ask questions which have been answered to my satisfaction. I am voluntarily 
signing this form. I will receive a copy of this consent form for my information.   
If at any time I have further questions, problems or adverse events, I can contact Dr. Ana Luisa 
Trejos, the principal investigator of the project, at (519) 661-2111 Ext. 89281 or any of the 
investigators and collaborators on the project.  
If I have any questions about the conduct of this study or your rights as a research subject I may 
contact Dr. David Hill, Scientific Director, Lawson Health Research Institute at (519) 6676649.   
By signing this consent form, I am indicating that I agree to participate in this study.  
  
  
_________________________  ___________________________  _______________  
Name of Participant  Signature of Participant  Date  
(Please print)  
  
  
_________________________  ____________________________  _______________  
Name of Person Obtaining  Signature of Person Obtaining   Date  
Informed Consent  Informed Consent  
  Version 2 
 
 
The research institute of London Health Sciences Centre  
and St. Joseph’s Health Care, London. 
TRIAL FORM 
 
Title of Research:  Patient Data Collection and Analysis for an Elbow Smart 
Brace 
Principal Investigator: Dr. Ana Luisa Trejos 
Co-Investigators: Shrikant Chinchalkar 
Coordinators: Emma Farago, Abelardo Escoto 
 
To be filled out by the Participant: 
If you are not comfortable answering any of these questions you do not have to respond.  
 
Age: ___________       Weight: _________ 
Dominant Hand: R  L     Height: __________ 
Gender: M  F  
 
To be measured and entered by the Coordinator:  
 
Upper arm length: ___________mm            Upper arm circumference: ____________mm 
Forearm length: _____________mm            Forearm circumference: ______________mm  
Hand length: ________________mm           Hand circumference: ________________ mm 
 
Subject Code: _____________ 
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PERMISSION LICENSE: EDUCATIONAL PRINT AND ELECTRONIC USE  
  
Request ID/Invoice Number: EMM621475430-1  
  
Date:  June 29, 2018  
  
To:   Emma Farago  
   Western University  
   1151 Richmond Street  
  London  
ONTARIO N6A 3K7  
Canada  
   "Licensee"  
  
McGraw-Hill Education Material  
  
Author: Barrett, et al.  
Title: Ganong's Review of Medical Physiology  
ISBN: 9780071825108  
Edition: 25  
Description of material: Figure 5-2 B-C on Page 101 (1 Figure ONLY)  
  
Fee: “Waived”  
  
Purpose of Reproduction  
  
Purpose of use: For use in a master’s thesis titled “Development of an EMG-based muscle health 
model for elbow trauma patients" School: Western University  
Professor: Dr. Ana Luisa Trejos  
Number of Copies/Number of Users: 3  
Semester: 2018  
Format: Print and Electronic (Electronic- open access website) Distribution: 
One-time educational use for the above purposes only.  
  
Permission for the use described above is granted under the following terms and conditions:  
  
1. McGraw-Hill Education hereby grants Licensee the non-exclusive right to use the 
McGraw-Hill Education Material as outlined and to reproduce and distribute the 
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McGraw-Hill Education Material as outlined on condition that the related textbook is 
the required text for the course identified above. The McGraw-Hill Education Material  
may be used only as outlined. All use of the McGraw-Hill Education Material is subject 
to the terms and conditions of this Agreement. This permission will automatically 
terminate at such time as the related textbook is no longer required.  
  
2. No changes may be made to the McGraw-Hill Education Material without the prior 
written consent of McGraw-Hill Education.  
  
3. Licensee will provide to McGraw-Hill Education the URL and password for the web 
site in which the McGraw-Hill Education Material appears (if applicable).  
  
4. McGraw-Hill Education makes no representations or warranties as to the accuracy of 
any information contained in the McGraw-Hill Education Material, including any 
warranties of merchantability or fitness for a particular purpose. In no event shall 
McGraw-Hill Education have any liability to any party for special, incidental, tort, or 
consequential damages arising out of or in connection with the McGraw-Hill Education 
Material, even if McGraw-Hill Education has been advised of the possibility of such 
damages. All persons provided with the McGraw-Hill Education Material must be 
provided with written notice of this disclaimer and limitation liability, either in an end-
user license and/or with an on-screen notice that is visible each time the end-user 
initiates access to the McGraw-Hill Education Material.  
  
5. A credit to McGraw-Hill Education shall be visible each time the end-user initiates 
access to any screen or page containing any of the McGraw-Hill Education Material. 
Such credit shall include the title and author of the work and a copyright notice in the 
name of McGraw-Hill Education.  
  
6. A SIGNED COPY OF THIS AGREEMENT should be sent to McGraw-Hill Global 
Education Holdings, LLC, Attn: Permissions Department, Wells Fargo Bank, Lockbox 
#6167, PO Box 8500, Philadelphia, Pa. 19178-6167.  
  
7. This permission does not cover the use of any third-party copyrighted material, 
including but not limited to photographs and other illustrations, which appears in the 
McGraw-Hill Education Material with a credit to other sources. Written permission to 
use such material must be obtained from the cited source.  
  
8. McGraw-Hill Education shall have the right to terminate this Agreement immediately 
upon written notice to Licensee if Licensee is in material breach of this Agreement.  
  
9. Licensee shall indemnify McGraw-Hill Education from any damages, lawsuits, claims, 
liabilities, costs, charges, and expenses, including attorney's fees, relating to its use of 
the McGraw-Hill Education Material.  
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10. This Agreement incorporates the parties' entire agreement with respect to its subject 
matter. This Agreement may be amended only in writing and signed by both parties and 
shall be governed by the laws of New York. Licensee may not assign this Agreement or 
any rights granted hereunder to any third party.  
  
Please sign and return one copy to the address as outlined in Clause 6 of this agreement.  
  
For McGraw-Hill Education:   
  
  
________________________________________   
  
Laura Connolly 
Name___________________________________   
Permissions Department   
  
For Licensee:   
  
  
Name___________________________________   
  
Title___________________________________Ms.   
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JOHN WILEY AND SONS LICENSE TERMS AND CONDITIONS   
Jul 03, 2018 
 
  
This Agreement between Western University -- Emma Farago ("You") and John Wiley and 
Sons ("John Wiley and Sons") consists of your license details and the terms and conditions 
provided by John Wiley and Sons and Copyright Clearance Center. 
License Number 4377150051609 
License date Jun 27, 2018 
Licensed Content Publisher John Wiley and Sons 
Licensed Content Publication Wiley Books 
Licensed Content Title Basic Physiology and Biophysics of EMG Signal Generation 
Licensed Content Author T. Moritani, D. Stegeman, R. Merletti 
Licensed Content Date Jan 28, 2005 
Licensed Content Pages 25 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table 
number(s) 
Figure 1.1 
Will you be translating? No 
Title of your thesis / 
dissertation 
Development of an EMG-based muscle health model for 
elbow trauma patients 
Expected completion date Aug 2018 
Expected size (number of 
pages) 
180 
Requestor Location Western University 
1151 Richmond St  
    
  
London, ON N6A 3K7 
Canada   
Attn: Emma Farago  
Publisher Tax ID EU826007151 
Total 
Terms and Conditions 
0.00 CAD 
TERMS AND CONDITIONS 
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or 
one of its group companies (each a"Wiley Company") or handled on behalf of a society with 
which a Wiley Company has exclusive publishing rights in relation to a particular work 
(collectively "WILEY"). By clicking "accept" in connection with completing this licensing 
transaction, you agree that the following terms and conditions apply to this transaction 
(along with the billing and payment terms and conditions established by the Copyright 
Clearance Center Inc., ("CCC's Billing and Payment terms and conditions"), at the time that 
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you opened your RightsLink account (these are available at any time at 
http://myaccount.copyright.com). 
  
Terms and Conditions 
  
The materials you have requested permission to reproduce or reuse (the "Wiley 
Materials") are protected by copyright.  
  
You are hereby granted a personal, non-exclusive, non-sub licensable (on a standalone 
basis), non-transferable, worldwide, limited license to reproduce the Wiley Materials 
for the purpose specified in the licensing process. This license, and any CONTENT 
(PDF or image file) purchased as part of your order, is for a one-time use only and 
limited to any maximum distribution number specified in the license. The first 
instance of republication or reuse granted by this license must be completed within 
two years of the date of the grant of this license (although copies prepared before the 
end date may be distributed thereafter). The Wiley Materials shall not be used in any 
other manner or for any other purpose, beyond what is granted in the license. 
Permission is granted subject to an appropriate acknowledgement given to the author, 
title of the material/book/journal and the publisher. You shall also duplicate the 
copyright notice that appears in the Wiley publication in your use of the Wiley 
Material. Permission is also granted on the understanding that nowhere in the text is a 
previously published source acknowledged for all or part of this Wiley Material. Any 
third party content is expressly excluded from this permission. 
    
With respect to the Wiley Materials, all rights are reserved. Except as expressly granted 
by the terms of the license, no part of the Wiley Materials may be copied, modified, 
adapted (except for minor reformatting required by the new Publication), translated, 
reproduced, transferred or distributed, in any form or by any means, and no derivative 
works may be made based on the Wiley Materials without the prior permission of the 
respective copyright owner.For STM Signatory Publishers clearing permission 
under the terms of the STM Permissions Guidelines only, the terms of the license 
are extended to include subsequent editions and for editions in other languages, 
provided such editions are for the work as a whole in situ and does not involve 
the separate exploitation of the permitted figures or extracts, You may not alter, 
remove or suppress in any manner any copyright, trademark or other notices displayed 
by the Wiley Materials. You may not license, rent, sell, loan, lease, pledge, offer as 
security, transfer or assign the Wiley Materials on a stand-alone basis, or any of the 
rights granted to you hereunder to any other person. 
    
The Wiley Materials and all of the intellectual property rights therein shall at all times 
remain the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or 
their respective licensors, and your interest therein is only that of having possession of 
and the right to reproduce the Wiley Materials pursuant to Section 2 herein during the 
continuance of this Agreement. You agree that you own no right, title or interest in or 
to the Wiley Materials or any of the intellectual property rights therein. You shall have 
no rights hereunder other than the license as provided for above in Section 2. No right, 
license or interest to any trademark, trade name, service mark or other branding 
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you 
shall not assert any such right, license or interest with respect thereto 
    
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR 
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY, 
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EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS 
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE 
MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED 
WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY 
QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY, 
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES 
ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED 
BY YOU.  
    
WILEY shall have the right to terminate this Agreement immediately upon breach of 
this Agreement by you. 
    
You shall indemnify, defend and hold harmless WILEY, its Licensors and their 
respective directors, officers, agents and employees, from and against any actual or 
threatened claims, demands, causes of action or proceedings arising from any breach 
of this Agreement by you. 
    
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR 
ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY 
SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR 
PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN 
CONNECTION WITH THE DOWNLOADING, PROVISIONING, VIEWING OR 
USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION, 
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, 
NEGLIGENCE, INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT 
LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE, 
BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND 
WHETHER 
OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH 
DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY 
FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED 
HEREIN.  
    
Should any provision of this Agreement be held by a court of competent jurisdiction to 
be illegal, invalid, or unenforceable, that provision shall be deemed amended to 
achieve as nearly as possible the same economic effect as the original provision, and 
the legality, validity and enforceability of the remaining provisions of this 
Agreement shall not be affected or impaired thereby.     
The failure of either party to enforce any term or condition of this Agreement shall not 
constitute a waiver of either party's right to enforce each and every term and condition 
of this Agreement. No breach under this agreement shall be deemed waived or 
excused by either party unless such waiver or consent is in writing signed by the party 
granting such waiver or consent. The waiver by or consent of a party to a breach of 
any provision of this Agreement shall not operate or be construed as a waiver of or 
consent to any other or subsequent breach by such other party.  
    
This Agreement may not be assigned (including by operation of law or otherwise) by 
you without WILEY's prior written consent.     
Any fee required for this permission shall be non-refundable after thirty (30) days from 
receipt by the CCC. 
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These terms and conditions together with CCC's Billing and Payment terms and 
conditions (which are incorporated herein) form the entire agreement between you and 
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes 
all prior agreements and representations of the parties, oral or written. This Agreement 
may not be amended except in writing signed by both parties. This Agreement shall be 
binding upon and inure to the benefit of the parties' successors, legal representatives, 
and authorized assigns.  
    
In the event of any conflict between your obligations established by these terms and 
conditions and those established by CCC's Billing and Payment terms and 
conditions, these terms and conditions shall prevail.     
WILEY expressly reserves all rights not specifically granted in the combination of (i) 
the license details provided by you and accepted in the course of this licensing 
transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment terms 
and conditions. 
    
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type 
was misrepresented during the licensing process. 
    
This Agreement shall be governed by and construed in accordance with the laws of the 
State of New York, USA, without regards to such state's conflict of law rules. Any 
legal action, suit or proceeding arising out of or relating to these Terms and 
Conditions or the breach thereof shall be instituted in a court of competent jurisdiction 
in New York County in the State of New York in the United States of America and 
each party hereby consents and submits to the personal jurisdiction of such court, 
waives any objection to venue in such court and consents to service of process by 
registered or certified mail, return receipt requested, at the last known address of such 
party. 
    
WILEY OPEN ACCESS TERMS AND CONDITIONS 
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription 
journals offering Online Open. Although most of the fully Open Access journals publish 
open access articles under the terms of the Creative Commons Attribution (CC BY) License 
only, the subscription journals and a few of the Open Access Journals offer a choice of 
Creative Commons Licenses. The license type is clearly identified on the article. 
The Creative Commons Attribution License 
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and 
transmit an article, adapt the article and make commercial use of the article. The CC-BY 
license permits commercial and non- 
Creative Commons Attribution Non-Commercial License 
The Creative Commons Attribution Non-Commercial (CC-BY-NC)License permits use, 
distribution and reproduction in any medium, provided the original work is properly cited 
and is not used for commercial purposes.(see below) 
    
Creative Commons Attribution-Non-Commercial-NoDerivs License 
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND) 
permits use, distribution and reproduction in any medium, provided the original work is 
properly cited, is not used for commercial purposes and no modifications or adaptations are 
made. (see below) 
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Use by commercial "for-profit" organizations 
Use of Wiley Open Access articles for commercial, promotional, or marketing 
purposes requires further explicit permission from Wiley and will be subject to a fee. 
Further details can be found on Wiley Online Library 
http://olabout.wiley.com/WileyCDA/Section/id-410895.html 
  
  
Other Terms and Conditions: 
    
  
  
v1.10 Last updated September 2015 
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or 
+1-978-646-2777. 
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JOHN WILEY AND SONS LICENSE TERMS AND CONDITIONS   
Jul 03, 2018 
 
  
This Agreement between Western University -- Emma Farago ("You") and John Wiley and 
Sons ("John Wiley and Sons") consists of your license details and the terms and conditions 
provided by John Wiley and Sons and Copyright Clearance Center. 
License Number 4377141360992 
License date Jun 27, 2018 
Licensed Content Publisher John Wiley and Sons 
Licensed Content Publication Muscle and Nerve 
Licensed Content Title Physiologic basis of potentials recorded in electromyography 
Licensed Content Author Daniel Dumitru 
Licensed Content Date Oct 23, 2000 
Licensed Content Volume 23 
Licensed Content Issue 11 
Licensed Content Pages 19 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table 
number(s) 
Figure 1D 
Will you be translating? No 
Title of your thesis / 
dissertation 
Development of an EMG-based muscle health model for 
elbow trauma patients 
Expected completion date Aug 2018 
Expected size (number of 
pages) 
180 
Requestor Location Western University 
1151 Richmond St  
    
  
London, ON N6A 3K7 
Canada   
Attn: Emma Farago  
Publisher Tax ID EU826007151 
Total 
Terms and Conditions 
0.00 CAD 
TERMS AND CONDITIONS 
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or 
one of its group companies (each a"Wiley Company") or handled on behalf of a society with 
which a Wiley Company has exclusive publishing rights in relation to a particular work 
(collectively "WILEY"). By clicking "accept" in connection with completing this licensing 
transaction, you agree that the following terms and conditions apply to this transaction 
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(along with the billing and payment terms and conditions established by the Copyright 
Clearance Center Inc., ("CCC's Billing and Payment terms and conditions"), at the time that 
you opened your RightsLink account (these are available at any time at 
http://myaccount.copyright.com). 
  
Terms and Conditions 
  
The materials you have requested permission to reproduce or reuse (the "Wiley 
Materials") are protected by copyright.  
  
You are hereby granted a personal, non-exclusive, non-sub licensable (on a standalone 
basis), non-transferable, worldwide, limited license to reproduce the Wiley Materials 
for the purpose specified in the licensing process. This license, and any CONTENT 
(PDF or image file) purchased as part of your order, is for a one-time use only and 
limited to any maximum distribution number specified in the license. The first 
instance of republication or reuse granted by this license must be completed within 
two years of the date of the grant of this license (although copies prepared before the 
end date may be distributed thereafter). The Wiley Materials shall not be used in any 
other manner or for any other purpose, beyond what is granted in the license. 
Permission is granted subject to an appropriate acknowledgement given to the author, 
title of the material/book/journal and the publisher. You shall also duplicate the 
copyright notice that appears in the Wiley publication in your use of the Wiley 
Material. Permission is also granted on the understanding that nowhere in the text is a 
previously published source acknowledged for all or part of this Wiley Material. Any 
third party content is expressly excluded from this permission. 
    
With respect to the Wiley Materials, all rights are reserved. Except as expressly granted 
by the terms of the license, no part of the Wiley Materials may be copied, modified, 
adapted (except for minor reformatting required by the new Publication), translated, 
reproduced, transferred or distributed, in any form or by any means, and no derivative 
works may be made based on the Wiley Materials without the prior permission of the 
respective copyright owner.For STM Signatory Publishers clearing permission 
under the terms of the STM Permissions Guidelines only, the terms of the license 
are extended to include subsequent editions and for editions in other languages, 
provided such editions are for the work as a whole in situ and does not involve 
the separate exploitation of the permitted figures or extracts, You may not alter, 
remove or suppress in any manner any copyright, trademark or other notices displayed 
by the Wiley Materials. You may not license, rent, sell, loan, lease, pledge, offer as 
security, transfer or assign the Wiley Materials on a stand-alone basis, or any of the 
rights granted to you hereunder to any other person. 
    
The Wiley Materials and all of the intellectual property rights therein shall at all times 
remain the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or 
their respective licensors, and your interest therein is only that of having possession of 
and the right to reproduce the Wiley Materials pursuant to Section 2 herein during the 
continuance of this Agreement. You agree that you own no right, title or interest in or 
to the Wiley Materials or any of the intellectual property rights therein. You shall have 
no rights hereunder other than the license as provided for above in Section 2. No right, 
license or interest to any trademark, trade name, service mark or other branding 
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you shall 
not assert any such right, license or interest with respect thereto     
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR 
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REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY, 
EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS 
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE 
MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED 
WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY 
QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY, 
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES 
ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED 
BY YOU.  
    
WILEY shall have the right to terminate this Agreement immediately upon breach of 
this Agreement by you. 
    
You shall indemnify, defend and hold harmless WILEY, its Licensors and their 
respective directors, officers, agents and employees, from and against any actual or 
threatened claims, demands, causes of action or proceedings arising from any breach 
of this Agreement by you. 
    
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR 
ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY 
SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR 
PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN 
CONNECTION WITH THE DOWNLOADING, PROVISIONING, VIEWING OR 
USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION, 
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, 
NEGLIGENCE, INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT 
LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE, 
BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND 
WHETHER 
OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH 
DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY 
FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED 
HEREIN.  
    
Should any provision of this Agreement be held by a court of competent jurisdiction to 
be illegal, invalid, or unenforceable, that provision shall be deemed amended to 
achieve as nearly as possible the same economic effect as the original provision, and 
the legality, validity and enforceability of the remaining provisions of this 
Agreement shall not be affected or impaired thereby.     
The failure of either party to enforce any term or condition of this Agreement shall not 
constitute a waiver of either party's right to enforce each and every term and condition 
of this Agreement. No breach under this agreement shall be deemed waived or 
excused by either party unless such waiver or consent is in writing signed by the party 
granting such waiver or consent. The waiver by or consent of a party to a breach of 
any provision of this Agreement shall not operate or be construed as a waiver of or 
consent to any other or subsequent breach by such other party.  
    
This Agreement may not be assigned (including by operation of law or otherwise) by 
you without WILEY's prior written consent.     
Any fee required for this permission shall be non-refundable after thirty (30) days from 
receipt by the CCC. 
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These terms and conditions together with CCC's Billing and Payment terms and 
conditions (which are incorporated herein) form the entire agreement between you and 
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes 
all prior agreements and representations of the parties, oral or written. This Agreement 
may not be amended except in writing signed by both parties. This Agreement shall be 
binding upon and inure to the benefit of the parties' successors, legal representatives, 
and authorized assigns.  
    
In the event of any conflict between your obligations established by these terms and 
conditions and those established by CCC's Billing and Payment terms and 
conditions, these terms and conditions shall prevail.     
WILEY expressly reserves all rights not specifically granted in the combination of (i) 
the license details provided by you and accepted in the course of this licensing 
transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment terms 
and conditions. 
    
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type 
was misrepresented during the licensing process. 
    
This Agreement shall be governed by and construed in accordance with the laws of the 
State of New York, USA, without regards to such state's conflict of law rules. Any 
legal action, suit or proceeding arising out of or relating to these Terms and 
Conditions or the breach thereof shall be instituted in a court of competent jurisdiction 
in New York County in the State of New York in the United States of America and 
each party hereby consents and submits to the personal jurisdiction of such court, 
waives any objection to venue in such court and consents to service of process by 
registered or certified mail, return receipt requested, at the last known address of such 
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Appendix B
MATLAB Code
This appendix includes the MATLAB codes used to conduct the EMG feature extraction and
analysis work presented in this thesis. The appendix is divided into sections describing the codes
used for segmentation (Section B.1), feature functions (Section B.2), feature extraction (Section
B.3), classification (Section B.4), and majority vote classification (Section B.5).
B.1 Segmentation Codes
The first step of EMG analysis was to segment the EMG data into meaningful regions of muscle
activation. This section describes the codes used to divide the data into segments representing
each motion.
Teager Kaiser Energy Operator (TKEO) Function
The emgprocessTKEO function was developed to condition the signals with the Teager Kaiser
Energy Operator (TKEO) in order to provide a clearer observation of the onset and offset of muscle
contractions during motion.
1 function TKEO = emgprocessTKEO(rawsignal , fs)
2 %set EMG baseline to zero
3 y = rawsignal - mean(rawsignal);
4 [l, w] = size(y);
5 %apply TKEO operator to the data
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6 TKEOop = zeros(l,w);
7 for i = 2:l-1
8 for j = 1:w
9 TKEOop(i,j) = y(i,j)^2 - y(i+1,j)*y(i-1,j);
10 end
11 end
12 %rectification
13 rect = abs(TKEOop);
14 %apply a 50Hz LPF to the data for threshold analysis
15 fc = 50;
16 [a,b] = butter (2,fc/(fs/2));
17 TKEO = filtfilt(a,b,rect);
18 end
Automatic Segmentation
The emgprocessTKEO function was implemented in the codes used for data segmentation. The
automatic segmentation code is shown below.
1 p = [331 49 1164 948];
2 set(0, 'DefaultFigurePosition ', p)
3 fs =1925.93; % sampling frequency Hz
4 motions = {'EFE', 'PS', 'WFE', 'URD', 'HOC'};
5 muscles = {'bb', 'tb1', 'tb2', 'pt', 'brd', 'ecu', 'fcu'};
6
7 %VARIABLES
8 file_output_motion = 'WF'; %motion to identify
9 health = 1; %health = 0 -> injured , health = 1 -> healthy
10 subjects = {'S137'}; %subject list
11 musc = 1; %muscle of interest
12 mot= 1; %motion of interest
13
14 for s = 1:numel(subjects)
15 filename = strcat('C:\Users\Emma\Documents\Data\', ...
16 subjects{s},'\',subjects{s},motions{mot},'.csv');
17 rawdata = xlsread(filename);
18 % IMPORT EMG DATA
19 rawemgdata=zeros(length(rawdata) ,7);
20 count = 1;
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21 if health ==0
22 cols = 2:8:50;
23 else
24 cols = 66:8:114;
25 end
26 for i = cols
27 rawemgdata (:,count)=rawdata(:,i);
28 count = count +1;
29 end
30
31 % CONDITION EMG DATA WITH TKEO
32 [~,filt] = emgprocessTKEO(rawemgdata ,fs);
33
34 % PLOT EMG SIGNAL
35 figure (1)
36 hold off
37 plot(filt(:,musc))
38 title(filename)
39 legend (muscles{musc})
40
41
42
43 % SELECT BASELINE REGION
44 [x_values ,~] = ginput;
45 x_values = floor(x_values);
46 baseline = filt(x_values (1):x_values (2),musc);
47
48 % FIND THRESHOLDS
49 h = 15;
50 T1 = mean(baseline)+h*std(baseline);
51 t2 = 25; %starting threshold
52 t3=200; %ending threshold
53
54 %DETERMINE ONSET AND OFFSET
55 divisions = zeros (3,2);
56 start =2;
57 for i = 1:3
58 count = 0;
59 % FIND POINT WHEN T2 CONSECUTIVE SAMPLES EXCEED T1
60 while count <t2
61 if filt(start ,musc)>T1 && filt(start -1,musc)>T1
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62 count = count +1;
63 else
64 count = 0;
65 end
66 start=start +1;
67 end
68 divisions(i,1) = start;
69 count = 0;
70 % FIND POINT WHEN T3 CONSECUTIVE SAMPLES ARE BELOW T1
71 while count <t3
72 if filt(start ,musc)<T1 && filt(start -1,musc)<T1
73 count = count +1;
74 else
75 count = 0;
76 end
77 start=start +1;
78 end
79 divisions(i,2) = start;
80 end
81
82 % VALIDATE WITH GRAPH
83 figure
84 plot(filt(:,musc))
85 hold on
86 scatter(divisions (:,1) ,[0,0,0], 'g')
87 scatter(divisions (:,2) ,[0,0,0], 'r')
88 title (strcat('validation ', subjects{s}))
89
90 % SAVE DATA TO FILE
91 if health ==0
92 name = 'Injured ';
93 else
94 name = 'Healthy ';
95 end
96 for i = 1:3
97 savefilename = strcat('C:\Users\Emma\Documents\Reps',...
98 '\',name ,'\',subjects{s},...
99 file_output_motion , '_R',num2str(i),'.csv');
100 A = rawemgdata(divisions(i,1):divisions(i,2) ,:);
101 csvwrite(savefilename ,A)
102 end
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103 end
Manual Segmentation
Each segmentation was observed visually in order to determine if the segmentation appeared to be
correct based on motion activation. If the segmentation was not conducted appropriately by the
automatic method, the segmentation was performed by manually indicating the desired regions to
segment using the sEMG voltage vs. time plot. The manual segmentation is shown below.
1 p = [331 49 1164 948];
2 set(0, 'DefaultFigurePosition ', p)
3 fs =1925.93; % sampling frequency Hz
4 motions = {'EFE', 'PS', 'WFE', 'URD', 'HOC'};
5 muscles = {'bb', 'tb1', 'tb2', 'pt', 'brd', 'ecu', 'fcu'};
6
7 %VARIABLES
8 file_output_motion = 'WF'; %motion to identify
9 health = 1; %health = 0 -> injured , health = 1 -> healthy
10 subjects = {'S137'}; %subject list
11 musc = 1; %muscle of interest
12 mot= 1; %motion of interest
13
14 for s = 1:numel(subjects)
15 filename = strcat('C:\Users\Emma\Documents\Data\', ...
16 subjects{s},'\',subjects{s},motions{mot},'.csv');
17 rawdata = xlsread(filename);
18 % IMPORT EMG DATA
19 rawemgdata=zeros(length(rawdata) ,7);
20 count = 1;
21 if health ==0
22 cols = 2:8:50;
23 else
24 cols = 66:8:114;
25 end
26 for i = cols
27 rawemgdata (:,count)=rawdata(:,i);
28 count = count +1;
29 end
30
31 % CONDITION EMG DATA WITH TKEO
B.1 Segmentation Codes 172
32 [~,filt] = emgprocessTKEO(rawemgdata ,fs);
33
34 % PLOT DATA
35 figure (1)
36 hold off
37 plot(filt(:,musc))
38 title(filename)
39 legend (muscles{musc})
40
41 % DEFINE FILE NAME
42 if health ==0
43 name = 'Injured ';
44 else
45 name = 'Healthy ';
46 end
47
48 %SELECT SEGMENTS MANUALLY AND SAVE
49 [x_values ,~] = ginput;
50 x_values = floor(x_values);
51 for i = 1:3
52 savefilename = strcat('C:\Users\Emma\Documents\Reps',...
53 name ,'\',subjects{s},...
54 file_output_motion , '_R',num2str(i),'.csv');
55 A = rawemgdata(x_values(i*2-1):x_values(i*2) ,:);
56 csvwrite(savefilename ,A)
57 end
58 end
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B.2 Feature Function Codes
Functions were developed to calculate each EMG feature. Window size and increment could
be implemented, if necessary. If window size and increment were not specified in the function
inputs, the feature was calculated for the entire EMG signal. This section provides the codes to
generate each of the features implemented in this thesis. The feature function codes were developed
with assistance from Julian Saldarriaga, and by referring to the Myoelectric Control Development
Toolbox [122]. Feature functions for the ApEn and HFD features were developed after referring
to codes available on MATLAB Central File Exchange [123,124].
EMG Feature Function Template
The feature functions are all very similar to each other. The functions first develop data windows
based on the window size and increment specified by the user. Features are then extracted from
each window segment. The following code is the full feature function code for the MAV feature.
This code demonstrates the basic template for the feature functions. Other feature functions were
implemented by changing the “feature calculation” region indicated in the MAV function code to
the required code for each feature.
1 %Mean Amplitude Value (MAV)
2 function feat = mavfeat(X,winsize ,wininc)
3 if nargin < 3
4 if nargin < 2
5 winsize = size(X,1);
6 end
7 wininc = winsize;
8 end
9
10 datasize = size(X,1);
11 Nsignals = size(X,2);
12 datawin = ones(winsize ,1);
13 numwin = floor(( datasize - winsize)/wininc)+1;
14 feat = zeros(numwin ,Nsignals);
15 st = 1;
16 en = winsize;
17
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18 for i = 1: numwin
19 curwin = X(st:en ,:).* repmat(datawin ,1,Nsignals);
20 %feature calculation
21 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
22 feat(i,:) = mean(abs(curwin));
23 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
24 st = st + wininc;
25 en = en + wininc;
26 end
The “feature calculation” regions for the other feature functions are shown below:
Time Domain: Energy
MMAV1:
1 temp = 0;
2 for j = 1: winsize
3 if (0.25* winsize) <= j && j <= (0.75* winsize)
4 w_i = 1;
5 else
6 w_i = 0.5;
7 end
8 temp = temp + w_i*abs(curwin(j,:));
9 end
10 feat(i,:) = temp/winsize;
MMAV2:
1 temp = 0;
2 for j = 1: winsize
3 if ((0.25* winsize) <= j) && (j <= (0.75* winsize))
4 w_i = 1;
5 elseif j < (0.25* winsize)
6 w_i = 4*j/winsize;
7 else
8 w_i = 4*(j-winsize)/winsize;
9 end
10 temp = temp + w_i*abs(curwin(j,:));
11 end
12 feat(i,:) = temp/winsize;
IEMG:
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1 feat(i,:) = sum((abs(curwin)));
SSI:
1 temp = 0;
2 for j = 1: winsize
3 temp = temp + curwin(j,:) .^2;
4 end
5 feat(i,:) = temp/winsize;
VAR:
1 temp = 0;
2 for j = 1: winsize
3 temp = temp + curwin(j,:) .^2;
4 end
5 feat(i,:) = temp/(winsize -1);
RMS:
1 temp = 0;
2 for j = 1: winsize
3 temp = temp + curwin(j,:) .^2;
4 end
5 feat(i,:) = sqrt(temp/winsize);
LOG:
1 temp = 0;
2 for j = 1: winsize
3 temp = temp + log10(abs(curwin(j,:)));
4 end
5 feat(i,:) = exp(temp/winsize);
Time Domain: Information
WL:
1 temp = 0;
2 for j = 1:winsize -1
3 temp = temp + abs(curwin(j+1,:)-curwin(j,:));
4 end
5 feat(i,:) = temp;
AAC:
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1 temp = 0;
2 for j = 1:winsize -1
3 temp = temp + abs(curwin(j+1,:)-curwin(j,:));
4 end
5 feat(i,:) = temp/winsize;
DASDV:
1 temp = 0;
2 for j = 1:winsize -1
3 temp = temp + abs(( curwin(j+1,:)-curwin(j,:)).^2);
4 end
5 feat(i,:) = sqrt(temp/(winsize -1));
Time Domain: Frequency
The time domain features that were related to the frequency also required an optional threshold
value to be set. The preliminary part of the feature function was therefore modified for the time
domain: frequency features as follows:
1 function feat = zcfeat(X,winsize ,wininc ,threshold)
2 if nargin < 4
3 if nargin < 3
4 if nargin < 2
5 winsize = size(X,1);
6 end
7 wininc = winsize;
8 end
9 threshold = 0;
10 end
The feature calculation codes are as follows:
ZC:
1 for k = 1: Nsignals
2 temp = 0;
3 for j = 1:winsize -1
4 if sign(curwin(j,k)*curwin(j+1,k)) == -1
5 sgn = 1;
6 else
7 sgn = 0;
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8 end
9 if abs(curwin(j,k)-curwin(j+1,k)) >=threshold
10 check = 1;
11 else
12 check = 0;
13 end
14 if sgn == 1 && check == 1
15 temp = temp + 1;
16 end
17 end
18 feat(i,k) = temp;
19 end
SSC:
1 for k = 1: Nsignals
2 temp = 0;
3 for j = 2:winsize -1
4 if (curwin(j,k)- curwin(j-1,k)) > threshold
5 f1 = 1;
6 else
7 f1 = 0;
8 end
9 if (curwin(j,k)- curwin(j+1,k)) > threshold
10 f2 = 1;
11 else
12 f2 = 0;
13 end
14 temp = temp + f1*f2;
15 end
16 feat(i,k) = temp;
17 end
WAMP:
1 for k = 1: Nsignals
2 temp = 0;
3 for j = 1:winsize -1
4 if abs(curwin(j,k)-curwin(j+1,k)) >=threshold
5 temp = temp + 1;
6 else
7 temp = temp + 0;
8 end
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9 end
10 feat(i,k) = temp;
11 end
MYOP:
1 temp = 0;
2 for k = 1: Nsignals
3 for j = 1: winsize
4 if curwin(j,k) >=threshold
5 temp = temp + 1;
6 end
7 end
8 feat(i,k) = temp/winsize;
9 end
Time Domain: Multiple Features
The MAVS function calculates the MAV function for a series of consecutive windows. The feature
outputs are the differences between the features.
MAVS:
1 function feat = mavsfeat(X,winsize ,wininc ,k)
2
3 if nargin <4
4 if nargin < 3
5 if nargin < 2
6 winsize = size(X,1);
7 end
8 wininc = winsize;
9 end
10 k=3;
11 end
12 datasize = size(X,1);
13 Nsignals = size(X,2);
14 datawin = ones(winsize ,1);
15 numwin = floor(( datasize - winsize)/wininc)+1;
16 feat = zeros(numwin ,Nsignals *(k-1));
17
18 st = 1;
19 en = winsize;
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20 for i = 1: numwin
21 curwin = X(st:en ,:).* repmat(datawin ,1,Nsignals);
22 winsize_k = floor(winsize/k);
23 mav = zeros(k,Nsignals);
24 st2 = 1;
25 en2 = winsize_k;
26 for w = 1:k
27 curwin_k = curwin(st2:en2 ,:);
28 %feature calculation
29 %------------------------------------------------
30 mav(w,:) = mean(abs(curwin_k));
31 %-------------------------------------------------
32 st2 = st2 + winsize_k;
33 en2 = en2 + winsize_k;
34 end
35 for i2 = 1:k-1
36 feat(i,i2) = mav(i2+1,:)-mav(i2);
37 end
38 st = st + wininc;
39 en = en + wininc;
40 end
MHW:
1 %create 3 hamming windows with 30% overlap
2 L = length(curwin);
3 %length hamming
4 LH = floor (5/12*L);
5 w = hamming(LH);
6 for k = 1: Nsignals
7 feat1 = sum(( curwin (1:LH,k).*w).^2);
8 feat2 = sum(( curwin(floor(LH*.7):floor(LH*.7)+LH -1,k).*w).^2);
9 feat3 = sum(( curwin(L-LH+1:L,k).*w).^2);
10 feat (i,(k-1) *3+1:k*3) = [feat1 , feat2 , feat3];
11 end
MTW:
1 %create 3 trapezoidal windows with 30% overlap
2 L = length(curwin);
3 %length of window
4 LH = floor (5/12*L);
5 w = trapmf (1:LH ,[1 LH/4 LH*3/4 LH]);
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6 for k = 1: Nsignals
7 feat1 = sum(( curwin (1:LH,k) '.*w).^2);
8 feat2 = sum(( curwin(floor(LH*.7):floor(LH*.7)+LH -1,k) '.*w).^2);
9 feat3 = sum(( curwin(L-LH+1:L,k) '.*w).^2);
10 feat (i,(k-1) *3+1:k*3) = [feat1 , feat2 , feat3];
11 end
Prediction Model Coefficients
The prediction model coefficient codes for AR and CC features are shown in full. Both codes were
designed to be used for any order, but the default order is 4.
AR:
1 function feat = ARfeat( X, winsize ,wininc , order)
2 if nargin <4
3 if nargin < 3
4 if nargin < 2
5 winsize = size(X,1);
6 end
7 wininc = winsize;
8 end
9 order = 4;
10 end
11
12 datasize = size(X,1);
13 Nsignals = size(X,2);
14 datawin = ones(winsize ,1);
15 numwin = floor(( datasize - winsize)/wininc)+1;
16 feat = zeros(numwin ,Nsignals ,order);
17 st = 1;
18 en = winsize;
19 for i = 1: numwin
20 curwin = X(st:en ,:).* repmat(datawin ,1,Nsignals);
21 for k = 1: Nsignals
22 %feature calculation
23 %------------------------------------------------
24 temp = -aryule(curwin(:,k),order);
25 feat (i,k,1: order) = temp (2: order +1);
26 end
27 %-------------------------------------------------
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28 st = st + wininc;
29 en = en + wininc;
30 end
CC4:
1 function feat = ccfeat( X, winsize ,wininc , order)
2 if nargin <4
3 if nargin < 3
4 if nargin < 2
5 winsize = size(X,1);
6 end
7 wininc = winsize;
8 end
9 order = 4;
10 end
11
12 datasize = size(X,1);
13 Nsignals = size(X,2);
14 datawin = ones(winsize ,1);
15 numwin = floor(( datasize - winsize)/wininc)+1;
16
17 feat = zeros(numwin ,Nsignals*order);
18
19 st = 1;
20 en = winsize;
21 for i = 1: numwin
22 curwin = X(st:en ,:).* repmat(datawin ,1,Nsignals);
23
24 %feature calculation
25 %------------------------------------------------
26 for k = 1: Nsignals
27
28 temp = -aryule(curwin(:,k),order);
29 c = zeros(1,order);
30 c(1) = -temp (2);
31 for p = 2:order
32 temp2 = 0;
33 for l = 1:p-1
34 temp2 = temp2 +(1-l/p)*temp(p+1)*c(p-l);
35 end
36 c(p) = -temp(p+1)-temp2;
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37 end
38 feat (i,(k-1)*order +1:k*order) = c;
39 end
40 end
41 %-------------------------------------------------
42 st = st + wininc;
43 en = en + wininc;
44 end
Frequency Domain Features
MNF:
1 fs = 1925.93; %Sampling frequency (Hz)
2 feat(i,:) = meanfreq(curwin)*fs/2/pi;
MDF:
1 fs = 1925.93;
2 feat(i,:) = medfreq(curwin)*fs/2/pi;
PKF:
1 %Peak frequency (PKF) feature calculation
2 fs = 1925.93;
3 for k = 1: Nsignals
4 xdft = fft(curwin(:,k));
5 if mod(winsize ,2) == 0
6 xdft = xdft (1: winsize /2+1); %even window size
7 else
8 xdft = xdft (1:( winsize +1) /2); %odd window size
9 end
10 %compute power spectral density (PSD)
11 psdx = (1/(2* pi*winsize)) * abs(xdft).^2;
12 psdx (2:end -1) = 2*psdx (2:end -1);
13 freq = 0:fs/winsize:fs/2;
14 [~,b] = max(psdx);
15 feat (i,k) = freq(b);
16 end
MNP:
1 fs = 1925.93;
2 xdft = fft(curwin);
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3 if mod(winsize ,2) == 0
4 xdft = xdft (1: winsize /2+1); %even window size
5 else
6 xdft = xdft (1:( winsize +1) /2); %odd window size
7 end
8 %compute power spectral density (PSD)
9 psdx = (1/(2* pi*winsize)) * abs(xdft).^2;
10 psdx (2:end -1) = 2*psdx (2:end -1);
11 feat (i,:) = sum(psdx)/winsize;
TTP:
1 fs = 1925.93;
2 xdft = fft(curwin);
3 if mod(winsize ,2) == 0
4 xdft = xdft (1: winsize /2+1); %even window size
5 else
6 xdft = xdft (1:( winsize +1) /2); %odd window size
7 end
8 %compute power spectral density (PSD)
9 psdx = (1/(2* pi*winsize)) * abs(xdft).^2;
10 psdx (2:end -1) = 2*psdx (2:end -1);
11 feat (i,:) = sum(psdx);
SM1–3:
1 fs = 1925.93;
2 xdft = fft(curwin);
3 if mod(winsize ,2) == 0
4 xdft = xdft (1: winsize /2+1); %even window size
5 else
6 xdft = xdft (1:( winsize +1) /2); %odd window size
7 end
8 %compute power spectral density (PSD)
9 psdx = (1/(2* pi*winsize)) * abs(xdft).^2;
10 psdx (2:end -1) = 2*psdx (2:end -1);
11 freq = 0:fs/winsize:fs/2;
12 sm1feat (i,:) = freq*psdx;
13 sm2feat (i,:) = freq .^2* psdx;
14 sm3feat (i,:) = freq .^3* psdx;
VCF:
1 fs = 1925.93;
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2 xdft = fft(curwin);
3 if mod(winsize ,2) == 0
4 xdft = xdft (1: winsize /2+1); %even window size
5 else
6 xdft = xdft (1:( winsize +1) /2); %odd window size
7 end
8 %compute power spectral density (PSD)
9 psdx = (1/(2* pi*winsize)) * abs(xdft).^2;
10 psdx (2:end -1) = 2*psdx (2:end -1);
11 freq = 0:fs/winsize:fs/2;
12 M1 = freq*psdx;
13 M0 = sum(psdx);
14 M2 = freq .^2* psdx;
15 feat (i,:) = M2/M0 -(M1/M0)^2;
FR:
1 fs = 1925.93;
2 %Low Frequency Band
3 LLC = 15;
4 ULC = 45;
5 %High Frequency Band
6 LHC = 95;
7 UHC = 500;
8 xdft = fft(curwin);
9 if mod(winsize ,2) == 0
10 xdft = xdft (1: winsize /2+1); %even window size
11 else
12 xdft = xdft (1:( winsize +1) /2); %odd window size
13 end
14 %compute power spectral density (PSD)
15 psdx = (1/(2* pi*winsize)) * abs(xdft).^2;
16 psdx (2:end -1) = 2*psdx (2:end -1);
17 freq = 0:fs/winsize:fs/2;
18 %find index
19 %Low Frequency Band
20 [~, LLC_i]= min(abs(freq -LLC));
21 [~, ULC_i]= min(abs(freq -ULC));
22 %High Frequency Band
23 [~, LHC_i]= min(abs(freq -LHC));
24 [~, UHC_i]= min(abs(freq -UHC));
25 lower_band = sum(psdx(LLC_i:ULC_i));
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26 upper_band = sum(psdx(LHC_i:UHC_i));
27 feat (i,:) = lower_band/upper_band;
PSR:
1 fs = 1925.93;
2 n=20;
3 for k = 1: Nsignals
4 xdft = fft(curwin(:,k));
5 if mod(winsize ,2) == 0
6 xdft = xdft (1: winsize /2+1); %even window size
7 else
8 xdft = xdft (1:( winsize +1) /2); %odd window size
9 end
10 %compute power spectral density (PSD)
11 psdx = (1/(2* pi*winsize)) * abs(xdft).^2;
12 psdx (2:end -1) = 2*psdx (2:end -1);
13 freq = 0:fs/winsize:fs/2;
14
15 %find f0
16 [~,b] = max(psdx);
17 f0 = freq(b);
18
19 %Frequency Bands
20 [~, LC_i]= min(abs(freq -10));
21 [~, UC_i]= min(abs(freq -500));
22
23 [~, LC2_i]= min(abs(freq -(f0-n)));
24 [~, UC2_i]= min(abs(freq -(f0+n)));
25 P = sum(psdx(LC_i:UC_i));
26 P0 = sum(psdx(LC2_i:UC2_i));
27
28 feat (i,k) = P0/P;
29 end
Entropy Features
The full codes for the entropy features are shown below.
ApEn:
1 function feat = ApEnfeat(X,winsize ,wininc ,m1,r)
2 if nargin <5
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3 if nargin <4
4 if nargin < 3
5 if nargin < 2
6 winsize = size(X,1);
7 end
8 wininc = winsize;
9 end
10 m1 = 2;
11 end
12 r = 0.2* std(X);
13 end
14 m = m1;
15 datasize = size(X,1);
16 Nsignals = size(X,2);
17 datawin = ones(winsize ,1);
18 numwin = floor(( datasize - winsize)/wininc)+1;
19
20 feat = zeros(numwin ,Nsignals);
21
22 st = 1;
23 en = winsize;
24 for i = 1: numwin
25 curwin1 = X(st:en ,:).* repmat(datawin ,1,Nsignals);
26 for j = 1: Nsignals
27 curwin = curwin1(:,j);
28 Phi_m = zeros (1,2);
29 %feature calculation
30 %------------------------------------------------
31 for k = 1:2
32 m = m+k-1;
33 count = zeros(1,winsize -m+1);
34 %make the correlation dimension matrix (i.e. matrix of u_i)
35 corr_dim = zeros (m,winsize -m+1);
36 for i2 = 1:m
37 corr_dim(i2 ,:) = curwin(i2:winsize -m+i2);
38 end
39
40 %calculate Cm
41 for i3 = 1:winsize -m+1
42 tempMat = abs(corr_dim - repmat(corr_dim(:,i3),1,winsize -m+1));
43 boolMat = any(tempMat > r);
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44 count(i3) = sum(~ boolMat)/(winsize -m+1);
45 end
46 %calculate Phi_m
47 Phi_m(k) = sum(log(count))/(winsize -m+1);
48 end
49 feat(i,j) = Phi_m (1)- Phi_m (2);
50 m=m1;
51 end
52 %------------------------------------------------
53 st = st + wininc;
54 en = en + wininc;
55 end
SampleEn:
1 function feat = SampleEnfeat(X,winsize ,wininc ,m1,r)
2 if nargin <5
3 if nargin <4
4 if nargin < 3
5 if nargin < 2
6 winsize = size(X,1);
7 end
8 wininc = winsize;
9 end
10 m1 = 2;
11 end
12 r = 0.2* std(X);
13 end
14 m = m1;
15 datasize = size(X,1);
16 Nsignals = size(X,2);
17 datawin = ones(winsize ,1);
18 numwin = floor(( datasize - winsize)/wininc)+1;
19
20 feat = zeros(numwin ,Nsignals);
21
22 st = 1;
23 en = winsize;
24 for i = 1: numwin
25 curwin1 = X(st:en ,:).* repmat(datawin ,1,Nsignals);
26 for j = 1: Nsignals
27 curwin = curwin1(:,j);
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28 Phi_m = zeros (1,2);
29 %feature calculation
30 %------------------------------------------------
31 for k = 1:2
32 m = m+k-1;
33 count = zeros(1,winsize -m+1);
34 %make the correlation dimension matrix (i.e. matrix of u_i)
35 corr_dim = zeros (m,winsize -m+1);
36 for i2 = 1:m
37 corr_dim(i2 ,:) = curwin(i2:winsize -m+i2);
38 end
39
40 %calculate Cm
41 for i3 = 1:winsize -m+1
42 tempMat = abs(corr_dim - repmat(corr_dim(:,i3),1,winsize -m+1));
43 boolMat = any(tempMat > r);
44 count(i3) = (sum(~ boolMat) -1)/(winsize -m+1);
45 end
46 %calculate Phi_m
47 Phi_m(k) = sum(count)/(winsize -m);
48 end
49 feat(i,j) = -log(Phi_m (2)/Phi_m (1));
50 m=m1;
51 end
52 %------------------------------------------------
53 st = st + wininc;
54 en = en + wininc;
55 end
Fractal Dimension Features
The codes for the feature calculations of the fractal features are shown below.
MFL:
1 temp = 0;
2 for j = 1:winsize -1
3 temp = temp + (curwin(j+1,:)-curwin(j,:))^2;
4 end
5 feat(i,:) = log10(temp);
HFD:
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1 %get time series
2 kmax = 128;
3 X2 = zeros(kmax ,kmax ,winsize);
4 for k = 1:kmax
5 for m = 1:k
6 limit = floor ((winsize -m)/k);
7 j = 1;
8 for i2 = m:k:(m + (limit*k))
9 X2(k,m,j) = curwin(i2);
10 j = j + 1;
11 end
12 end
13 end
14 L = zeros(1, kmax);
15 for k = 1:kmax
16 L_m = zeros(1,k);
17 for m = 1:k
18 R = (winsize - 1)/( floor(( winsize - m)/k) * k);
19 aux = squeeze(X2(k,m,logical (~isnan(X2(k,m,:))))); %We get the sub -serie without
the NaNs.
20 for i2 = 1:( length(aux) - 1)
21 L_m(m) = L_m(m) + abs(aux(i2+1) - aux(i2));
22 end
23 L_m(m) = (L_m(m) * R)/k;
24 end
25 L(k) = sum(L_m)/k;
26 end
27 %Compute the HFD:
28 x = 1./(1: kmax);
29 aux = polyfit(log(x),log(L) ,1);
30 feat(i,n) = aux (1);
DFA:
1 %Detrended Fluctuation Analysis (DFA) feature calculation
2 for j = 1: Nsignals
3 curwin = curwin1(:,j);
4 %Step 1: Integrate
5 y = zeros(1,winsize);
6 t= 1:1: winsize;
7 for k = 1: winsize
8 y(k) = sum(curwin (1:k));
B.2 Feature Function Codes 190
9 end
10
11 %Step 2: Calculate Box Sizes
12 boxsize = 4;
13 nmax = winsize /10;
14 while boxsize(end)<nmax
15 boxsize(end+1)=boxsize(end)*2;
16 end
17
18 %Step 3: Fit Each Box to Quadratic Least Squares
19 for n = 1: length(boxsize)
20 temp = 0;
21 p = zeros (1,3);
22 pv = zeros(1,winsize);
23 m = boxsize(n);
24 for i2 = 1:m:winsize -m+1
25 temp = temp +1;
26 p(temp ,:)=polyfit(t(i2:i2+m-1),y(i2:i2+m-1) ,2);
27 pv(i2:i2+m-1) = polyval(p(temp ,:),t(i2:i2+m-1));
28
29 end
30 %Step 4: Calculate RMS
31 F(n)= sqrt ((1/ winsize)*sum(y-pv)^2);
32 end
33
34 %Step 5: Calculate self -similarity parameter , alpha (i.e. the feature)
35 fit = polyfit(log(boxsize),log10(F) ,1);
36 feat(i,j) = fit (1);
37 end
Higher Order Features
The codes for the feature calculations of the higher order features are shown below.
SKEW:
1 sigma = std (curwin);
2 mu = mean(curwin);
3 temp = 0;
4 for j = 1: winsize
5 temp = temp + (( curwin(j,:)-mu)/sigma).^3;
6 end
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7 feat(i,:) = temp/winsize ;
KURT:
1 sigma = std (curwin);
2 mu = mean(curwin);
3 temp = 0;
4 for j = 1: winsize
5 temp = temp + (( curwin(j,:)-mu)/sigma).^4;
6 end
7 feat(i,:) = (temp/winsize) -3; %subtract 3 to get 0 for a normal distribution
Spike Shape Analysis Features
The full code to generate all five of the major spike shape analysis features is shown below.
1 function feat = spikefeat( X, winsize ,wininc , th)
2 if nargin <4
3 if nargin < 3
4 if nargin < 2
5 winsize = size(X,1);
6 end
7 wininc = winsize;
8 end
9 th = 0;
10 end
11
12 datasize = size(X,1);
13 Nsignals = size(X,2);
14 datawin = ones(winsize ,1);
15 numwin = floor(( datasize - winsize)/wininc)+1;
16
17 feat = zeros(numwin ,Nsignals *5);
18
19 st = 1;
20 en = winsize;
21 for i = 1: numwin
22 curwin = X(st:en ,:).* repmat(datawin ,1,Nsignals);
23 for k = 1: Nsignals
24
25 %feature calculation
26 %------------------------------------------------
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27 time_dur = 5.1923e-04* length(curwin);
28 data_10 = curwin(:,k);
29
30 [pks ,locs] = findpeaks(data_10 ,'MinPeakHeight ',th);
31 [btm ,locbtm ]= findpeaks(-data_10 ,'MinPeakHeight ',th);
32 btm = -btm;
33
34 peak_no = length(pks);
35
36 %how to find spikes
37 spike_no = 0;
38 Ax = [];
39 Ay = [];
40 Bx = [];
41 By = [];
42 Cy = [];
43 Cx = [];
44
45 for j = 2: length(pks)-1
46 btml = max(find(locbtm <locs(j)));
47 btmlv = locbtm(btml);
48 btmh = min(find(locbtm >locs(j)));
49 btmhv = locbtm(btmh);
50
51 if isempty(btmlv) == 0 && isempty(btmhv)==0
52 if btmlv > locs(j-1) && btmhv < locs(j+1)
53 Ax(end+1) = btmlv;
54 Ay(end+1) = btm(btml);
55 Bx(end+1) = locs(j);
56 By(end+1) = pks(j);
57 Cy(end+1) = btm(btmh);
58 Cx(end+1) = btmhv;
59 spike_no = spike_no +1;
60 else
61 peaks_index = find(locs >btmlv & locs <btmhv);
62 test = btmlv;
63
64 if isempty(Ax) == 0
65 if test ~= Ax(end)
66 [By(end+1),ind] = max(pks(peaks_index));
67 Bx(end+1) = locs(peaks_index(ind));
B.2 Feature Function Codes 193
68 Ax(end+1) = btmlv;
69 Ay(end+1) = btm(btml);
70 Cy(end+1) = btm(btmh);
71 Cx(end+1)= btmhv;
72 spike_no = spike_no +1;
73 end
74 else
75 [By(end+1),ind] = max(pks(peaks_index));
76 Bx(end+1) = locs(peaks_index(ind));
77 Ax(end+1) = btmlv;
78 Ay(end+1) = btm(btml);
79 Cy(end+1) = btm(btmh);
80 Cx(end+1)= btmhv;
81 spike_no = spike_no +1;
82 end
83 end
84 end
85 end
86
87 %calculate single spike amplitudes (SA) and spike slopes (SS)
88 SA = zeros(1,spike_no);
89 SS = SA;
90 SD = SA;
91
92 for j = 1: spike_no
93 SA(j) = (By(j)-Ay(j)) + (By(j)-Cy(j))/2;
94 SS(j) = (By(j)-Ay(j))/(Bx(j)-Ax(j));
95 SD(j) = Cx(j)-Ax(j);
96 end
97
98 %% FEATURES %%
99
100 %MSA (Mean Spike Amplitude)
101 MSA = mean(SA);
102
103 %MSF (Mean Spike Frequency)
104 MSF = (spike_no +2)/time_dur;
105
106 %MSS (Mean Spike Slope)
107 MSS = mean(SS)/5.1923e-04;
108
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109 %MNPPS (Mean Number of Peaks per Spike)
110 MNPPS = peak_no/spike_no;
111
112 %MSD (Mean Spike Duration)
113 MSD = mean(SD)*5.1923e-04;
114
115 temp = [MSA , MSF , MSS , MNPPS , MSD];
116 feat(i,(k-1) *5+1:k*5) = temp;
117 %-------------------------------------------------
118 st = st + wininc;
119 en = en + wininc;
120 end
121 end
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B.3 Feature Generation Codes
The sEMG feature functions described in the previous section were implemented within the feature
generation codes to extract feature vectors. In addition to the sEMG feature functions, a function,
emgprocess trigno ( ) was developed to filter the EMG signals with a 20–400 Hz bandpass
filter and a 60 Hz notch filter as follows:
1 function f2 = emgprocess_trigno(rawsignal)
2 fs =1925.93; %Sample frequency
3
4 %Centre on x-axis
5 m = rawsignal - mean(rawsignal);
6
7 %Bandpass filter 20 - 400 Hz
8 [b,a]= butter (2 ,[20/(fs/2) ,400/(fs/2)]);
9 f1 = filtfilt(b,a,m);
10
11 %Notch filter 60 Hz
12 wo = 60/(fs/2);
13 bw = wo/10;
14 [b,a] = iirnotch(wo ,bw);
15 f2 = filtfilt(b,a,f1);
16 end
Feature generation codes for extracting features were developed for both single and multiple win-
dows. Features were extracted for each segment of data, and saved in separate files for each feature
and motion type.
Single Window Feature Generation
The following code extracts features for one window segment of the data.
1 %Basic Feature Generation Code
2 number_of_channels = 7;
3 feature_list = {'mflfeat ','myopfeat '};
4 health = {'Healthy ','Injured '};
5 motion_sets = {'EF', 'EE','P','S','WF','WE','UD','RD','HC','HO'};
6 number_of_features = length(feature_list);
7
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8 %GENERATE FEATURES
9 for h = 1:numel(health)
10 for k=1: numel(motion_sets)
11 if strcmp(health{h},'Injured ') == 1
12 %Injured Subjects
13 subjects = {'S84','S85','S86',...
14 'S137'};
15 else
16 %Healthy Subjects
17 subjects = {'S84','S85','S86',...
18 'S137'};
19 end
20 for f = 1:numel(feature_list)
21 B = zeros(length(subjects),number_of_channels);
22 for s = 1:numel(subjects)
23 A = zeros(3, number_of_channels *( number_of_features));
24 for r = 1:3
25 %Import EMG data
26 input_data_file = strcat('C:\Users\Emma\Documents\Data\Repetition Data
',motion_sets{k},'\',health{h},'\', subjects{s},motion_sets{k}, '_R
',num2str(r), '.csv');
27 emg_data = xlsread(input_data_file);
28 %Filter EMG data
29 emg_data = emgprocess_trigno(emg_data);
30 %Extract features
31 st = 1;
32 for ch = 1: number_of_channels
33 feature_function = str2func(feature_list{f});
34 %Feature array for all repetitions for one subject
35 A(r,st) = feature_function(emg_data(:,ch));
36 st = st+1;
37 end
38 end
39 B((s-1) *3+1:s*3,:) = A; %Feature array for all subjects
40 end
41 %Save array
42 savefilename = strcat('C:\Users\Emma\Documents\Data\Feature Data\',health{h},'\
',motion_sets{k},feature_list ,'.xlsx');
43 xlswrite(savefilename ,B);
44 end
45 end
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46 end
Multi-window Feature Generation
The following code is similar to the first feature generation code, but is developed for multiple
windows. The subject number for each window is saved within the feature set to allow patients to
be identifiable during the next step of leave-one-patient-out cross-validation.
1 %Generate Multi -window Features
2 number_of_channels = 7;
3 feature_list = {'mflfeat ','myopfeat '};
4 health = {'Healthy ','Injured '};
5 motion_sets = {'EF', 'EE','P','S','WF','WE','UD','RD','HC','HO'};
6
7 %Window Sizes
8 window_size = 500;
9 increment_size = 250;
10 number_of_features = numel(feature_list);
11
12 for f = 1:numel(feature_list)
13 %Develop list of subjects
14 for h = 1:numel(health)
15 for k=1: numel(motion_sets)
16 if strcmp(health{h},'Injured ') == 1
17 %Injured Subjects
18 subjects = {'S84','S85','S86',...
19 'S137'};
20 else
21 %Healthy Subjects
22 subjects = {'S84','S85','S86',...
23 'S137'};
24 end
25 B = [];
26 for s = 1:numel(subjects)
27 R = [];
28 for r = 1:3
29 A = [];
30 %Import EMG data
31 input_data_file = strcat('C:\Users\Emma\Documents\Data\Repetition Data
',motion_sets{k},'\',health{h},'\', subjects{s},motion_sets{k}, '_R
B.3 Feature Generation Codes 198
',num2str(r), '.csv');
32 emg_data = xlsread(input_data_file);
33 %Filter EMG data
34 emg_data = emgprocess_trigno(emg_data);
35
36 %Calculate number of windows
37 datasize = length(emg_data);
38 numwin = floor(( datasize - window_size)/increment_size)+1;
39 %Develop feature array
40 st = 1;
41 for ch = 1: number_of_channels
42 feature_function = str2func(feature_list{f});
43 A = [A,feature_function(emg_data(:,ch),window_size ,increment_size)
];
44 end
45 R = [R;A]; %Array of all repetitions for each subject
46 end
47 R = [R,ones(size(R,1) ,1)*s]; %Save subject numbers
48 B = [B;R]; %Feature array of all subjects
49 end
50 %Save array
51 savefilename = strcat('C:\Users\Emma\Documents\Data\Feature Data\',health{h},'\
',motion_sets{k},feature_list{f},'.xlsx');
52 xlswrite(savefilename ,B);
53 end
54 end
55 end
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B.4 Classification
Following feature extraction, classification models for individual features or for feature sets were
developed and evaluated. The classification model code imports the feature data from the indi-
vidual excel files for each feature. The classification model options are linear discriminant analysis
(LDA), support vector machines (SVM), or random forest (RF). The accuracy of classification
using leave-one-patient out is determined for each individual motion. Classification model codes
were developed to categorize between two classes (healthy or injured) and between three classes
(healthy, early stages of rehabilitation, late stages of rehabilitation).
Healthy or Injured classification
The following code categorizes between the healthy and injured limbs of the patients.
1 %Basic Classification
2 feature_list = {'mflfeat ', 'myopfeat '};
3 model_type = 'LDA'; %LDA , SVM , or RF
4 motion_sets = {'EF','EE', 'P','S','WF','WE','UD','RD','HC','HO'};
5
6 A = zeros(1,numel(motion_sets));
7 for k = 1:numel(motion_sets)
8 healthy = [];
9 injured = [];
10 %Import feature sets
11 for f = 1: length(feature_list)
12 %Healthy features
13 healthy_name = strcat('C:\Users\Emma\Documents\Data\Feature Data\Healthy\',
motion_sets{k},feature_list{f},'.xlsx');
14 healthytemp= xlsread(healthy_name);
15 healthy = [healthy ,healthytemp ];
16 %Injured features
17 injured_name = strcat('C:\Users\Emma\Documents\Data\Feature Data\Injured\',
motion_sets{k},feature_list{f},'.xlsx');
18 injuredtemp = xlsread(injured_name);
19 injured = [injured ,injuredtemp ];
20 end
21
22 %Feature Set Arrays
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23 full = [healthy;injured ];
24 type = [ones(size(healthy ,1) ,1);zeros(size(injured ,1) ,1)];
25
26 match = 0; %Number of correct classifications
27 %Number of data sets
28 N = size(full ,1);
29 nds = size(healthy ,1);
30
31 for i = 1:3: nds
32 %Assign training data sets and test data sets
33 %Assign one subject to the test data set
34 train_data = full;
35 train_data ([i:i+2,nds+i:nds+i+2],:)= [];
36 train_type = type;
37 train_type ([i:i+2,nds+i:nds+i+2],:)= [];
38 test_data = full([i:i+2,nds+i:nds+i+2] ,:);
39 test_type = type([i:i+2,nds+i:nds+i+2] ,:);
40
41 %Train model
42 switch model_type
43 case 'LDA'
44 Mdl = fitcdiscr(train_data ,train_type);
45 case 'SVM'
46 Mdl = fitcecoc(train_data ,train_type);
47 case 'RF'
48 Mdl = TreeBagger (200, train_data ,train_type);
49 end
50 label = predict(Mdl ,test_data);
51 if strcmp(model_type ,'RF') == 1
52 label = str2num(cell2mat(label));
53 end
54 test_result = sum(eq(label ,test_type));
55 match = match + test_result;
56 end
57 accuracy = match/N*100 ;
58 A(k) = accuracy;
59 end
60 T = array2table(A,'VariableNames ',{'EF', 'EE','P','S','WF','WE','UD','RD','HC','HO'})
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Three levels of health classification
The following code implements classifiers for three levels of health. The training data sets are
developed using 12 data sets randomly from each group in order to balance the number of train-
ing sets representative of each of the three categories. The evaluation is repeated 10 times and
the average of the classification accuracies is determined in order to obtain an estimate of the
classification accuracy.
1 %Three Levels of Health Classification
2 feature_list = {'mflfeat ', 'myopfeat '};
3 model_type = 'LDA'; %LDA , SVM , or RF
4 motion_sets = {'EF','EE', 'P','S','WF','WE','UD','RD','HC','HO'};
5
6 A = zeros(1,numel(data_sets));
7 for k = 1:numel(data_sets)
8 healthy = [];
9 injured = [];
10 %Import feature sets
11 for f = 1: length(feature_list)
12 %healthy features
13 healthy_name = strcat('C:\Users\Emma\Documents\Data\Feature Data\Healthy\',
motion_sets{k},feature_list{f},'.xlsx');
14 healthytemp= xlsread(healthy_name);
15 healthy = [healthy ,healthytemp ];
16 %injured features
17 injured_name = strcat('C:\Users\Emma\Documents\Data\Feature Data\Injured\',
motion_sets{k},feature_list{f},'.xlsx');
18 injuredtemp = xlsread(injured_name);
19 injured = [injured ,injuredtemp ];
20 end
21
22 %Hard Coded Groups of Early and Late Stage Patients
23 early = injured ([1:3 ,7:9 , 10:12 , 13:15, 25:42 ,49:51 ,58:60 , 73:75] ,:);
24 late = injured ([4:6 ,16:24 ,43:48 , 52:57 ,61:72 , 76:81] ,:);
25
26 match = 0;
27
28 %Repeat Classifications 10 times
29 for r = 1:10
30 %Assign training data sets and test data sets
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31 %Assign 13 random patients from each health group
32 %to the training data set
33
34 %Healthy
35 dataset=randperm (27 ,13);
36 msize=numel(dataset);
37 test=dataset(randperm(msize ,1));
38 testn = (1+(test -1) *3) :(1+( test -1) *3+2);
39 train=dataset(find(dataset ~=test));
40 for n = 1: length(train)
41 trainn (1+(n-1) *3:3+(n-1) *3) = (1+( train(n) -1)*3) :(1+( train(n) -1)*3+2);
42 end
43 healthy_train = healthy(trainn ,:);
44 healthy_test = healthy(testn ,:);
45
46 %Early
47 dataset=randperm (13 ,13);
48 msize=numel(dataset);
49 test=dataset(randperm(msize ,1));
50 testn = (1+(test -1) *3) :(1+( test -1) *3+2);
51 train=dataset(find(dataset ~=test));
52 for n = 1: length(train)
53 trainn (1+(n-1) *3:3+(n-1) *3) = (1+( train(n) -1)*3) :(1+( train(n) -1)*3+2);
54 end
55 early_train = early(trainn ,:);
56 early_test = early(testn ,:);
57
58 %Late
59 dataset=randperm (14 ,13);
60 msize=numel(dataset);
61 test=dataset(randperm(msize ,1));
62 testn = (1+(test -1)*3) :(1+( test -1) *3+2);
63 train=dataset(find(dataset ~=test));
64 for n = 1: length(train)
65 trainn (1+(n-1) *3:3+(n-1) *3) = (1+( train(n) -1)*3) :(1+( train(n) -1)*3+2);
66 end
67 late_train = late(trainn ,:);
68 late_test = late(testn ,:);
69
70 %Training Data Set
71 train_data = [healthy_train; early_train; late_train ];
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72 train_type = [ones (12*3 ,1);(ones (12*3 ,1) +2); (ones (12*3 ,1) +1)];
73
74 %Test Data Set
75 test_data = [healthy_test; early_test; late_test ];
76 test_type = [ones (3,1);ones (3,1)+2; ones (3,1) +1];
77
78 %Train models
79 switch model_type
80 case 'LDA'
81 Mdl = fitcdiscr(train_data ,train_type);
82 case 'SVM'
83 Mdl = fitcecoc(train_data ,train_type);
84 case 'RF'
85 Mdl = TreeBagger (200, train_data ,train_type);
86 end
87 label = predict(Mdl ,test_data);
88 if strcmp(model_type ,'RF') == 1
89 label = str2num(cell2mat(label));
90 end
91 test_result = sum(eq(round(label),test_type));
92 match = match + test_result;
93 end
94 A(k)=match /(9*r)*100;
95 end
96 T = array2table(A,'VariableNames ',{'EF', 'EE','P','S','WF','WE','UD','RD','HC','HO'})
B.5 Majority Vote
The majority vote code implements a separate classification for each of the motions in each data
set. The final classification result is the mode of the outputs of the individual motion models. The
weighted majority vote result is determined as the highest sum of the weights. A majority vote
can also be implemented using only the top data sets.
1 %Majority Vote
2 feature_list = {'mflfeat ','myopfeat '};
3 model_type = 'LDA'; %LDA , SVM , or RF
4 vote_type = 'TOP'; %ALL , WEIGHT , TOP
5 switch vote_type
6 case {'ALL','WEIGHT '}
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7 motion_sets = {'EF','EE','P','S','WF','WE','UD','RD','HC','HO'};
8 case 'TOP'
9 motion_sets = {'EF','EE','P','S','WF','UD','HC'};
10 end
11 number_of_subjects = 27;
12 nds = number_of_subjects *3; %Number of data sets
13 N= nds*2;
14 A = zeros(1,numel(motion_sets));
15 match = 0; %Number of correct classifications
16 for i = 1:3: nds
17 final_label = zeros (6, numel(motion_sets));
18 for k = 1:numel(motion_sets)
19 healthy = [];
20 injured = [];
21 %Import feature sets
22 for f = 1: length(feature_list)
23 %Healthy features
24 healthy_name = strcat('C:\Users\Emma\Documents\Data\Feature Data\Healthy\',
motion_sets{k},feature_list{f},'.xlsx');
25 healthytemp= xlsread(healthy_name);
26 healthy = [healthy ,healthytemp ];
27 %Injured features
28 injured_name = strcat('C:\Users\Emma\Documents\Data\Feature Data\Injured\',
motion_sets{k},feature_list{f},'.xlsx');
29 injuredtemp = xlsread(injured_name);
30 injured = [injured ,injuredtemp ];
31 end
32 %Feature Set Arrays
33 full = [healthy;injured ];
34 type = [ones(nds ,1);zeros(nds ,1)];
35
36 %Assign training data sets and test data sets
37 %Assign one subject to the test data set
38 train_data = full;
39 train_data ([i:i+2,nds+i:nds+i+2],:)= [];
40 train_type = type;
41 train_type ([i:i+2,nds+i:nds+i+2],:)= [];
42 test_data = full([i:i+2,nds+i:nds+i+2] ,:);
43 test_type = type([i:i+2,nds+i:nds+i+2] ,:);
44
45 %Train Model
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46 switch model_type
47 case 'LDA'
48 Mdl = fitcdiscr(train_data ,train_type);
49 case 'SVM'
50 Mdl = fitcecoc(train_data ,train_type);
51 case 'RF'
52 Mdl = TreeBagger (200, train_data ,train_type);
53 end
54 label = predict(Mdl ,test_data);
55 if strcmp(model_type ,'RF') == 1
56 label = str2num(cell2mat(label));
57 end
58 final_label (:,k) = label;
59 end
60 %Majority Vote
61 switch vote_type
62 case {'ALL','TOP'}
63 vote = mode(final_label ') ';
64 case 'WEIGHT '
65 %Assign weights based on previous results
66 weights = [71 72.8 67.9 67.9 69.1 63 64.8 67.3 67.3 60.5];
67 healthy_sum = sum(final_label .*weights ,2);
68 injured_sum = sum(abs(final_label -1).*weights ,2);
69 vote = healthy_sum >injured_sum;
70 end
71 test_result = sum(eq(round(vote),test_type));
72 match = match + test_result;
73 end
74 accuracy = match/N*100
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